There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Executive summary
Health is central to the development of any country. Nigeria's gross domestic product
is the largest in Africa, but its per capita income of about ₦770 000 (US$2000) is
low with a highly inequitable distribution of income, wealth, and therefore, health.
It is a picture of poverty amidst plenty. Nigeria is both a wealthy country and a
very poor one. About 40% of Nigerians live in poverty, in social conditions that create
ill health, and with the ever-present risk of catastrophic expenditures from high
out-of-pocket spending for health. Even compared with countries of similar income
levels in Africa, Nigeria's population health outcomes are poor, with national statistics
masking drastic differences between rich and poor, urban and rural populations, and
different regions.
Nigeria also holds great promise. It is Africa's most populous country with 206 million
people and immense human talent; it has a diaspora spanning the globe, 374 ethnic
groups and languages, and a decentralised federal system of governance as enshrined
in its 1999 Constitution. In this Commission, we present a positive outlook that is
both possible and necessary for Nigeria to deliver equitable and optimal health outcomes.
If the country confronts its toughest challenges—a complex political structure, weak
governance, poor accountability, inefficiency, and corruption—it has the potential
to vastly improve population health using a multisector, whole-of-government approach.
Major obstacles include ineffective use of available resources, a dearth of robust
population-level health and mortality data, insufficient financing for health and
health care, sub-optimal deployment of available health funding to purchase health
services, and large population inequities. Nigeria's demographic dividend has unguaranteed
potential, with a high dependency ratio, a fast-growing population, and slow reduction
in child mortality. Effective, quality reproductive, maternal, and child health services
including family planning, and female education and empowerment are likely to accelerate
demographic transition and yield a demographic dividend.
This Commission was written in the context of the COVID-19 pandemic, which has laid
bare the inability of the public health system to confront new pathogens with threats
to human health. However, despite a history of weak surveillance and diagnostic infrastructure,
the scale up of COVID-19 diagnostics suggests that it is possible to rapidly improve
other areas with sufficient local effort and resources.
The Lancet Nigeria Commission aims to reposition future health policy in Nigeria to
achieve universal health coverage and better health for all. This Commission presents
analysis and evidence to support a positive and realistic future for Nigeria. The
Commission addresses historically intractable challenges with a new narrative. Nigeria's
path to greater prosperity lies through investment in the social determinants of health
and the health system.
Addressing multiple, intersecting disease burdens in a diverse population requires
an equal balance between prevention and care
Nigeria is not making use of its most precious resource—its people—by not adequately
enacting policies to address preventable health problems. Health is influenced by
access to quality health services, but other influencing factors lie outside this
sphere. Huge gains in health can and must be made by ensuring adequate sanitation
and hygiene, access to clean water, and food security, especially for children, and
by addressing environmental threats to health, including air pollution.
Nigeria has a young population, yet, despite spending more on health than many countries
in west Africa (mostly from out-of-pocket payment), Nigerians have a lower life expectancy
(54 years) than many of their neighbours. Nigeria's lower life expectancy is partially
due to having more deaths in children of 5 years and younger than any other country
in the world, including more populous India and China and countries experiencing widespread
long-term conflict, such as Somalia. Chronic diseases and a high infectious disease
burden, and an ever-present risk of epidemics of Lassa fever, meningitis, and cholera,
present additional challenges. A rising population and inadequate infrastructure development
over the past 30 years have contributed to increasing deaths from trauma through road
injuries and conflicts driven by inequitable distribution of resources.
Addressing Nigeria's health challenges requires a whole-of-government and whole-of-society
approach to prevent ill health. This means investing in highly cost-effective health-promoting
policies and interventions, which have extremely high cost–benefit ratios, and offering
clear political benefits for implementation. Interventions are needed to improve child
nutrition, reduce indoor and outdoor air pollution, address unmet family planning
needs, and improve access to safe drinking water and sanitation.
Key messages
•
We call for a new social contract centred on health to address Nigeria's need to define
the relationship between the citizen and the state. Health is a unique political lever,
which to date has been under-utilised as a mechanism to rally populations. Good health
can be at the core of the rebirth of a patriotic national identity and sense of belonging.
A commitment to a “One Nation, One Health” policy would prioritise the attainment
of Universal Health Coverage for the most vulnerable subpopulations, who also bear
the highest disease burden.
•
We recommend that prevention should be at the heart of health policy given Nigeria's
young population. This will require a whole-of-government approach and community engagement.
An explicit consideration of equity in the implementation of programmes and provision
of social welfare, education and employment opportunities should be paramount.
•
We propose an ambitious programme of healthcare reform to deliver a centrally determined,
locally delivered health system. The goal of government should be to provide health
insurance coverage for 83 million poor Nigerians who cannot afford to pay premiums.
Implementation of a reinvigorated National Strategic Health Development Plan (NSHDP
III) should be supported by structured and explicit approaches to ensure that Federal,
State and Local Governments deliver and are held accountable for non-delivery. NSHDP
III should be supported by a ring-fenced budget and have a longer horizon of at least
a decade during which common rules should apply to all parts of the system.
•
At the same time, the system should encourage innovation. Future health system reform
should engage communities to ensure that existing nationally driven schemes have local
buy-in and are sustainable. Further, since more than 50% of health services are provided
in the private sector, often with poor quality and high costs, reforming the policy
and regulatory landscape to unleash the market potential of the private sector is
important.
•
We outline options for improving health financing and ensuring better accountability
and distribution of resources. The rationalised governance schemes we have proposed
should improve the efficient use of existing resources devoted to health. Ultimately,
the proportion of spending allocated to health needs to be increased. We envision
a future of Nigeria's health without foreign aid. This will require substantial increase
in domestic investments. Foreign aid (multilateral, bilateral, and philanthropic)
has led to fragmentation of the already complex health development landscape, with
huge asymmetries in legitimacy between foreign actors and the Nigerian state as well
as weak accountability. Defragmenting and decolonizing the Nigerian health landscape
requires domesticating health financing.
•
We recommend a whole system assessment of the invest-ment needs in Nigeria's health
security. The COVID-19 pandemic has exposed the weaknesses of Nigeria's health security
system. Nigeria needs better manufacturing capacity for essential health products,
medicines and vaccines, the provision of diagnostics, surveillance and preventive
public health measures in health facilities and community settings, as well as other
preventive and curative measures.
•
We call on the Federal Government, working with state governments, to fund and lead
the development of standards for the digitisation of health records and better data
collection, registration and quality assurance systems. A National Medical Research
Council with 2% of the health budget and central government funding to award competitive
peer reviewed grants will support high quality evidence and innovation.
Governance and prioritisation of health are the first places to start
We call for the thoughtful use of existing institutions as an approach to achieve
better governance and prioritisation of health. Although corruption has undermined
the Nigerian health system, we can harness existing institutions for the benefit of
population health. All levels of Government in Nigeria (federal, state, and local),
and traditional leadership structures, civil society, the private sector, religious
organisations, and communities, influence health.
Efforts towards a balance between centralisation and localisation should focus on
common policies, standards, and accountability. Concurrently, there is an equal need
for localisation of implementation, meaning actual community and local government
ownership of health service delivery. All three levels of Government are crucial,
and we provide recommendations for each level. Differences in regional needs and context
must also dictate programmes and interventions. What is needed in the northeast, in
a context of ongoing insecurity and a crisis of internally displaced persons, is quite
different from needs in wealthier, more secure urban centres, or in the face of the
different level of insecurity found in oil-producing areas in the Niger Delta.
Prioritisation of health requires additional funds. We have provided a clear investment
case on health to convince politicians and governments that improved population health
will reap political, demographic, and economic dividends. Our call for a whole-of-government
approach to health will allow the delivery of multisectoral policies to address the
social determinants of health, prioritise health-care expenditure to major causes
of burden of diseases, and substantially increase healthy and productive lifespans.
Leapfrogging the health system into the 21st century
Nigeria's health system was built in an ad hoc way, layering traditional community
health systems with colonial medicine aimed at maximising resource extraction. This
origin has resulted in inbuilt inequalities, a dysfunctional focus on curative care,
and a detrimental social distance from users and communities. Post-independence policies
to redress problems have only been partially implemented.
However, the current health system is sprawling, multifarious, disintegrated, and
frequently inaccessible, with very minimal financial risk protection and low financial
accessibility of services. Nigerians variously seek care from medical personnel and
auxiliaries, community health workers, medicine vendors, marabouts and spiritual healers,
traditional birth attendants, and other informal providers. The system relies on a
mixture of quasi-tax-funding, fee-for-service, and minimal health insurance coverage.
What kind of health system do Nigerians deserve, and should the country's leaders
work towards? The core need of most Nigerians today is for accessible basic health
services, and for this to be achieved, improvements in public sector delivery supported
by an enhanced complementary private sector, including faith-based organisations,
is the way forward.
We lay out a path for Nigeria to move towards a system that, although remaining diverse,
better serves the needs of the population. Within this diversity, we believe there
is an opportunity for a “one nation and one health” approach, whereby Nigeria guarantees
a minimum standard and delivery of health care for all with an emphasis on strengthening
public and private (including faith-based and non-profit) systems. Nigeria should
also leverage the private sector for certain functions, such as expanding innovation,
discovery, and manufacturing capacities to claim a leadership role on the African
continent and globally. Government investment in private industry should be mission-driven,
supporting innovation and claiming dividends for society from its investments.
Core functions of the health system require immediate attention, in particular, good
quality health data. This Commission strongly recommends better recording, storage,
and use of data. Paper systems are unworkable. A drive towards digitisation can result
in major improvements, for both patient care and devolved health decision-making.
Mobile digital technologies should allow a relatively rapid expansion of population
health data and linked existing datasets. Human resources in rural and poor regions
of the country are worsened by brain drain. We propose prioritising the optimal development
and redistribution of health workers at all levels.
Financing health for all by rationalising contributions from insurance, out-of-pocket
payments, donor funding, and taxes
A viable health system requires dedicated, efficient, and equitable health financing
mechanisms, complemented by optional health insurance. Countries with systems comparable
with Nigeria's, such as Ethiopia and Indonesia, have planned or implemented ambitious
programmes to deliver health insurance coverage.
Nigeria's public health system should be supported by a comprehensive health insurance
system for all people, funded using through both contributions and taxation, with
trials underway in states such as Anambra. Access to health insurance for society's
most vulnerable people must be government funded. Considerable political will is needed
to bring a greater proportion of the informal sector accessed by most Nigerians under
government governance mechanisms.
There is also a need to expand the fiscal space by increasing overall government revenue,
which will lead to higher health funding, allowing health and the determinants of
health to be addressed. Achieving these financing goals will require an optimistic
political economy approach, considering current context, alongside future steps. A
starting point could be explicit declaration by governments at all tiers that the
achievement of universal health coverage is a priority goal.
Nigeria is a country with so much wealth in terms of human talent and potential, but
also beset by challenges, including inadequate provisions for optimal health-care
delivery and well-being of its people. For Nigeria to fulfil its potential, the leaders
and people alike must embrace the implications of what they know already—that health
is wealth.
Section 1: introduction
Nigeria is at an important crossroad. Nigeria's population is projected to increase
from approximately 200 million people in 2019 to an estimated 400 million in 2050,
and 733 million people by 2100,
1
becoming the world's third most populous country after India and China. These estimates
assume that the average number of children per mother will decline from 5·1 currently
to 3·3 on average by 2050 and 2·2 children on average by 2100. If this projected decline
in fertility is to fall short by half a child per mother, Nigeria's population will
reach 985 million by 2100. The potential gain from this expansion will only be possible
if population growth is managed and supported by equitably distributed prosperity.
A rapidly rising population, coupled with the absence of reliable access to high-quality
health care, education, and other public services will serve only to increase the
potential for unrest, drive large-scale unplanned migration, and consequent regional
and even global destabilisation. A large population of uneducated and unemployed youth
risks further instability and security challenges.
2
These demographic and socio-economic challenges are further compounded by climate
vulnerability. Nigeria is one of the ten countries most vulnerable to climate change
3
due to extreme weather, rising sea levels, and increasing land temperature.
4
Conversely, a healthy and secure Nigerian population living within planetary boundaries
could make untold contributions to human progress, now and in the future. Accordingly,
integrated efforts to address health inequalities and climate vulnerabilities is a
crucial priority for the country.
5
If the right policies are implemented, Nigeria is poised to become a global superpower.
6
Nigeria's significance to global health and the health of Africans is self-evident,
particularly considering its large and mobile population.
7
Major health gains in Nigeria should improve health outcomes in Africa by directly
improving health security and through the sharing of good practice and policy to neighbouring
nations.
But Nigeria faces numerous challenges in confronting both population growth and climate
vulnerability ensuring a healthy future for its population. The country did not achieve
any of the health-related Millennium Development Goals (MDGs), and progress towards
health-related Sustainable Development Goal (SDG) targets has been modest at best.
8
According to almost all health metrics, Nigeria's health outcomes are dismal with
inadequate progress made over the past three decades for the majority of its population.
Investment in health is low at 4% of GDP in 2018,
9
whereas substantial resources continue to be spent fighting insecurity without addressing
its root causes, and sustaining a large and complex governance structure, with too
little left over for health and education. The macro-fiscal environment is not favourable,
with only modest economic growth and a sharp worsening of the economic outlook due
to the COVID-19 pandemic.
10
Conversely, given Nigeria's low starting base, reforms towards achieving universal
access to high-quality public health services have the potential to achieve large
positive effects on population health outcomes.
Despite its considerable human and material assets, achieving universal health coverage
will be challenging. The modest resources allocated to health have been mismanaged
by successive governments since independence in 1960. A series of national plans,
strategies, and policy documents have only ever been partially implemented, with missed
opportunities to apply health as a tool for development. Given the scale of the challenge,
there has also arguably been an inadequate focus, with the most recent plan outlining
48 strategic objectives.
11
Several policy documents allude to “quality, effective, efficient, equitable, accessible,
affordable, acceptable and comprehensive health care services” for all Nigerians,
11
yet these goals are elusive. Nigeria's most recent development plan ended in 2020
with, at best, partial success,
12
presenting an opportunity to better frame health as a determinant of national achievement
in the next plan. There are immense opportunities to alter Nigeria's population health
and economic development trajectory, if only they can be seized. Reducing maternal
and child mortality and unmet need for family planning are basic first steps to improve
families' well-being, with implications for security, resource utilisation, economic
growth, and shared prosperity. Reducing the burden of HIV, tuberculosis, malaria,
and other communicable diseases will change the epidemiological landscape, allowing
greater scope to simultaneously tackle rising non-communicable diseases. Taking bold
multisectoral preventive action on the determinants of health can in turn prevent
and even reverse the rise of non-communicable diseases. Government action needs to
move away from treating disease to creating health. And importantly, such efforts
must be integrated with climate action for healthy resilient futures.
The Lancet Nigeria Commission aims to reposition future health policy in Nigeria to
achieve universal health coverage and better health for all. A detailed critical evaluation
of the historical and current challenges facing the health of the country is presented
to contextualise recommendations for the future. There is a distinct opportunity to
redefine the national social contract using health benefits to the most vulnerable
households as a key element of the relationship of citizens to the state. And despite
the country's reputation for intractable governance, developments over the past two
decades have shown that positive reforms are possible. The initiation of the Basic
Health Care Provision Fund scheme and the introduction of state health insurance have
provided an important starting point for future reform towards universal health coverage.
Improvements in infectious disease surveillance led by the Nigeria Centre for Disease
Control (NCDC) have resulted in timely national data reporting on outbreaks of COVID-19
13
and monkeypox.
14
Similarly, the completion of the largest ever population-based HIV/AIDS survey by
the National Agency for the Control of AIDS (NACA)
15
within the allocated budget and on time illustrates what is feasible. Success will
depend on effective implementation of a coherent set of policies, by translating evidence
into action and measuring effects on population health. In this Commission, we aim
to present a new path to better health with consequences on development, wealth creation,
and strengthening of human capital, notably by proposing comprehensive approaches
for improving all components of health care in Nigeria (panel 1).
Panel 1
Overview of Commission recommendations
Nigeria has a great opportunity to implement policies that effectively promote population
health. Well-intended and seemingly well-designed policies, including most recently
the second National Strategic Health Development Plan (2018–22), have often struggled
in the past to meet objectives due to poor coordination of a complex multipartner
system in the implementation phase and insufficient stakeholder and community engagement,
inadequate legal frameworks, perverse incentives, insufficiently robust accountability
mechanisms, inadequate adaptation to Nigeria's federal structure, and suboptimal allocation
and utilisation of funds. There is now a chance that Nigeria can build on lessons
of the past to chart a new course into the future.
Our recommendations build on lessons from within Nigeria's national and state health
systems and the experiences of countries that have been more successful in tackling
similar challenges. Some of these would require modest resources and be easier to
implement, whereas others would require consultation and more fundamental reform.
Building on the work of colleagues, we reiterate and reinforce recommendations from
previous policy documents, adding evidence-based views on how they can be implemented
and by whom.
We call for a new social contract centred on health as a transformational way to define
Nigeria's relationship between the citizen and the state. One approach to achieve
this goal is committing to a “One Nation, One Health” policy, by offering Universal
Health Coverage through greater allocation of ring-fenced resources underpinned by
strong accountability systems. This slogan also makes a rhetorical link to the One
Health paradigm, which recognises the interconnection between all people, animals,
plants, and their shared environment, and the need for a collaborative, multisectoral,
and transdisciplinary approach at the local, state, and national levels. Nigeria should
also radically revisit its strategy in seven key areas connected to health.
Recommendation 1
Political leadership should operationalise previous recommendations to adopt a multisectoral
response to health (ie, Health in All Policies) via cabinet-level orders to implement
a whole-of-government approach. Each government agency should define goals and indicators
aligned to achieving health targets, led by the presidency and with strong funded
coordination of the complex multipartner structure by the Health Ministry, National
Economic Council, and state governments to:
•
Prioritise health investments to address key social determinants of health including
adequate sanitation, access to clean air and water, and food security, especially
for children
•
Consider a standing multisector council on hygiene to coordinate actions of various
stakeholders towards prevention
•
Enforce existing government policy and regulation on products that are known to be
detrimental to health and elevate the risk of non-communicable diseases including
sugar-sweetened beverages, ultraprocessed foods, skin lightening cosmetics, and tobacco
as outlined in the 2019 National Multisectoral Action Plan for the Prevention and
Control of non-communicable diseases, through non-regressive levies and taxation
•
Address population growth through improving access to modern contraceptive methods
at all health-care levels, female education, and increasing the age of sexual debut
•
Adopt an integrated planetary health governance approach, including tackling sources
of indoor and outdoor air pollution, and other environmental risk factors, in rural
areas and urban centres with a focus on protecting the poor through improved housing
and access to clean cooking fuel and enforcing limits on pollution from industrial
and transportation sectors, and incentivising transition to renewable energy sources
such as solar energy—Kenya provides an example that could be emulated, with the inclusion
of health impacts and health in climate adaptation measures into Nationally Determined
Contributions, placing health at the centre of policies to reduce emissions in the
energy, food, agricultural, and transport sectors for both health and economic returns.
16
•
Integrate health and health service delivery into climate adaptation strategies (examples
include integrated surveillance of flood risk and water-related illnesses, climate
vulnerability assessments of primary care clinics in communities to limit service
delivery interruption in the event of extreme weather events, and urban design that
ensures equitable access to green space to reduce land surface temperatures and heat-related
illnesses)
•
Ensure a multisectoral response that is implemented by Functional Health units, which
should be opened in all ministries, departments, and agencies at the federal and state
levels where they do not exist, which would ensure that all ministers have a planetary
health portfolio with the explicit responsibility of assessing the human health and
ecological impact of any decisions, strategies, and policies;
17
using the performance of this portfolio as an indicator against which all sectors
are assessed to encourage and support health creation that is cognisant of climate
realities
•
Explicitly require equity assessments in the implementation of programmes and provision
of social welfare, education, and employment opportunities by federal and state governments
•
Systematise a delivery approach across the spectrum—performance management and accountability
systems, building on successful application of Emergency Operations Centres as delivery
units.
Recommendation 2
Federal government, with full engagement of the National Assembly, state and local
governments, civil society organisations, the private sector, community groups, development
partners, and technical oversight and funded coordination of implementation by the
Ministry of Health, should lead a comprehensive reform of the health sector, led by
the presidency, to inform the next National Strategic Health Development Plan (NSHDP
III) premised on a collectively determined but locally delivered health service, building
on policy reforms over the past two decades
•
Unify national health delivery standards, improve supply chains, and incentivise manufacturing
through national legislation, with funding from the federal level in consultation
with state governments
•
Build the capacity of local government health officials to deliver basic health services
and products based on minimum national standards through state government legislation
to prioritise health and support local government implementation
•
Define responsibility for governance, purchasing and provision in the health system
with oversight and policy formulation led by the Federal Ministry of Health at the
national level and State Ministries of Health at the state level
•
Maintain high-quality state-government services and enable private sector-run health-care
services that are evaluated using federally-led performance management systems for
monitoring, evaluation, and quality assurance, using best practices for incentives
and penalties linked to targets
•
Ensure that auditable public financial management and accountability mechanisms for
commissioning and purchasing are developed to improve transparency, efficiency, and
equity, and eliminate corruption in the deployment and use of resources
•
Build on the improvements in national and state level surveillance and diagnostics
achieved through the response to COVID-19 and allocate specific resources to ensure
sustainability
•
Unlock the potential of health-care markets across the value chains
Recommendation 3
The federal government should lead efforts to improve health financing (ie, revenue
mobilisation, pooling and management of funds, and purchase of services), aligning
the investment case with political incentives, levers of accountability, and the rhetorical
appeal of “health for wealth” among the Nigerian population. To achieve these improvements
the government should:
•
Establish legally ring-fenced predetermined health budgets outside of the electoral
cycle, which occurs every 4 years to ensure sustainable funding and strategic planning
building on the Basic Health Care Provision Fund, and using the third National Strategic
Health Development Plan to reach the goal of 15% of the annual budget allocated to
health
•
Establish structural reforms to withdraw inequitable subsidies towards financing health
and social services building on lessons from the Presidential Task Force on COVID-19
(eg, 1·5 trillion Naira in petroleum subsidy can free up fiscal space to be redirected
towards health)
•
Fund health insurance coverage to all Nigerians by paying the estimated 15 000 Naira
per capita annual premium for 83 million least wealthy individuals (approximately
40% of the population) with revenue raised through the Basic Healthcare Provision
Fund, taxation, and levies, and each state to fund residents through their state health
insurance scheme supported by a national mechanism to assure quality; today, it would
cost 1·2 trillion Naira or 9% of the current budget to cover individuals who cannot
afford to pay current premiums in National and State Health Insurance Schemes
•
Improve the efficiency of systems for pooling and purchasing of health finances by
establishing national and state purchasing organisations with oversight for allocation
of funds, raised through revenues generated from taxation, levies, or donors, and
the payer at each level should use strategic health purchasing to provide more health
services using available resources
•
Increase the national fiscal space for health through more efficient tax collection
(company profit tax, and capital gains) and through innovative health financing such
as levies on commercial services (eg, mobile phone use, financial transactions, and
air travel) to reach the existing goal of reducing the proportion of out-of-pocket
expenditure to below 30% by the end of NSHDP III and improve health outcomes
•
The federal government should anticipate donor transition and prepare for post-aid
status in which technical assistance, knowledge, and learning are more relevant than
donor projects, which will require domesticating financing of health, research, and
development, to achieve health independence and decolonise the Nigerian health space.
Local institutions must be prepared to step up.
Recommendation 4
Federal and state governments should leverage public–private partnerships based on
accountability, mutual trust, information sharing, and joint planning to overhaul
Nigeria's dilapidated hospital infrastructure and support manufacturing by:
•
Creating an enabling environment for functional health markets while protecting the
poor, supported by sound policies, regulations, and access to long term capital
•
Using private sector capital to modernise and expand the capacity of hospitals with
appropriate accountability mechanisms
•
Investing in a coherent state supported and private sector-led approaches to increase
local production of vaccines, medicines, and other health products and services
Recommendation 5
Federal and state governments should collaborate to address deficiencies and imbalances
in the health workforce by engaging in dedicated planning to train and retain adequate
numbers of staff at all levels.
•
State Ministries of Health should, based on national standards, engage in regular
workforce planning reviews to determine the number and type of staff needed at regular
time horizons and establish incentive systems to allocate health workers appropriately
and specifically increasing incentives to work at primary health care level
•
State governments should work with the main health worker regulatory bodies to ease
the process of licensure and tracking of members at state level
•
The federal government, through the Ministry of Education, should consider expansion
of quality medical and allied health professional training to boost human resources
and talent
•
Federal and state governments should jointly develop and implement strategies to retain
staff through career development support, appropriate remuneration and other measures
to discourage brain drain between rural and urban areas and internationally
Recommendation 6
Federal and state governments should actively manage the demand for health and health
services by engaging communities, with a focus on areas such as vaccine hesitancy
and the quality and acceptability of government-provided maternity services
•
Using adapted guidance from the federal level, local governments should conduct regular
consultations to gain a full understanding of community health needs and desires and
co-create delivery systems that respond to these needs while ensuring minimum national
standards
•
State and local governments should establish state-level health forums that meet every
6 months to address local issues with membership drawn from Ward Development Committees
across the state
•
The federal government should create a national health forum as a deliberative platform
for bringing together a wide and inclusive range of stakeholders to discuss complex
health challenges, and to provide meaningful and substantive input to NSHDP III
•
The federal government should strengthen the voice of citizens using technological
and mobile platforms to amplify voices of citizens on needed reforms and accountability
Recommendation 7
Define and urgently implement enhanced research and data systems to support planning,
monitoring, and accountability at all levels
•
The federal government should create a Nigeria Medical Research Council, with permanent
federal funding, to strengthen and coordinate health and health-care research; the
establishment of the council should be informed by a thorough review of existing research
to know where the gaps are. A competitive funding programme targeting investigators
at universities, hospitals, and research institutions and complementing other extramural
funding systems such as the TETFund should identify research areas based on Nigeria's
burden of disease, with priority given to conditions affecting the poorest and most
vulnerable
•
The federal government, through the Ministry of Health and National Bureau of Statistics,
should set national standards for the digitisation of health records, building on
existing systems such as District Health Information System version 2, the Surveillance
Outbreak Response Management and Analysis System, and the National Health Logistics
Information System to improve preventive and curative care, support decision making,
and guide system management at all levels. Local and state governments should maintain
ownership of local digital infrastructure, using federal funds. Data assurance mechanisms
based on a non-blame culture and regular audit cycles improving the quality and timeliness
of information, combined with rapid feedback and local use of all collected data,
will show value. Federal and state governments should co-fund these data systems,
including the cost of internet access for all health workers and access to appropriate
technology. The evidence we have reviewed in this Commission suggests digitisation
is good value for money
•
Federal laws should link access to services and entitlements with registration of
births and deaths, and systems to show the value of such data for the economy and
to achieve the engagement of civil society. Federal, state and local governments should
review existing legislation and develop an action-oriented implementation plan to
improve vital registration systems in close collaboration with local stakeholders
and institutions such as religious and traditional leaders
Post Commission phase
This Commission aims to inspire the next phase of Nigeria's health journey, using
evidence-based recommendations to influence the programme of work of the Nigerian
Government and its development partners. In tandem with this Commission, we have designed
a programme of strategic engagement with key influencers in and out of government,
at federal and state levels, to ensure wide dissemination and uptake of key messages
among the broader community of policy actors, including the National Assembly. For
specific policy makers, we will disseminate the evidence generated through policy
briefs and policy roundtables. We will also use the report to generate further discussions
using targeted convenings, innovative science-arts approaches, media outreach including
via high profile opinion pieces and social media-based delivery of tailored messages
for key audiences, including civil society and development partners.
We also hope and expect that co-production of the evidence presented here with members
of the target audience, the Nigerian health policy community, will facilitate appropriate
and prompt dissemination of our recommendations. We also acknowledge that positive
attitudinal change by both the leaders and citizens is key in achieving optimal health
outcomes and prosperity in the country. Several senior leaders in the health sector
and beyond are contributing to the public engagement strategy to ensure the Commission
reaches the right actors. It is intended that through liaison with the two major political
parties and by influencing the planned Health Reform Committee of the current government,
this Commission will directly set the pace for changes over the next decade. We will
continue as a group of experts to work with civil society groups, the Nigerian Government
and the legislature to advocate for the changes recommended in this Commission and
summarise progress towards implementing the recommendations in future reports and
on the Lancet Nigeria Commission website. By setting out the challenges, synthesising
the evidence, and outlining bold recommendations for action, this Commission presents
an opportunity for Nigeria to achieve optimal health outcomes and prosperity ensuring
that “health is wealth”.
Our Commissioners combine expertise in the diverse disciplines required to shape national
health policy, including public health and epidemiology, political science, history,
economics, public policy, sociology, demography, law, anthropology, and health systems.
We ensured representation with respect to gender and local origin, included a range
of political and health policy views among experts based within and outside Nigeria,
and consulted with a diverse group of policy stakeholders to provide insight into
the challenges of delivering health and health care in Nigeria. From the outset, we
set a 10-year timeframe for our analyses, looking beyond the lifespan of the current
Nigerian Government, to ensure relevance to current and future administrations in
Nigeria. The core values that underpin this Commission are fairness, equity, pragmatism,
and evidence-driven approaches.
The Commission focuses on generation and synthesis of evidence to inform policy and
programme implementation, with a view to building a strengthened health system that
meets the needs of all Nigerians. First, we review Nigerian history to understand
current structures and systems by rooting them in pre-colonial, colonial, and modern-day
trends and events. Second, we analyse the country's disease burden, the major causes
of morbidity and mortality based on the best available data and models, and projected
future trends where possible. Third, we analyse Nigerian health systems and policy,
and intersectoral governance and policies that influence health beyond health care,
and articulate key challenges and suggested systems-level leverage points. Fourth,
we combine health economic analyses with the work on disease burden to generate evidence
on the most cost-effective combination of interventions to achieve health goals and
summarise approaches to improve health financing. Our concluding section brings together
these analyses in the form of specific recommendations and an agenda for action. Finally,
we use case studies throughout the Commission to illustrate the lessons, gaps, and
opportunities for action. Well-functioning health systems generally prevent maternal,
neonatal, and child deaths, and thus we have presented one case study per section
of the Commission on this subject.
Section 2: evolution of a health system skewed away from population needs
Pre-colonial community health systems provided broad access to holistic care
Organised systems of health-care delivery and disease control have long been present
in the territory now known as Nigeria. In the centuries preceding colonial rule, this
region was governed by the Hausa States and Kanem-Bornu Kingdoms in the north and
the Oyo and Benin Kingdoms in the south. In the southeast, the Igbos used an alternative,
more decentralised, governance system, as did numerous other ethnic groups (over 350
ethnic groups inhabit the country today).
18
Each sovereign area operated its own form of traditional medical care. The dibia of
the Igbo peoples, wombai of the Hausa, and the adahunse of the Yoruba peoples were
widely trusted to deliver traditional medical care.
19
Although belief systems and social structures, including health care, varied across
these societies, the practice of divination, incantations, exorcism, and other spiritual
practices to provide care was commonplace in pre-colonial Nigeria.
18
Diagnosis and treatment were based on notions of complete therapy and cure, accounting
for the individual patient's cultural, social, and physical environment. In particular,
diagnosis included sociocultural analysis of the patient's situation, and therapy
was sometimes an avenue to cement fragmented relationships between individuals and
offended spirits.20, 21 As many still do today, traditional medical practitioners
used leaves, roots, tree bark, animal parts, and minerals from the soil in preparing
remedies to heal or prevent unpleasant health events in the lives of their clients.
19
Health systems were structured so that every community had a full-time healer and
nearly every extended family had a part-time healer who could treat common minor ailments.
20
More serious health problems were referred to a qualified medicine man or woman, as
indeed the agricultural surpluses of pre-colonial economic systems allowed for the
creation of specialist trades.
20
Although some healers possessed an integrated body of knowledge of the causes and
treatments of diverse illnesses, others (eg, medicine men, diviners, midwives, magicians,
bonesetters, and barber-surgeons) concentrated on specific biopathological and social
aspects of health. In each community or village, it was not uncommon to find specialists
who attended to pregnancy and birth, child health, general welfare, bewitchment, diarrhoeal
diseases, and complicated cases such as arthritis.
20
Consequently, all members of society had access to some basic health services from
a healer.19, 22, 23 In modern terms, the health-care delivery could be said to follow
a community-based approach, rendering it accessible to much of the population,
24
with referral systems to specialised healers. Patients with chronic illnesses or incapacitated
individuals (eg, people with severe mental illness and leprosy) stayed in special
treatment rooms in the practitioner's compound until they were better, whereas those
with acute or non-incapacitating illnesses (eg, childbirth or delivery complications,
accidents, and bewitchment) were usually treated in their own homes.
However, pre-colonial Nigeria was not a classless society and so access to some health
services was unequal. Although treatment and care were sometimes paid for in kind,
19
those with greater wealth, power, and prestige had more access to the most expensive
forms of medicines available, such as for bewitchment.
25
During the period of state formation that preceded colonialism, population inequities
grew substantially. Currency devaluations (in currencies including cowrie shells and
copper manillas) and the increasingly virulent trade in enslaved people resulted in
societies that were more militarised, stratified, and predatory, sowing the seeds
of mistrust of government authorities that is still a factor in state–society relations
today.
26
Yet during this era, the role of the traditional healer was not (fully) commodified;
in all ethnic groups, healers had a common role of providing care to all individuals
in their communities.
Colonial health care services laid the foundation for today's inequitable health system
The introduction of Western medicine to Nigeria's pre-colonial societies began with
the first incursions of western European traders in the early 15th century and was
linked to primarily commercial and extractive ends. During the transatlantic slave
trade beginning in the 16th century, doctors were brought to deliver health-care services
to slave traders and later to guarantee traders' investments by assessing enslaved
people's fitness for travel.
27
Endemic diseases such as malaria largely impeded European incursions into the interior
of the continent. However the use of quinine as prophylaxis and therapy for malaria
beginning in the mid-19th century was a major boon for the imperial agenda,
27
making it easier for Europeans to stay longer, venture further inland, and engage
local chiefs and kings in treaties of commerce and so-called friendship, ultimately
allowing effective colonisation.
Early colonial authorities established health facilities in cities and towns near
the Atlantic coast in Lagos and Calabar, and in Lokoja, the capital of the British
Northern Nigeria protectorate, for the use of European merchants, military men, colonial
officials, and, much later, Africans employed in mining and construction.
27
As colonialism gained momentum from the 1860s onwards, mission hospitals also began
to appear. Like colonial government hospitals, these were concentrated in Lagos (table
1). Mission hospitals were rarely funded by the colonial government, yet they served
the political interest of promoting colonial rule, as preferential treatment was given
to Nigerians associated with the Christian mission.
29
With health services concentrated in urban areas, there was little to no provision
for people in rural areas who were less economically valuable to the imperialists.
The colonial state-organised Rural Health Units were stifled by funding shortages.
30
Indigenous healers were still the main providers of health services to most of the
population.
Table 1
Regional distribution of Nigerian hospitals (1895–1960)
21
alongside estimated population (1963)
North
East
West
Lagos
Total
Government
39
26
24
12
101
Mission
31
16
1
70
118
Unknown*
14
11
5
1
31
Total (%)
84 (34%)
53 (21%)
30 (12%)
83 (33%)
250 (100%)
Population – Total (%)†
29·8 million (54%)
12·3 million (22%)
12·8 million (23%)
675 000 (1%)
55·6 million (100%)
*
Leprosarium, nursing homes, and others. Could include some government-owned and mission-owned
facilities.
†
Data are from the Institute of Current World Affairs
28
Colonial medical services established the basis for Nigeria's medical and nursing
schools, and introduced primary health care (PHC) and hospital care grounded in allopathic
medicine. However, the extractive colonial agenda shaped Nigeria's nascent allopathic
health system in other ways. The colonial state showed a particular concern for maternal
and child health as reproduction promoted population growth and therefore, the expansion
of British imperial interests.
31
Somewhat paradoxically, British health services otherwise maintained a curative bias,
with much less emphasis placed on preventive activities such as immunisation, health
education, and environmental sanitation. Environmental health campaigns were generally
aimed at protecting the European population; for example, Governor of Lagos' massive
antimalaria campaign that was initiated around 1900 drained swampy areas and sprayed
insecticide to prevent mosquito breeding. Boots, nets, and quinine were distributed
only to government officials and their families. Even in the late colonial era, campaigns
like the Rockefeller Foundation-funded Yellow Fever Initiative in West Africa, were
motivated more by global biosecurity concerns stemming from the rampant spread of
yellow fever in countries including the USA, rather than by concern for Africans'
health.
32
The human resource demands of the pre-colonial health system were initially met primarily
by European doctors and medical staff. Under the sponsorship of the Church Missionary
Society, James Africanus Beale-Horton and William Broughton Davis were the first Nigerian
doctors trained in Scotland in 1858, although neither practiced in Nigeria.
33
The first Nigerian doctor to practice within the country was Nathaniel King who qualified
in 1874.
33
It was not until 1930 that the Yaba Medical Training College in Lagos began training
assistant medical officers, and it was not until 1952 that the first teaching hospital
in Nigeria, the University College Hospital Ibadan, was established, finally allowing
for domestic training of medical and nursing personnel. After the World War 1 and
World War 2, many Nigerian physicians became members of the Nationalist Movements
demanding better conditions and equality from the colonial government.34, 35 One response
of the colonial government to nationalist agitations was to extend modern health services
to all Nigerians, one of several factors leading to the issuance of the 10-year National
Development Plan (1946–1956), which projected the building of new hospitals, rural
health centres, and nursing training schools. It was during this timeframe that a
Ministry of Health was established and health services from all stakeholders, such
as the missionaries, colonial government, and trading companies, became centralised.
However, the plan continued the prior emphasis on curative services, and there was
no budgeted funding for sanitation, health education, or other preventive health-care
services. Most new health facilities were in the southern region of Nigeria, mainly
in urban areas, as opposed to the rural areas where they were most needed.
20
Independent Nigeria's recurring crises and governance challenges hinder efforts to
improve population health
Nigeria's independence in 1960 ushered in new hopes to realign state and society and
re-orient public spending and governance towards the good of the population. For example,
in the 1960s, following the Ashby Commission report,
36
second-generation medical schools were established in Zaria in the north of Nigeria,
Lagos and Ilé-Ifé̀ in the west, and Enugu in the east. Unfortunately, recurring economic
crises and ongoing political instability, with a series of military coups in 1966,
1975–76, 1983, 1985, 1993 and persisting until 1999, created a challenging environment
for sustained reform. Since the return to democracy in 1999, the political situation
has arguably stabilised, albeit with ongoing popular agitation rooted in grievances
about the allocation of political and economic benefits. Insecurity is still a major
problem in many parts of the country, as are fragile and incomplete democratisation
and fiscal weakness. Taken together, these trends have complicated durable progress
towards improving population health.
27
The development of the PHC system in the 1980s and the 1990s under the leadership
of Professor Olikoye Ransome-Kuti is a notable exception. Prof Ransome-Kuti, as the
health minister, helped develop the first National Health Policy in 1988, and led
the introduction of the PHC model in 52 pilot Local Government Areas (LGAs), with
the primary focus of promoting preventive medicine at the community level. Among other
successes, child immunisation coverage reached over 80% by 1990, meeting the Universal
Child Immunisation target.
37
To ensure the continued progress of PHC service delivery, the National Primary Health
Care Development Agency (NPHCDA) was established in 1992. However, the 1993 military
coup d'état hastened the collapse of the PHC system and brought an end to the giant
strides recorded under the leadership of Ransome-Kuti from 1985 to 1992, and other
successes from that period, for example in immunisation coverage, have also not been
sustained to the present day. Although PHC is a focus of health reforms—for example
with the 2011 Primary Health Care Under One Roof policy, which integrates PHC service
delivery under one authority—implementation by states and local governments has been
slow and fragmentary.
Key informants familiar with the development of the Nigerian health system in the
post-independence period offered varying explanations, many of which appear linked
to underlying political issues such as citizens' inability to hold leaders to account
(panel 2). Although the colonial inheritance of a generally weak, unequal, curative-oriented
system offered a poor start to independent Nigeria, there has arguably been a failure
to re-establish a social contract, including an underlying ethos and expectation of
the government's duty to provide health-creating conditions, including a functioning
basic health system.
Panel 2
Key informants' views of constraints to the development of the Nigerian health system
in the modern era
We interviewed key informants with direct personal knowledge of the development of
the Nigerian health-care system in the modern post-colonial era. Respondents included
professors of medicine, former ministers of health, and traditional rulers. They identified
key determinants in the development of the national health system:
•
Political volatility and constant shifts in political structures meant that positive
health reforms were not sustained and consolidated into durable health systems improvement
•
Development plans were ineffectively implemented and deployed due to delayed execution,
neglect of community stakeholders, non-involvement or limited consultation with medical
experts, inadequacy of resource commitment, and neglect of integral policies and institutional
structures to enable continuity
•
Infrastructural projects were prioritised instead of fundamental development projects
designed to effectively tackle Nigeria's persistent health system deficiencies
•
Political leaders perceived that investing in the development of efficient health
structures would not yield immediate returns, both economically and in terms of goodwill
and attribution of success from the served population
•
Inadequate funding resulted in degradations of infrastructure and human resources,
including the so-called brain drain of qualified personnel
•
Constitutional provisions for health are vague, resulting in unclear distribution
of responsibilities across governance levels
•
Primary health care reform attempts were undermined by a failure to engage with communities
to raise awareness, clarify individual responsibilities, or solicit inputs in the
reform processes
•
Attempts to restructure the three tiers of health-care service delivery occurred in
complete isolation, leading to the overburdening of whichever tier was most functional
at the period in question
•
Political attitudes characterised by narrow individualism and widespread corruption
have played a major role in perpetuating the current dysfunctional state of the health
sector
See appendix for methodology
One key challenge has been Nigeria's complex, opaque, and poorly specified governance
arrangements, which obscure constitutional responsibility and accountability. Since
1979, Nigeria's federal presidential system has divided responsibilities between federal,
state, and LGAs, and although the 1999 constitution asserts that “The State shall
direct its policy towards ensuring that there are adequate medical and health facilities
for all persons”
38
(a provision it transparently does not meet), little further detail is enshrined about
how this entitlement is meant to be delivered. Since the 2014 National Health Act,
the tertiary level of care is nominally the responsibility of the federal government,
states manage secondary healthcare, and the primary level, including PHC centres,
are managed by LGAs. In reality, the separation is non-existent as states still have
their own tertiary care facilities, whereas for primary care, the federal government
provides a regulatory advisory function, alongside centralised provision of some services
(such as immunisation) and finances infrastructural improvements through the NPHCDA.
The poor delineation of responsibilities among these levels has resulted in a complex
and contested distribution of resources, a referral system widely agreed to be defective,
and an unclear responsibility structure that frequently results in neglect at all
three levels. This division of responsibilities partly explains why primary care is
generally weak in Nigeria as responsibility for this critical level of care has been
devolved to the weakest level of government (ie, LGAs) while control of primary care
resources is driven by the state governors.
The division between federal, state, and local obligations also risks entrenching
historical inequities between geographical regions, with areas that were formerly
highly centralised and autonomous during colonial rule (eg, in the north of Nigeria)
resisting federal autocratic regimes, which has led to retaliation through under-investment
in federal services.
39
These trends can help explain some of the greater concentration of hospitals (managed
at tertiary level) and other formal health structures in the south as compared with
the north (figure 1), despite the proportionally larger population in the north. Subsequent
investment by the state governments and the private sector further ensured that the
density of hospitals and health centres in the south of Nigeria improved and diverged
further post-independence. Furthermore, although the rural population constitutes
about 50% of residents, it is served by fewer health facilities.40, 41
Figure 1
(A) Distribution of public hospitals, health centres/clinics and dispensaries in Nigeria
(2019), (B) Number of health facilities per 100 000 population and (C) Health infrastructure
quality index by state, 2012
Further compounding these issues, population health has not been highly prioritised
in national and state budgets throughout Nigeria's modern history. It is difficult
to escape the conclusion that the political will to deliver “health for all”, including
universal health coverage, has been grossly inadequate, due to in part the population's
limited ability to effectively demand improved health services. Since the 1970s, financial
gains from oil revenues have been a funding source for health, albeit one that political
leaders have repeatedly failed to harness. Political turnover has not been an impetus
for change; for example, the dire state of the health system was cited as one of the
reasons for the 1985 coup overthrowing General Muhammadu Buhari,
42
however his successor, General Ibrahim Babangida, allocated only 2·7% of the national
budget to the health sector.
35
Following the collapse of petroleum prices thereafter, Nigeria was subjected to the
well-documented ravages of the Structural Adjustment Programme, during which both
allocation to the health sector and per capita expenditure on health were reduced.
43
Out-of-pocket payments have since become the most common mechanism of financing health
care for individuals and households,
44
creating a cost barrier and decreasing the use of health-care services and adherence
to medications. Prospective patients are thus driven to use traditional medicine,
which is easily accessible and relatively affordable.
Government health expenditures have risen somewhat under the Fourth Republic, however,
Nigeria's total government spending as a share of overall health spending was at 4·6%
in 2017, lower than the African average of 7·2% and the world average of 10·3%.
45
In contrast, out-of-pocket expenditure is extremely high, at 77% of total health spending
in Nigeria, compared with 37% for the African average, and a much lower 18% for the
world average. Compounding Nigeria's health inequities are low in investment in water
and sanitation infrastructure compared with other low-income and middle-income countries
(LMICs),
46
as well as generally low government spending across sectors.
Overall, Nigeria's model of health-care financing since the First Republic has gradually
transformed into one focused on the generation of revenue for hospital management
through the charging of user fees. Public health centres have been pseudo-commercialised
as they are restructured to generate funds to work efficiently and independently.
In the public and organised private sectors, neoliberal reforms have led health-care
provision to be more market-oriented, even though 60% of the Nigerian population are
estimated to have minimal disposable income.
47
As a result of underfunding, the capacity and quality of government health facilities
and health services dwindled due to the persistent unavailability of drugs and equipment,
resulting in increasing reliance on home treatment, medicine sellers, traditional
medical systems, and faith healing by the Nigerian populace.
48
The accumulated results of this history can be traced throughout the health system,
with a case study of maternal health services providing an example of the resulting
challenges and opportunities (panel 3).
Panel 3
The effect of historical trends on maternal health services
The delivery of maternal health-care services relies on the entire health system,
and systems-level issues influence access to and uptake of services, quality of care,
and health outcomes.
49
Therefore, the historical construction of the Nigerian health system can be examined
through the lens of maternal mortality, and the diagnosis is dire. Nigeria's maternal
mortality ratio (814 per 100 000 livebirths in 2019) is among the world's highest,
and the country accounts for 20% of the world's maternal deaths.
50
Large inequities in access to perinatal health services (including antenatal care,
delivery, and post-natal care), are found along the political, social, and economic
fault lines characterising the allopathic health system since its origins in the early
colonial period. There are marked disparities between geopolitical zones,
51
with women in northern Nigeria less likely to deliver in a health facility than those
in southern Nigeria,
52
and also between urban and rural areas,51, 53 with rural residents twice as likely
as their urban counterparts to drop out between antenatal care and delivery. Distance
to the health facility is a common barrier to accessing antenatal care and facility
delivery,53, 54 compounded by poor road access and unavailability of transport late
at night or during the day, especially in rural areas.
55
The poorly functioning referral system, with unclear repartition of responsibilities
between the three levels of governance leads to late presentation and consequent adverse
maternal outcomes in tertiary facilities.
56
The ability of women to seek maternal health services is substantially moderated by
the cost of care, an unsurprising finding given that out-of-pocket payments have become
the main source of financing of basic healthcare. High cost is a major factor hindering
both the use of antenatal care services and the decision or ability to give birth
in a facility.57, 58 Cost as a barrier is most pronounced in rural and semi-urban
areas, and the challenge is even greater when women are referred to a higher level
of care. The most common reasons for discontinuation of treatment include the cost
of services, drugs, and laboratory expenses, and scarcity of transportation to the
hospital (which is also often an issue of cost).
59
These problems are not irremediable; pilot federal government-led initiatives that
include financial incentives in the form of subsidies for antenatal care services
or free maternal and child health services increase antenatal care utilisation.
54
Problems of access for ordinary Nigerians, including pregnant women, are measured
not only in miles or naira, but also in the social and cultural distance between traditional,
holistic care systems and formal medicine, which has only widened since the pre-colonial
period. In the formal health system, the poor attitude and behaviour of health facility
staff influence antenatal care, formal delivery, and postnatal care service use.
57
A systematic review
60
found a broad range of disrespectful and abusive behaviours towards parturient Nigerian
women, ranging from non-dignified care to physical abuse, which sowed distrust and
undermined service utilisation. Aversion to such abuse is only one component of the
psycho-social barriers to access. In the context of Nigeria's pluralist health system,
there is often a strong preference for accessing traditional maternal care, which
differentially effects maternal morbidity and mortality, and contributes to health
inequities. Rather than in formal facilities, women frequently deliver in herbal or
traditional maternity homes, on church premises, or at home due to cultural beliefs,
avoidance of the patriarchal (medical) system, affordability and ease of payment,
convenience, strong interpersonal relationships with healers, and fear of medical
procedures, such as blood collection for investigations and pelvic examinations during
delivery.54, 55 There is a strong sense of trust in traditional birth attendants,
especially in rural communities, as they are perceived to be more compassionate than
formal health workers and provide options such as home delivery, presenting an opportunity
to skill up community-based providers who can support normal deliveries and refer
pregnant women needing further care.
Section 3: an evolving burden of disease challenges a system focused on curative care
Burden of disease
Demographic context
With an estimated population of 206 million, of which almost 44% is aged under 15
years, Nigeria is both the most populous nation in Africa and one of the youngest.
61
Almost 111 million Nigerians are of working age (25–64 years) compared with 95 million
of non-working age, and the size of the workforce is projected to grow substantially.
Although the UN Population Fund refers to such a situation in which the share of the
working-age population is larger than the non-working-age group as a demographic dividend
with the potential to drive economic growth into the future,
62
no country has tapped into these benefits while faced with unchecked population growth.
East Asian countries (eg, Singapore, Indonesia and South Korea) used demographic changes
to achieve economic development by incorporating new workers and driving up incomes,
productivity, and development indicators.
63
However, these countries also simultaneously tackled population growth by lowering
fertility rates; between the 1950s and 2010, the total fertility rate in east Asia
declined from 5·8 to 2·3.
64
Unfortunately, Nigeria still ranks very low on the World Bank's Human Capital Index
2020, as one of only 24 countries out of 174 globally with a score below 0·4.
65
Indeed Nigeria's score of 0·36 out of 1 means a Nigerian child born today will only
be “36 percent as productive when she grows up as she could be if she enjoyed complete
education and full health”.
66
Therefore, investments need to be made now to enable the demographic dividend and
to avoid population growth outstripping economic growth and pushing more people into
poverty.
The country can harness its human resources by ensuring population growth is managed
well and a demographic dividend is realised. By investing in reducing unmet need for
family planning, closing the gender gap in education through increasing education
of the female population, increased opportunities for women's participation in the
labour market, and reducing child mortality, Nigeria's fertility rate can decrease
towards replacement levels (2·1 children per woman) so that the large proportion of
children and youths today at the bottom of the population pyramid become the engine
of the economy (Onwujekwe O, unpublished). Such a bulge in the middle of the population
structure if realised would mean a high workforce to dependents ratio and can drive
growth. This growth is conditional on large investments in good education and health
now so that the potential workers of tomorrow are skilled and healthy.
Despite modest decreases in fertility over the past four decades, the fertility rate
is high relative to the global average, at around five livebirths per woman (figure
2). The number of births across the country has continued to increase,
67
leading to population growth of 2·6% a year, a rate that will lead to a doubling of
the population within less than 27 years, placing extensive pressure on communities
and social services.
61
This figure masks substantial variations in fertility across the country. Various
states in the northern geopolitical zone, rural and poorer households, and specific
sociocultural and religious groups report higher fertility rates.
68
Data from the National HIV/AIDS Indicator and Impact Survey reported an average household
size ranging from 3·8 in the South-South Region to 5·9 in the North-East Region (figure
3), and lower in urban areas compared with rural regions.
Figure 2
Fertility rate and total births in Nigeria, 1950–2020
Data are from the UN Department of Economic and Social Affairs.
61
Figure 3
Nigeria Average Household Size by State from the National HIV/AIDS Indicator and Impact
Survey, 2018/19—Sample Size
Faster decreases in fertility driven by family planning and female education, especially
in regions and groups with the highest growth rate, will be required for Nigeria to
effectively reap its demographic dividend.64, 69 Ensuring access to family planning
and contraception is vital to ensuring gender equality and human rights, reducing
unplanned pregnancies and achieving broader improvements in health, education, and
economic outcomes.70, 71 Yet, unmet need for modern contraception in Nigeria is estimated
at over 20%, with only slight decreases in the past two decades.
72
Unmet need among married women is estimated to be lower than among unmarried women
but still high.
73
Meeting the demand for contraception and increased investment in and access to education
services is therefore essential, and will require wide-reaching efforts to overcome
gender inequities across the population
74
and taking into account sociocultural challenges that drive high fertility.
Indeed, the link between the empowerment of women and increased demand for modern
contraception has been shown around the world. More broadly, education has been shown
to be a key determinant of health seeking behaviour, with the effect particularly
pronounced for girls.
75
Although the proportion of Nigerian women aged 15–49 years with no education has reduced
between 1999 and 2018, it is still relatively high, with 34·9% of women having no
formal education as of 2018 (figure 4). The percentage of women with secondary education
or higher is highest in the south of Nigeria and lowest in the north (appendix p 32),
indicating the long distance to travel in improving female education and in addressing
the country's regional disparities.
76
Figure 4
Trends in percent distribution of women aged 15-49 years by highest level of schooling
completed, Nigeria DHS 1999–2018
Data are from the National Population Commission (Nigeria]) and ICF 74.
Healthy life expectancy, morbidity, and mortality
Nigeria continues to bear an extremely high burden of death, disease, and disability,
even compared with other LMICs. The UN estimates life expectancy at birth in Nigeria
to be just over 54 years, the fifth lowest in the world (appendix p 33).
61
The burden of death and disability in Nigeria has historically been dominated by communicable,
maternal, and neonatal diseases along with nutritional deficiencies, which continue
to be the case in 2019, although non-communicable diseases are having an increasing
effect on the population over time.
67
Much of Nigeria's disease burden is uncertain given the near absence of relevant data;
for example, in its latest SCORE assessment, WHO estimates that only 10% of deaths
in Nigeria are registered.77, 78 The paucity of data is strongly indicative that decision
making is rarely based on appropriate evidence, an enormous challenge that is nonetheless
surmountable provided key hurdles are scaled. Panel 4 summarises the data sources,
challenges, and suggests areas for improvement.
Panel 4
Data systems and quality in Nigeria
This Commission has relied heavily on the Global Burden of Diseases (GBD) Injuries
and Risk Factors study,79, 80 which provides ongoing estimates of the mortality and
morbidity burden attributable to a wide array of conditions and exposure to risk factors
in all countries. In addition to the use of GBD results, the Commission undertook
bespoke data collection and assessed the quality of existing data to inform future
disease burden estimates. Population level data (demographic surveillance sites and
census information), national facility-based databases (eg, District Health Information
System version 2 [DHIS2]), surveys and surveillance databases eg, Surveillance Outbreak
Response Management and Analysis System (SORMAS), Nigeria HIV/AIDS Indicator and Impact
Survey, and National Primary Health Care Development Agency immunisation coverage
data), and morbidity and mortality records from hospitals across the country were
requested.
The process of collating data was not without its challenges, beginning with identifying
where the data was situated and requesting permission to access it, due to insufficient
institutional memory and frequent leadership changes. Although some organisations
were confused as to who the rightful guardian of the data was, others had several
custodians with numerous channels to permission, each of whom had to consent for data
to be released. Approval processes were therefore complex and slow. Where data existed,
as in many health facilities, it was not captured using electronic medical record
systems, and was therefore often incomplete and marred with inaccuracies. Furthermore,
despite approval from the National Health Research Ethics Committee, each organisation
had its own guidelines, which were expected to be fulfilled before data issuance.
Reluctance to share data in some institutions was based on concerns about opportunities
to publish their own data, cost of extracting data, and apprehensions about privacy
and data misuse.
To illustrate the limitations of existing data, we undertook a data quality audit
of DHIS2—a key source of input for GBD estimates—in 31 districts across Nigeria selected
to achieve geographical representation and data quality spread. We selected districts
in the following regions or states: Cross River, South South; Ebonyi, South-East;
Oyo, South-West; Kano, North-West; Yobe, North-East; and Nasarawa, North-Central.
The results of this audit showed that during the period January to March, 2020, facility-reported
data completeness on the DHIS2 platform varied between 58·3% and 71·7%. To illustrate
the level of missingness, some public tertiary facilities, responsible for caring
for a large proportion of cases out of six facilities audited in each state, did not
report any data to the DHIS2 platform. The absence of tertiary hospital data is particularly
important for conditions that can only be diagnosed in such centres. In addition to
these quality gaps, DHIS2 does not include data from the private sector in most states,
where a large proportion of Nigerians access care.
However, some states, such as Lagos, have implemented initiatives to ensure private
hospital data are compiled.
Our review of data sources, quality, and analysis support the following measures to
improve disease burden estimation and policy making. First, there is a need to create
a value proposition for data supported by multiway data communication. As we sourced
data for the Commission, we found that institutions often had a shortage of resources
and motivation to compile and collate information useful for sub-regional and national
planning. Any attempts to sustainably improve data availability, access, and use must
feed information back to stakeholders to establish the value proposition. Second,
electronic record keeping and digitisation should be implemented. Although there has
been some progress in digitising data for health (eg, the recently rolled out SORMAS
system during the 2014–15 Ebola virus outbreak for communicable diseases), the vast
majority of health records and health-related data are collected on paper and accessible
only within health facilities. Nigeria urgently needs to digitise health records at
all levels of care. Data-handling and security advances, low cost and portable hardware,
new population identifier programs, and National Identification Numbers, combined
with a young, digitally-adaptable and under-employed workforce provide favourable
conditions for comprehensive health system digitisation. These changes will additionally
strengthen supply chains, enable forecasting, and reduce waste. Third, data systems
will benefit from strengthening at all stages including collection, collation, and
analysis in all sectors. In addition to data on disease epidemiology, health-care
staffing, costs, and expenses, Nigeria struggles to collect and manage data around
vital registration, demographics, economic activity, educational attainment, and other
key development metrics. Population-level data are scarce in Nigeria, census data
are rare, and most private sector providers are not part of government data systems.
Consequently, there is little information available to provide denominator data for
surveys or to parameterise models. Community-led strengthening of vital registration
will be essential for future economic and health planning, a step which will require
appropriate legislation and enforcement of laws, supported by a digital infrastructure
linking data from villages and districts to the National Population Commission and
the National Bureau of Statistics. Finally, Nigeria should better support existing
Health and Demographic Surveillance System (HDSS) sites and establish additional ones.
Worldwide, countries use HDSS sites to collect rich data sets or nest studies to answer
pertinent questions that cannot be addressed with national data that have less depth.
Nigeria only has two partially functional HDSS sites in operation. Multiple attempts
at establishing HDSS sites have collapsed, in part due to insufficient initial funding.
A structured, government-funded effort to initiate or re-initiate HDSS sites is needed.
To focus the work of the Commission in understanding and analysing Nigeria's complex
burden of disease, an e-Delphi process was conducted in late 2020 with twenty-three
commissioners and key Nigerian policy makers to identify the conditions and risk factors
most important to address to improve population health in Nigeria (appendix). Eleven
conditions and five risk factors were prioritised as particularly important to the
Nigerian health system (figure 5). We present GBD data for these prioritised conditions,
including communicable diseases and non-communicable diseases, diseases with epidemic
potential, and maternal and child health. A comprehensive analysis of the burden of
disease in Nigeria compared with other west African countries is presented in full
elsewhere, with key results referenced here.
81
Figure 5
Deaths and disability-adjusted life-years for key conditions in Nigeria, 1998–2019
Data are from the Institute for Health Metrics and Evaluation. (A) Age-standardised
mortality. (B) All age mortality. (C) Age-standardised disability-adjusted life-years.
(D) All age disability-adjusted life-years.
Nigeria has achieved substantial improvements in the rate of morbidity and mortality
of historically leading causes of death. The three leading causes of death in 1998
have shown large declines in age-standardised mortality rates; diarrhoeal diseases
have reduced by 59% from 227 deaths to 92 deaths per 100 000 population, malaria from
161 to 112 deaths per 100 000 population (–30%), and lower respiratory infections
from 148 to 97 deaths per 100 000 population (–34%). Malaria had the highest age-standardised
mortality rate in Nigeria in 2019, however, the importance of cardiovascular diseases
has grown with ischaemic heart disease (105 deaths per 100 000 population), the second
leading contributor to age-specific mortality, and stroke the fifth (91 deaths per
100 000 population), despite decreases in the mortality rates of 18% for ischaemic
heart disease and 31% for stroke since 1998. Taken together, cardiovascular diseases
were the leading contributor to age-standardised mortality over the comparison period.
Infections and neonatal disorders (panel 5) were the largest contributors to age-standardised
years of life lost and disability-adjusted life-years across the population in both
1998 and 2019, reflecting their effect on younger population groups (panel 5). This
progress over the past 25 years is salutary, but the burden of communicable diseases
is untenably high in Nigeria and the rate of progress has slowed considerably in the
past decade. Nigeria has not leveraged water, sanitation, and hygiene (WASH) interventions
nor deployed technologies such as enteric and respiratory vaccines, which could have
driven a further decline.
Panel 5
Burden of maternal and neonatal diseases is unacceptably high despite some successful
programmes
Nigeria has stated its longstanding commitment to maternal, neonatal, and child health;
however, mothers and children continue to bear a major portion of the national burden
of ill-health. Neonatal conditions are in the top three causes of years of life lost
in Nigeria, showing the constraints of health-care delivery underpinned by a highly
vertical and centralised system. Despite the ongoing burden, Nigeria has achieved
substantial reductions in neonatal, under-5, and maternal mortality over the past
four decades and there are numerous examples of successful programmes to reduce this
burden, which could provide lessons for future programmes to build on. Programmes
have been able to increase the uptake of skilled maternal health attendants and encourage
the use of facility-based maternal and child health services,
82
reduce mother to child HIV transmission,
83
prevent strokes in children with sickle-cell disease,84, 85 and generally improve
collaboration and promote uptake of evidence-based interventions.86, 87, 88
Nonetheless, rates are well above the levels required to meet SDG 3·1 and 3·2 to substantially
reduce maternal, neonatal, and child mortality. UN estimates of neonatal mortality
in 2019 were of 36 per 1000 livebirths and GBD estimates of 49 per 1000 livebirths,
both at levels far above the targets. 12 per 1000 livebirths have been set for 2030
under the SDGs in spite of some reductions in neonatal mortality rate.81, 89 Levels
of stillbirth and under-5 mortality per 1000 livebirths are equally high based on
UN and WHO estimates of 117 in 201 9
89
for under-5 mortality and 43 in 201 5
90
for still births, far above SDG targets. Estimates for maternal mortality range from
91 7 per 1000 livebirths
91
from the UN and WHO in 2017 to 528 (351–815) from the GBD study in 2019 compared with
the SDG target of 140. These rates of child and maternal mortality are among the worst
in west Africa, contrasting sharply with Nigeria having among the lowest mortality
rates for males over the age of 50 years in the region.
92
Further analysis of GBD data suggests that the leading cause of maternal mortality
in 2019 was maternal haemorrhage (accounting for 5000 deaths) followed by maternal
abortion and miscarriage (almost 2600), and late maternal deaths (over 2200 deaths).
The local burden of disease study analysis92, 93 shows subnational geographical variation
with an increasing gradient of deaths from the south to the north of Nigeria. Between
2000 and 2017, most of southern Nigeria had seen considerable improvement in child
deaths, with only the north central states and some coastal communities experiencing
a high disease burden.
Among infections, diseases with epidemic potential were also prioritised through the
e-Delphi process. Nigeria has experienced outbreaks of cholera, meningococcal meningitis,
Lassa fever, and monkey pox over the last decade, with variable case fatalities. Nigeria's
epidemic detection and response mechanism is becoming more responsive,
94
with improved laboratory diagnostics, a better trained cadre of field epidemiologists
who can be rapidly deployed when needed, and better coordination from the NCDC. WHO's
Joint External Evaluation of Nigeria's pandemic preparedness suggested an improvement
in the score from 39% in 2017 to 46% in 2019,
94
leaving much room for continued improvement. Some of these gains have the potential
to be leveraged for other diseases of epidemic and pandemic concern including Ebola
haemorrhagic fever, and, most recently, COVID-19. The COVID-19 pandemic has however
shown how easily this growing capacity can be strained and there is need to continue
to develop the response capacity, and resilience within it, because Nigerians are
at risk of several epidemic-prone diseases in addition to the threat from future pandemics.
Non-communicable diseases accounted for an age-standardised 567 deaths per 100 000
people in 2019, overtaking group 1 (communicable, maternal, neonatal, and nutritional
diseases) in 2015 as the leading contributor to mortality in Nigeria. After the most
prominent communicable and neonatal diseases, cardiovascular diseases are the next
leading cause of death accounting for over one-third of deaths caused by non-communicable
diseases. Neoplasms, responsible for almost 17% of deaths, were the only prioritised
disease group that had a higher death rate in 2019 than 1998 (98 per 100 000 in 2019
as opposed to 80 in 1998). Transport injuries accounted for 4% of deaths. Federal
Road Safety Corps data obtained for this Commission suggests that at least 10 966
individuals died in 2019, with a further 71 962 injured on Nigerian roads. The Council
for Foreign Relations terrorism tracker estimates a cumulative total of 70 000 deaths
from violence between 2011 to 2021.
95
More broadly, there is an urgent need to boost disease testing infrastructure. Within
health facilities, Nigeria needs to better deploy diagnostics, including point-of-care
tests that can be used at the primary health-care level. In addition to enhancing
individual patient care, these tests will provide the precision necessary to generate
high-quality health data
96
and support epidemic preparedness. Presently, only 13·8% of children under 5 years
with a fever had blood taken for malaria testing.
76
Blood cultures, which are needed to diagnose a range of diseases such as typhoid fever,
meningococcal and pneumococcal infections among others, are only available at a handful
of sentinel laboratories. Available evidence suggests that the burden from other communicable
diseases, which can only be reliably confirmed with laboratory testing, such as pneumococcal
disease, is likely to be high and is largely unknown.
97
Infrastructure deficits negatively effect access to life-saving procedures (eg, emergency
caesarean sections and supplemental oxygen supplies for infants with pneumonia) at
times of critical need, exacerbating the consequences of late referrals. Simultaneous
with addressing the root causes of maternal mortality within health facilities is
the pressing need to increase access and acceptability of antenatal and maternity
care as an estimated 33% of mothers did not receive antenatal care from a skilled
provider.
76
Health is made within communities and at home: health creation and disease prevention
Since the late 1990s, it has been widely accepted that improved health outcomes observed
across the world's population, and particularly in LMICs, resulted predominantly from
improvements in socioeconomic and environmental factors including education, income,
and progress in overcoming entrenched social inequalities.75, 98, 99, 100 Although
a well-functioning and resourced health system will be vital to improve the health
of Nigerians, much of the disease burden experienced across the country results from
factors that lie outside the health system. A multisectoral or Health-in-all-Policies
(HiaP) approach to address key risk factors and social determinants of health including
nutrition, access to clean water and sanitation, family planning, and healthy environments
would be a cost-effective approach to improve population health outcomes and drive
sustainable development, while simultaneously relieving pressure on health services.
Cities in particular concentrate many of these social and environmental exposures
that adversely affect health. Accordingly, without due attention to health equity,
the rapid rate of urbanisation occurring in Nigeria coupled with climate vulnerability
can further accelerate health inequities.
Key risk factors driving the burden of ill-health in Nigeria
Through the e-Delphi process, the Lancet Nigeria Com-missioners and key Nigerian policy
makers prioritised five risk factors (table 2) alongside the deaths and disability-adjusted
life-years (DALYs) attributed to each.
67
Child and maternal malnutrition accounted for the most deaths and DALYs in both 1998
and 2019, with almost 420 000 (26% of total) deaths and over 39 million DALYs (34%)
in 2019. Over this 21-year period, there was a reduction in the rate of death and
DALYs per 100 000 people for prioritised risk factors, except high plasma glucose
and blood pressure, which increased. Most deaths in children aged under 5 years can
be attributed to three risk factors: malnutrition (estimated to account for 54% of
under-five deaths), unsafe WASH (20%), and air pollution (15%). In the older age groups,
metabolic risks are more prevalent.
81
Action to address the key risk factors for both child health and for the broader population,
as well as other social determinants of health (eg, access to education, overcoming
gender inequality, and environmental sustainability) will be important to improving
the health of Nigerians.
Table 2
Deaths and disability-adjusted life-years attributable to key risk factors in Nigeria
in 1998 and 2019
Deaths (95% CI)
Disability-adjusted life-years (95% CI)
1998
2019
1998
2019
Air pollution
223 951 (179 960–283 558)
197 567 (160 424–240 680)
15 252 238 (12 056 035 –19 663 184)
12 643 592 (9 997 069– 15 930 925)
Child and maternal malnutrition
554 763 (480 200–625 969)
419 866 (330 659–537 308)
49 655 623 (43 079 827–5 931 935)
39 037 560 (31 241 661– 49 104 528)
High fasting plasma glucose
36 861 (28 525–47 899)
57 698 (43 014–74 008)
948 140 (755 737–173 865)
1 535 009 (1 183 849– 1 918 815)
High systolic blood pressure
75 204 (56 323–101 955)
114 125 (89 995–140 573)
1 790 920 (1 339 473–2 463 974)
2 877 768 (2 241 093– 3 602 326)
Unsafe water, sanitation, and handwashing
311 528 (224 820–395 596)
212 217 (162 226–271 595)
23 482 301 (17 289 431–29 399 440)
16 042 318 (12 143 327– 20 910 914)
Data are from the Institute for Health Metrics and Evaluation.
Water, sanitation, handwashing, and nutrition
By addressing maternal and child malnutrition, and ensuring access to clean water,
facilities for handwashing, and sanitation for all Nigerians, the country could substantially
decrease preventable neonatal and child deaths.
81
Poor access to WASH predispose Nigerians, and in particular vulnerable children, to
enteric infections, among the most common causes of under-five mortality.
81
Both trachoma and schistosomiasis, which can be controlled by improving WASH, are
endemic in the poorest communities of Nigeria; cholera outbreaks in some parts of
the country are also attributable to poor access to WASH.101, 102 Insufficient or
non-existent water supply in health facilities is also a major barrier to infection
prevention and control, which predisposes for hospital-acquired infections, and are
an important risk factor for maternal and neonatal mortality. Infection Prevention
and Control gaps are exacerbated by Nigeria's long-standing infrastructural deficits
such as poor access to running water, even for health facilities, and chronic, seemingly
intractable, electric power shortages. These in turn make it challenging to implement
hand hygiene and other requirements of Nigeria's most recent Infection Prevention
and Control policy (SITAN studies).
103
Environmental and cardiometabolic risk factors
In line with the increased burden of non-communicable diseases on the Nigerian population,
a growing number of deaths and DALYs in Nigeria are attributable to cardiometabolic
risk factors (appendix p 33).
81
Although the majority of this burden falls on older Nigerians, evidence suggests that
cardiometabolic risk factors are occurring at increasingly earlier ages.104, 105 As
such, the risk factors for cardiometabolic disease need to be addressed at younger
ages, not later, as is commonly believed.
As the Nigerian population continues to grow, the relationship between the population
and the environment will be increasingly important. Almost 200 000 deaths were estimated
to be attributable to air pollution across Nigeria in 2019 (12% of total deaths).
Air pollution was included as a key driver of 24% of neonatal deaths and half of all
deaths resulting from lower respiratory infections.
67
Air pollution is also an important cause of the increased burden of non-communicable
diseases alongside the metabolic risks identified, with 31% from ischaemic heart diseases,
38% from stroke, 23% from diabetes, and 58% from chronic obstructive pulmonary disease
being attributed to air pollution.
67
Despite these alarming contributions of air pollution to mortality in Nigeria, previous
institutional and legislative frameworks have often focused on mitigating pollution
from the oil and gas sector, including transport and generators, even though there
is substantial ambient air pollution from other sources such as cooking.
106
The built environment is also a key determinant of population health, in large part
because it affects physical activity. Although there is little to no population-level
data on physical activity among Nigerians today, about one-quarter of all deaths are
due to non-communicable diseases that can be related to low levels of physical activity.
107
Increasing levels of physical activity across the population will require widespread,
equitable access to open space and opportunities for safe physical activity. The key
interventions to address the risk factors presented by both air pollution and low
rates of physical activity must be undertaken outside the health sector. For example,
road transport is the primary source of ambient air pollution, and transport networks
are a key determinant of people's everyday physical activity, so working with the
transport sector offers the promise of substantial health gains. Panel 6 shows some
examples of potential interventions, however, more research is needed to produce a
rigorous evidence base of efficacious and cost-effective initiatives that have been
subjected to thorough impact and economic evaluation. Considerable inventiveness will
also be needed to implement analogous interventions in Nigeria's other cities, which
represent more difficult terrain with access to fewer resources than those pilot areas,
and to develop appropriate programmes for rural areas. For Nigeria's urban and rural
poor, indoor pollution due to cooking is a major risk. State and local governments
should support and incentivise efforts to build well ventilated cooking areas or kitchens
and open-air cooking. Governments and civil society should also work towards reducing
the use of solid fuel (ie, firewood) to more environmentally friendly fuel sources.
Panel 6
Case study on intersectoral norm-shifting initiatives in Lagos and Abuja
Lagos Urban Development Initiative
The World Bank estimated that Lagos has the highest premature death rate of any West
African city due to ambient air pollution leading to approximately 11 200 deaths in
2018.
108
Over half of these deaths were in children whereas adults had cardiovascular disease,
chronic obstructive pulmonary disease, and pulmonary cancer. The estimated loss from
air pollution in 2018 was $2·1 billion (2·1% of the state's GDP). The Lagos Urban
Development Initiative is a non-governmental organisation (NGO) that advocates for
a more inclusive, liveable, and sustainable Lagos. The team runs three major initiatives
to increase walkability, bicycle-friendliness, and promote an eco-friendly environment
in Lagos:
•
Walkability and bikeability in Lagos Island: this project attempts to implement simple
and affordable measures at the local government level to make roads safer for school
children, in alignment with the Lagos Non-Motorised Transport Policy
109
initiated in 2018, which aims to create an environment that supports increased accessibility
by prioritising the use of walking, cycling, and public transport. The policy seeks
to achieve a more equitable allocation of road space by incorporating non-motorised
and public transport in the planning, design, management, and budgeting stages of
transport projects. The overall aim is to reduce reliance on personal motor vehicles
and subsequently environmental pollution, congestion, and other health and safety
challenges such as traffic accidents. The programme is undergoing evaluation by the
University of Lagos and the Lagos Island Local Government
•
Linear Parks Projects: this project aims to reap the rewards of non-motorised transportation
and increased parkland within Lagos through the conservation of wetlands and promotion
of bikeability and climate-smart agriculture. This dual objective seeks to increase
the health and resilience of the city while rehabilitating degraded ecosystems, increasing
the number of trees, and constructing infrastructure for non-motorised transport.
In 2018, the Lagos Urban Development Initiative carried out a study to explore the
feasibility of the project and its potential benefits for government and citizens.
The study produced a design that included a 4 km off-road bicycle trail, parklands,
and a so-called agri-tainment centre. This project is being carried out in collaboration
with multiple government departments, agencies, and the private sector
•
Cargo bikes feasibility study: this project is carrying out a feasibility study on
the use of cargo bikes for delivery purposes by the commercial and informal sector
within some mapped areas in Lagos Island. The focus is mostly to improve delivery
of goods to and accessibility in low-income communities, however, by influencing decisions
and regulations by relevant authorities in Lagos Island, it also aims to reduce traffic
congestion and pollution and make the roads safer. The project is in its second year
and is undergoing evaluation. The Lagos Urban Development Initiative aims to replicate
this intervention in other parts of Lagos state if successful.
Ochenuel Mobility in Abuja
Ochenuel Mobility is an NGO that aims to develop smart and sustainable mobility solutions
in Africa that are people-centred and environmentally friendly. The organisation runs
two initiatives to improve walkability and cyclability, and reduce air pollution and
its effect in Abuja.
OpenStreets in Abuja
OpenStreets is a free event that brings together cycling and walking advocates, community
groups, residents, and local businesses to temporarily close major urban roads and
streets in the Abuja city centre to motor traffic, and open the road up for people
walking, cycling, skating, dancing, and playing. OpenStreets initially started a few
years ago in Colombia and is held in different cities across the world, including
Cape Town in South Africa and Addis Ababa in Ethiopia, in alignment with the SDGs
and the New Urban Agenda. In Abuja, the initiative seeks to overcome the city's car-oriented
development, which neglects active mobility modes such as walking and cycling, and
hinders mobility for persons with disabilities with a view to enabling residents and
visitors to explore neighbourhoods in a safe, fun, family-friendly manner. On an OpenStreets
day, a portion of a major urban road (2 km –10 km) is closed to motor vehicles. Musical
bands provide live music for participants with distribution of educational materials.
In addition, blood pressure and blood glucose screenings are carried out on the street
by health professionals. Relevant political leaders are invited to increase the profile
of the event and build a culture of returning the city back to the people, in collaboration
with the government (Ministry of Health) and NGOs, civil society, private entities,
and local community members.
The climate crisis poses an increasingly broad and severe set of threats to the health
of the population going forward. The spread of vector-borne diseases is predicted
to increase as a result of climate change, potentially increasing the effect of malaria
(estimated to account for 12% of deaths in 2019) and other diseases already placing
a large burden on the Nigerian population.
110
At the same time, the widespread effects of climate change on various sectors, ranging
from food production to natural disasters to communal conflicts, will have profound
effects on the health outcomes of the Nigerian population.111, 112 Desertification
in northern Nigeria is already effecting agricultural ecosystems and food security,
and rising sea levels are increasing flooding risk in the Niger Delta and major coastal
cities such as Lagos.
These vulnerabilities are set against a backdrop of rapid urbanisation and severe
environmental degradation, with the fast-growing population placing further pressures
on the very environments needed for healthy living. The interlinked climatic and health
hazards emerging from, and accelerated by, unsustainable population growth, urbanisation,
and climate change result in acute shocks and chronic stressors that can widen health
inequalities by increasing the burden of existing health problems, while creating
conditions for the emergence of new diseases and a more dangerous environment, with
increased flooding, heat islands, and droughts. These factors further affect health
through exposure to unhealthy environments, increased demand on health-care systems,
increasing socioeconomic vulnerability, and displacement and conflict that compromise
the ability of communities to effectively adapt. Measures to mitigate these effects
will be crucial to the health and development of the nation. Research partnerships
should evaluate the short-term and longer-term effect of initiatives such as these,
and support large scale implementation of evidence-informed interventions that address
key environmental risk factors to equitably create health in Nigeria.
Section 4: health system reform—a pathway to universal health coverage
Achievements and flaws of the current health system
Indicators of health outcomes and coverage of basic health services in Nigeria show
long-standing underperformance. However, the overall trend of indicators such as infant
and child mortality since independence in 1960 indicate a slow decline (panel 5).
In the past decade, successes against Guinea-worm disease, poliomyelitis, and Ebola
virus disease are areas of high performance despite systemic weaknesses.
113
Numerous health policies and development plans in Nigeria (figure 6) culminated in
the National Health Act of 2014, which has the potential to improve Nigeria's health
system, by guaranteeing federal funding through the Basic Healthcare Provision Fund
and defining state government responsibility for financing and delivery of PHC. Implementation
of health policies as intended is a core challenge as illustrated by the incomplete
realisation of the Second National Strategic Health Development Plan (NSHDP II),
114
partly due to governance challenges, with the division of responsibilities between
federal, state and local governments. Additionally, the role of development partners
in initiating some policies through vertical funding often leads to a lack of ownership
by national and sub-national policy makers, and the policy-making process itself not
taking formal and informal political considerations into cognisance.
Figure 6
Overview of Nigerian health plans, strategies and policies from independence to present
As discussed in Section 2, the three levels of health service delivery in Nigeria
(primary, secondary, and tertiary) do not function equally well, and many potential
patients bypass the PHC level when not available, trusted, affordable, or of sufficient
quality. Individuals who can afford it enter the system at a higher level, and those
who cannot afford care at higher levels sometimes resort to seeking informal care
from drug shops, pharmacies, and traditional healers, or seek no care at all.
115
The weakness of the PHC system is linked to the divided allocation of responsibilities
between federal, state, and LGA level. The weak state of PHC places a heavy burden
on tertiary hospitals, especially where secondary care is also weak or mostly provided
by the private sector, such that the bulk of patients are seen at the general outpatient
departments of tertiary hospitals staffed by family physicians (ie, general practitioners).
116
A 2019 survey of all federal government-owned tertiary care hospitals and five state-owned
tertiary institutions across Nigeria recorded a national monthly average of about
42 000 visits by patients per facility.
117
Only 3% of these visits were due to referrals from other facilities, which is consistent
with the observed trend of patients bypassing primary care. In addition, less than
45% of these visits led to specialist referrals within the surveyed facilities (table
3) further confirming that these tertiary institutions served as PHC facilities for
the patients. These statistics further reflect a heavy burden on general outpatient
departments of tertiary hospitals in Nigeria.
Table 3
General outpatient department visits and referrals by region—2019 nation-wide assessment
of Federal Tertiary Healthcare Institutions (the Hospital Modernisation Pathway questionnaire)
Number of patients visiting per day
Number of patients visiting per month
*
Monthly referrals received by facility
Referrals per visit (%)
Referrals per 1000 visits
Specialist referrals within facility (%)
†
Federal Capital Territory and north central
336
10213
297
2·9%
29
29%
Northeast
402
12 242
1087
8·9%
89
21%
Northwest
1801
54 826
3996
7·3%
73
70%
Southeast
3917
119 218
411
0·3%
3
53%
South
685
20 846
481
2·3%
23
40%
Southwest
834
25 398
1339
5·3%
53
41%
National average per facility
1374
41 808
1418
3·4%
34
44%
*
Estimated from values in the preceding column (number of patients visiting per day)
based on the assumption that a month is equal to 30·437 days.
†
Referrals from General Outpatient Departments to specialists within the same facility.
Previous efforts to provide federal support for PHC have been largely unsustainable—one
example is the Midwives Service Scheme. The ambitious nationally implemented government-run
Midwives Service Scheme was designed such that each of the three levels of government
made monthly contributions towards the salary and support of midwives posted to rural
communities to improve the quality of maternal health services. As salaries were inconsistent
and insufficient, and in some cases not provided at all (with federal contributions
proving the most reliable), the Midwives Service Scheme led to deep dissatisfaction
among the midwives employed.
118
A legislative measure to improve PHC delivery has been to centralise the governance
of PHC at the state level, so that state governments rather than local governments
take primary responsibility for PHC, in addition to their responsibility for secondary
care. Delivering on these responsibilities requires each state government to give
due political priority to PHC and increase their health budgets accordingly.
A similar federal initiative to the Midwives Service Scheme, the Free Maternal and
Child Health programme, was implemented in 12 states from 2009 to 2015.
119
This pilot initiative, which provided insurance coverage for mothers and children
in selected LGAs in those states, had a similar fate as the Midwives Service Scheme.
State governments defaulted on payment of their agreed counterpart funds, which made
the federal government terminate the project at the end of the pilot phase. The Free
Maternal and Child Health programme was not scaled up within pilot states or to other
states. However, it has been shown that the insufficient funds provided for the Basic
Health Care Provision Fund could be used to revitalise and scale-up the Free Maternal
and Child Health project if mothers and children most in need are targeted for coverage,
while sourcing for additional funds to ensure universal coverage of maternal and child
health services.
120
Rationalisation of policy making at federal, state, and local government levels
To strengthen domains for action and policy in the health system in Nigeria, we propose
a reformed set-up of centrally determined but locally delivered systems. Nigeria urgently
needs to digitise its health system at all levels. Centrally, there is a need to standardise
services, pool and streamline resources, and improve supply chains, manufacturing
and data management for products. Concurrently, there is a need to strengthen local
production of basic products, allocation decisions, defining basic health services
packages to align with local risk factors, and modes of community service delivery
sensitive to sociocultural norms.
Centralisation
With regards to information systems, evidence and experience indicate the need to
nationalise guidelines on completion and use of national surveillance forms, utilisation
of data, health information system training and mentoring, data quality assurance
processes, and supervision manuals. These guidelines need to be created and made available
nationally, with resources provided centrally to support their implementation. Implementation
support could be phased out over time and means-tested, based on the level of available
financial and technical resources in each state, with appropriate federal assistance.
However, during the development of the national guidelines, the specific roles and
responsibilities of the three levels of government, and of health facilities in health
information system management, should be clearly outlined. Alongside digitising the
health information system and centralisation of responsibility, capacity to use information
system across Nigeria will require reliable nationwide internet coverage.121, 122
Stable internet connectivity (which also requires constant electric power), technology
hardware, and continuous technical support are core prerequisites for the implementation
and utility of electronic information system tools—these requirements are yet to be
met in Nigeria.123, 124, 125, 126
The vaccine supply chain system (as with other centrally purchased health commodities)
receives inadequate and unreliable government funding and is stymied by a complex
multilayered governance architecture that depends on several decision-makers at the
federal, state, LGA, and health facility levels, and a poorly executed mix of push
and pull distribution mechanisms. Re-designing supply chain systems can reduce costs
and gaps in cold storage capacity—
127
for example, by decreasing the number of levels of vaccine in cold storage, increasing
the use of local data in procurement of vaccines, and implementing a central (ie,
federal or state government) push mechanism and a local (ie, LGA and health facility)
pull mechanism.128, 129 The push mechanism involves pushing vaccines (within a state)
directly from a few state stores to PHC facilities equipped with solar refrigerators,
thus bypassing LGA cold stores. PHC facilities draw from LGA stores when needed and
only when transport can be organised, which occurs often in PHC facilities with a
shortage of resources,
130
resulting in frequent stock outs. In the re-designed system, frontline health workers
no longer have to leave their posts to collect vaccines. Reverse logistics, such as
waste collection from service points, is a complementary intervention that can be
added to the direct delivery programme.
131
As most vaccines, diagnostics, medicines, and other health care consumables are currently
imported, centralising supply chains will also help to streamline and strengthen the
logistics and quality assurance of border transactions on importation. A long-term
strategy to produce vaccines, diagnostics and other consumables in Nigeria is however
necessary, as indicated by the challenge of procuring and distributing personal protective
equipment and vaccines in the COVID-19 response.
To increase the demand for and use of health services, the federal government can
develop national approaches to shifting normative practices, and improving and standardising
quality of care. National guidelines and quality standards could be used to formalise
processes and standards of care, for example, beginning with a national pilot of protocols
and guidelines for particular services such as maternal health services, which would
include antenatal care, delivery, and postnatal care. These protocols and guidelines
need to be matched with a national adoption and scale-up strategy, including electronic
mobile phone platforms through which their use will be facilitated, and the training,
supervision, and monitoring processes to facilitate their use, all made available
nationally to all health-care staff, preferably electronically and in a format that
would allow for local adaptation.
Localisation
PHC workers at the community level are the mainstay of an effective and functional
surveillance system. To localise information systems, attention should be paid to
strategies to increase the quality (including completeness and timeliness) of data
collected, beginning at local community level. One strategy is for health workers
to analyse and use the data they collect to make informed decisions in the communities
they serve.131, 132 The goal of data collection should not be solely for transmission
to higher levels for analysis and decision making, rather, information should be used
at the level at which it is collected. Local use of information can improve data quality
as corrections can easily be made at the point of collection in addition to helping
health providers monitor their performance. This strategy requires training and ongoing
mentoring on data use and interpretation at the local level. Introducing mobile technologies
at local level can further improve data quality due to its potential to reduce data
entry error and increase speed of reporting, thus enhancing the accountability that
local use of data collected at local level can trigger.
Although streamlining and centralisation of supply chain systems is an effective approach
to improving the supply side of access to commodities, it is crucial to ensure that
the system as a whole is responsive and adaptable to what is happening on the ground—for
example, through locally-driven and determined pull processes. Localisation is necessary
to optimise centralisation and to avoid creating new barriers to access and coverage.
Consideration of contextual factors including local political economy and culture
that would influence decisions or guide implementers and policy makers on approaches
for implementing direct vaccine delivery at local level is important in retaining
a sense of ownership and accountability at local and community level.130, 133
Careful consideration of context is integral to promoting the uptake and community
demand for health services and products (eg, vaccines and contraceptives), especially
given that cultural and socioeconomic factors that influence demand and uptake vary
greatly across Nigeria. A one-size-fits-all approach will not fare well. Community-based
approaches to promotion and delivery of health services would differ due to varying
degrees of public security and trust in authorities, and sensitivities or preferences
based on religious beliefs and cultural practices.
Rationalisation of links between public and private sectors
Strengthen public sector primarily but leverage private sector for specific tasks
To develop the overall health system landscape in Nigeria, it is important to strengthen
the public sector (especially at the PHC level) and expand the capacity of private
sector providers to increase their competitiveness in terms of breadth, quality, and
cost of services.
134
Public sector financing should address taxation corruption while increasing health
expenditure. Details on economic, and systemic budget reforms needed to strengthen
the overall Nigerian health system are presented in Section 5. At the moment, many
state governments struggle to mount the required funding to support their health systems.
In many instances, when there are limited functional PHC facilities within communities,
the private sector fills the service delivery gap in the form of for-profit services
(for those who can afford it), non-profit services (by non-governmental organisations
[NGOs] and faith-based organisations sometimes aimed at individuals who cannot pay
for services) and informal service providers.135, 136 To improve health care at the
PHC level, state governments could strategically secure funding for health systems
development with international donors and NGOs in addition to their federal allocation
(including specifically for health, guaranteed through the legislative change that
centralised PHC governance at the state level).137, 138 Although foreign funding is
not sustainable, with evidence-based planning and foresight, programmes supported
by international NGOs and bilateral or multilateral organisations can lead to sustainable
health system improvements by establishing health system infrastructure, especially
technical and physical infrastructure.
139
Nigeria has a dynamic private sector that can reposition the health system and improve
access and quality of care, as shown during the COVID-19 pandemic. The partnership
built between the private sector-led Coalition Against COVID-19 (CACOVID) and the
government during the pandemic was a potent force in the country's response to COVID-19,
successfully mobilising over 200 donors, including large corporate bodies, to generate
96% of an initial ₦40 billion resource target (Aliyu S, unpublished). CACOVID worked
closely with the national and state COVID-19 task force teams to support a wide array
of interventions (from case management to economic recovery), representing the first
time that the private sector took health system strengthening initiatives to scale,
and delivered them in an efficient and coordinated manner, without the encumbrances
of public sector bureaucracy, but with appropriate supervision and evidence based
decision making from the Presidential Task Force on COVID-19.
140
CACOVID, through its partners, contributed to the establishment of 39 isolation centres
and donated about 400 000 test kits early in the pandemic, supplied food relief materials
to an estimated 5% of the poorest Nigerian population, facilitated the vaccine roll
out through the provision of logistics and IT support, and provided storage facilities
nationwide for food and medical equipment. The logistic systems operated by CACOVID
provided broad-based innovative solutions to the challenges of the COVID-19 vaccine
and oxygen distribution in the country, thus enabling a more cost-effective and efficient
delivery system for goods. CACOVID also helped set up the Nigeria International Travel
Portal using their existing IT platforms and skilled staff to expedite the reopening
of international airports and economic recovery.
It is important to note, however, the different contexts represented by the pandemic
and the provision of health services on an ongoing basis. Evidence and experience
suggest that effective contracting of services to the private sector will require
a substantial capacity in the government sector to monitor and oversee these providers.
Private providers have been found to more frequently deviate from evidence-based practice,
have poorer patient outcomes, and be more likely to provide unnecessary testing and
treatment in LMICs.
141
Data on the comparative performance of private and public providers in Nigeria are
scarce, although treatment at private providers has been shown to be associated with
higher levels of catastrophic health expenditure,
142
poorer patient satisfaction and prescription of poor-quality medications.
143
To reinforce public and private sector collaboration in Nigeria, the framework should
be contingent on partnerships that are based on mutual trust, sharing of information,
joint planning, policy formulation, implementation and evaluation, and joint financing
of programmes and activities.
144
As a starting point to an effective partnership between the public and private sectors,
it is important to establish an up-to-date and comprehensive registry of private sector
providers in the health system. Such transparency is a central element of good engagement.
Encouraging informal providers to at least undertake basic registration is crucial
to accurately map the scale and scope of who is doing what in the health system. This
registration will be effective if it is simple, cheap, and fast.
145
Also, it is important to strengthen the mechanism for ongoing dialogue with the private
health sector to define common priorities. Furthermore, capacity for strategic financing
and contracting of services to the private health sector needs to be properly developed,146,
147 with the aim of filling access gaps that exist in specific health services across
Nigeria, including incentives to provide preventive services, which the private sector
often does little of as most of the revenue comes from out-of-pocket payments for
curative services.
145
Finally, it is important to include the considerations for the private health sector
in the development of public resources. Reliable and affordable infrastructure are
essential for private sector operations even though they are not primarily directed
at the private health sector. For health service businesses, access to electricity,
water, and sewerage facilities are core technical inputs. Efficient government production
of these services has a tangible benefit in terms of creating an enabling environment
for private providers.
144
Strategies for human resources and ameliorating brain drain
Deficits in human resources contribute to disparities in health and health-care access.
Nigeria has a large health workforce training capacity (and one of the largest health
workforce stocks) in Africa, but still has substantial deficits. These deficits are
partly due to a correspondingly large emigration of skilled health workers from the
country, known as brain drain, which is predominantly due to push factors.
148
It is not so much that the professionals plan from the beginning (ie, as students)
to leave because they are seeking greener pastures, but the conditions (eg, of life
and work) in the country typically experienced after graduation that makes them want
to leave. Emigration occurs at all stages of professional life, from early to late,
so what really matters in the long run is for Nigeria to have a health system that
works, so that they can stay. In addition, there are substantial disparities in the
supply and distribution of health professionals across states and geopolitical zones.
There are no national or sub-national policies guiding the postings and transfers
of health workers in Nigeria. Within states and LGAs, deployment is often based on
the discretion of administrative officers with multiple influences and competing interests.149,
150 Such policies are required at different levels of government.
The share of health personnel is relatively low. As of 2010, there are around ten
doctors per 100 000 population on average in each state in the country, a figure that
is lower than the sub-Saharan African average of 17 doctors per 100 000 population,
according to WHO Global Health Workforce estimates.
151
Community Health Extension Workers are local residents who receive training to provide
basic health services to their communities. They generally have less medical training
than doctors or nurses and make up the vast majority of healthcare workers at PHC
facilities, consisting of up to 57% of staff at health facilities in LGAs, much more
than than the proportion of doctors (8%), nurses (14%) and nurse-midwives (21%) at
health facilities at LGAs. There are opportunities to up-skill Community Health Extension
Workers, creating a professional career path linked to PHC facilities with defined
income, roles and responsibilities, and reporting and supervision arrangements, potentially
improving access to health services.
To minimise brain drain and maldistribution, it is important to establish local structures
for the main regulatory bodies so as to ease the process of licensure, employing,
and tracking of health professionals at state level.
152
Also, state and federal level technical support (eg, digitised registers) should be
provided to regulatory bodies to track exit of health workers effectively. These registers
need to capture internal and external migration, as well as retiring and deceased
health workers, with data periodically updated. Further, human resources for health
tracking and data management systems should be set up at state ministries of health
and linked to all training institutions and service delivery points, including the
private sector, to facilitate human resources for health planning.
Inter-professional rivalries (eg, among pharmacists, doctors, nurses, and laboratory
scientists) undermine collaborative care and the ability of the health workforce to
meet the care needs of the population.153, 154 This rivalry, as well as disputes around
remuneration, has led to multiple industrial actions like strikes and lawsuits in
Nigeria. Such actions can last from a few weeks to several months, disrupting health-care
services, worsening health outcomes, and further deteriorating working relationships
among health-care professionals.
155
These challenges require an overarching human resources for health framework developed
in a way that secures the relevant buy-in of professional groups.
To improve quality of care, it is important to standardise the training of skilled
health workers with national guidelines (eg, in undergraduate training institutions,
postgraduate specialist colleges, and for continuing education), in the public and
private training and service delivery sectors. There are examples of pilot experiences
of using WHO training manuals,
154
local training manuals,
131
or adapting international manuals.131, 132 However, efforts to standardise training
and practice will require a national process for developing (and adapting from international
examples), accrediting, and disseminating in-service or pre-service training manuals,
and incorporating them into nationally approved training curricula.156, 157, 158,
159, 160
Although the federal government could create national guidelines to improve the quality
of care, it is essential that such guidelines are localised within states and LGAs.
Improving relations between health workers and the communities they serve requires
localised training to the peculiar context of a community; for example, on interpersonal
communication or using community education to promote service uptake.
161
To ensure that health workers can perform their function as educators of the community
in matters of health, they themselves first need to learn to communicate effectively
and gain community trust.
The cadres of frontline health workers that provide health services vary by primary,
secondary, and tertiary providers. In most settings, non-physician caregivers have
little capacity to address specific conditions such as non-communicable diseases,
162
with access to care tightly linked to the country's uneven distribution of doctors.
Nurses and community health extension workers contribute substantially in rural areas
to tasks successfully shifted from physicians, but more is needed to improve non-physician
health-care worker competence for treatment of non-communicable diseases and to leverage
them for preventive care. Evidence exists showing that nurses can successfully manage
conditions such as hypertension; such task-shifting should be scaled up.
163
Technological innovation can be used to obviate on-site need for specific scarce skills
but requires sustained improvement in power and information technology infrastructure
and output. For example, electronic or mobile health (eg, eHealth and mHealth) can
be used to provide decision-making support to non-physician health-care workers in
decision making at a primary care level and for self-care of non-communicable diseases.
164
Improving health literacy for self-care or family-oriented care will also contribute
by supporting culturally-appropriate interventions.
165
Digitisation
Digital data for health
Access to media and technology is essential in improving health seeking behaviour.
For example, inadequate access and exposure to print or digital mass media (eg, newspapers,
magazines, television, radio, and mobile phones) is a consistent predictor of underutilisation
of antenatal care services.53, 54, 166 Access to these platforms is associated with
awareness of the value and availability of services.57, 167 Access to mass media tends
to be lower in rural settings than in urban settings resulting in inequitable access
to evidence-based health information. More efforts are needed to address inequities
brought on by information and technological barriers.
168
Broadcasting infrastructure via radio or digital signal should be prioritised to reach
women in remote areas, particularly individuals who are unable to read. Electronic
mass media can play a big role in targeting education and efforts to increase awareness.
Furthermore, much work needs to be done to educate Nigerians nationwide on non-communicable
diseases. For instance, patients with cancer tend to present with advanced disease,
even among people with high literacy. This results in ineffective curative efforts,
which contributes to a community perception that cancer is untreatable, and can lead
to a vicious cycle of late presentation, high mortality rates, and distrust of the
medical establishments, which are then only seen as a last resort.
169
Integration of basic preventive and curative non-communicable diseases education programmes
into print or digital mass media can improve attitudes towards non-communicable disease
prevention, diagnosis, and treatment, coupled with training of community health workers
and other health workers involved in primary care.
Digital data for decision making
Digitising aspects of service delivery can promote access and cost-effectiveness.
There are over 190 million active mobile phone lines in Nigeria, or about one per
inhabitant, with mobile internet subscriptions of 105 million per month.
170
The growth and penetration of mobile communications provides millions of people in
rural areas access to reliable communication and data transfer technology. The handiness,
widespread adoption of, and people's attachment to their mobile phones makes it an
attractive platform for delivering health programmes and services. In the hands of
trained health workers,
146
mHealth devices can assist with record keeping, obviating the need for paper-based
forms, and reducing wait times with electronic administration systems. The increased
use of digitised data will increase its visibility, accountability, and speed of work
and communication among facilities and between levels of government.
171
mHealth devices can also facilitate the quality of service delivery by developing
algorithmic clinical guidelines and job aids that could be uploaded and used from
mobile phones on which health workers can access user-friendly guidelines and protocols,
especially at the PHC level. Although national electronically-enabled guidelines,
protocols, and standard of care could be developed centrally, they require space for
local adaptation (taking into consideration local disease patterns, human resources
for health availability, and task shifting realities), supported by training and mentoring
to achieve desired improvements in quality of care.
172
The benefits of digitising health information systems in a middle-income country such
as Nigeria outweigh the investments necessary for its actualisation, and commitment
to such a system will eventually lead to increased data quality and usage.173, 174
In Nigeria, private sector telecommunication companies, backed by international investment
are constructing infrastructure for mobile internet access. Regulatory support by
the federal government is needed for its improvement in urban areas and expansion
into rural and remote parts of the country.
The Federal Ministry of Health (FMoH) has invested in the implementation of a District
Health Information System version 2 (DHIS2), which is an open access, cloud-based
data management system for data collection, management, and analysis in use by ministries
of health in 72 LMICs.
175
Designed for use in integrated health information systems, it has the potential to
increase effectiveness and efficiency of health information management systems.124,
129 A major barrier to implementing DHIS2 software at the LGA level (ie, LGA health
department office) and State Health Management Information System office level is
a shortage of or absence of functional computers, internet connectivity, and budget
support by states and local governments.174, 176 Private hospitals and federal public
hospitals, which as noted in panel 4 are not currently uploading data to DHIS2, tend
to have functional computers and internet connections (even if only in the offices
of senior personnel),122, 177 and equipment which tend to be lacking in state level
hospitals and PHC facilities.
177
Further work to improve the completeness and quality of data in DHIS2 is needed. An
essential part of this work will be further transparency and accountability in audits
and quality improvement programmes for DHIS2.
Computers might not always be the optimal choice of health information system hardware.
First, mobile phones are the most used information and communication technology device
in Nigeria,
146
and most health-care workers know how to use smartphones.
126
Second, software such as DHIS2 supports data entry via the DHIS2 web portal, mobile
Android app, or direct import, meaning that mobile technology hardware such as smartphones
can be used for direct data entry by clinicians in facilities, Community Health Extension
Workers in communities, or even officers in LGA offices for transmission to a computer
in which accountability for it can be assured. Third, data entered through phones
is more likely to be cloud-stored compared with data entered on a computer so that
the loss or theft of a phone is less likely to result in large amounts of data being
lost. Fourth, due to frequent and long-lasting power outages in Nigeria, computers
could be impossible to use for real-time data entry, whereas phones and tablets by
contrast have long-lasting batteries and require less energy for recharge. Fifth,
phones offer more options for connectivity than computers. Finally, for data capture
in remote areas, the portability of small mobile devices is an asset particularly
when health-delivery materials (eg, vaccines) must also be transported.
Mobile data entry by different people onto the same database speeds up reporting,
126
and can make the process more convenient for time pressed and overworked health workers.
Although it could increase fragmentation in the short term, the degree of fragmentation
is substantially less than with paper-based records currently in use. Health-care
facilities at all levels, private and public, and State Health Management Information
System offices and local governments, should be supported and incentivised to take
advantage of collaborative opportunities presented by local and international hardware
and software developers and engineers in testing and advancing innovative solutions
to their health information and communication technology challenges. To aid progress
towards routine use of electronic information systems—whether they are facility based
or used for collection of population level data on health and the determinants of
health—investment in homegrown health information and communication technology solutions,
generation and dissemination of high-quality evidence, and standardised evidence-based
guidelines for the adoption and implementation of electronic health information systems
are necessary. As the benefits of electronic systems are realised by a growing number
of actors in the health sector, demand for health information and communication technology
will increase.
121
Further, digitisation can enable the analysis and use of data by health workers who
are also responsible for collecting the data, thus increasing the completeness and
accuracy (ie, quality) of data and promoting local accountability,127, 128, 129 and
encouraging motivation and commitment. Although digitisation can ensure centralisation
of data analysis and decision making, it can also promote its localisation and facilitate
completeness, accuracy, and timeliness of data collected, beginning at the community
level.
However, we understand that a reformed set-up of centrally determined but locally
delivered systems cannot be achieved without the buy-in of ministers of health who
will be saddled with the responsibility of midwifing this idea. One key challenge
of the Nigerian health system since 1960 is the nature of the qualifications and skillsets
of previous health ministers, who are mostly not a good fit to provide the correct
leadership and direction of the health sector in Nigeria. For instance, many of the
health ministers in Nigeria from 1960 to date have been trained medical doctors, but
without broader public or systems training in many cases. Others include a health
economist, a professor of parasitology, an educationist, two Nigerian navy admirals,
a civil engineer with a law degree, a lawyer who was also a pharmacist, and a reformist
or teacher. There is still a latent understanding in Nigeria that medical doctors
are more suited for the office of a health minister. As health-care delivery models
have evolved, the skillset and portfolio needed in leadership positions to deliver
the required improvements in the Nigerian health system need to be updated as well,
with political leadership making these selections sensitised accordingly. Nigeria
needs health sector leaders who are versed in health policy and administration, health
economics, one health, digital health, planetary health, and with vast understanding
of what works in the Nigerian context.
Improved links with communities and traditional institutions
As discussed in Section 2, the history of the Nigerian health system, particularly
given its colonial roots, has resulted in a particular estrangement from communities,
traditional leadership structures, and religious entities. Yet there is compelling
evidence showing that religious organisations play an important role in health promotion
and service uptake. Christian and Muslim leaders promote HIV prevention through preaching,
counselling, and education sessions,
178
although religious groups tend to centre their HIV prevention messages on abstinence
and faithfulness within marriage, and on punishment and condemnation for people with
HIV. There are denominational differences in messaging, and urban churches have more
resources for HIV prevention programmes compared with rural churches. In addition,
religious leaders across Nigeria have a high level of knowledge about sickle cell
disease, engage in premarital counselling on sickle cell disease, and promote genetic
testing and counselling among their congregation members.
167
There is also a tendency for a higher level of contraceptive uptake among women who
had exposure to family planning messages from religious leaders compared with individuals
without such exposure.
179
The Global Polio Eradication Initiative in Nigeria was enabled by the positive role
that religious leaders play in health promotion and service uptake.
180
Religious leaders across northern Nigeria, particularly in Muslim communities, mobilised
caregivers against social norms that prevent families from vaccinating their children.
Muslim and Christian clerics delivered messages during sermons and other religious
gatherings to dispel negative attitudes toward vaccinations and other health services.
Cooperation between immunisation teams and religious leaders means that vaccines can
be received at places of worship. The awareness campaigns championed by the religious
leaders have contributed substantially to the polio eradication efforts and reduction
in infant and maternal mortality in these states.
137
Indeed, religious leaders of different faiths are active change agents for shaping
norms and informing behaviours about health in Nigeria. As gatekeepers, they substantially
influence and shape people's ideas and views about health issues—effects that can
be magnified when they form networks with traditional leaders (panel 7). Despite this,
both groups are often ignored in efforts geared towards accelerating action in several
areas of health.
Panel 7
Landscape mapping and social network analysis of traditional leaders in six northern
Nigerian states
Traditional and religious institutions in northern Nigeria are among the most trusted
and influential institutions in communities across the region. A landscape mapping
and social network analysis of the network of traditional community leaders was conducted
in six states (Bauchi, Borno, Kaduna, Kano, Sokoto, and Yobe) to describe the characteristics
of the group, identify influential persons within the traditional institutions and
communities, and describe how their social network influenced health-related decisions
at the community level (see appendix for additional details on methodology).
The study analysed actors in separate influence and contact networks, revealing considerable
diversity among the six states, in terms of governance of the clusters of traditional
leaders in both their influence and contact networks. Each network includes 1000 actors
who are mentioned the highest number of times in all interviews. In states such as
Bauchi, the study revealed a network of influence with distinct cliques within several
local areas and a separate cluster corresponding to actors with state-wide relevance
and influence. Influencers in some local areas operated both at local and state levels;
in other areas, influencers were only at the local level, and yet in some other areas,
only at the state level. In contrast, influence networks in Sokoto did not display
distinct local area or state-wide influence structures, likely due to a failure to
establish robust governance structures that mix hierarchical and peer relationships.
Another type of governance structure was observed in Borno where influence networks
within all local areas are well-developed, but a state-wide influence network does
not exist, nor are local area-level influence networks connected laterally to one
another. This situation means that influencers are confined to a defined local area
without access to a state-wide influence network to reinforce or extend their influence.
The composition of influence and contact networks in the six states as a function
of actor type showed dominance of traditional leaders in influence networks whereas
religious leaders dominated contact networks. The combination of traditional and religious
leaders appears to be the mechanism for extending the influence of traditional leaders
who have more restricted contact networks. This analysis informed the community engagement
strategy developed in the six states to increase demand for routine immunisation and
primary health-care services.
Section 5: investing in the future of Nigeria—health for wealth
Prosperity, macroeconomics, and health
The total GDP of Nigeria was estimated at $448 billion in 2019.
181
Five sectors are the major contributors to Nigeria's GDP with the largest being agriculture
contributing about 24·5% to the total nominal GDP in 2020,
182
followed by trade at 13·9%, manufacturing at 12·8%, information and communication
at 11·2%, construction at 7·6%, and mining and quarrying at 7·1%.
182
The GDP per capita was US$2230 in 2019,
183
the per capita total health expenditure was $72·7 and the proportion of total health
expenditure relative to GDP was 3·6% in 2018.
184
Moreover, most of this expenditure was private with public spending as a percentage
of total health expenditure constituting only 16·3%, whereas private spending as a
percentage of total health expenditure was 76·6% and out-of-pocket spending as a percentage
of total health expenditure was 74·9%.
184
External resources as a percentage of total health expenditure was 7·7%.
184
Total health expenditure as a percentage of GDP has remained between 3·4% and 4·1%
since 2006 (figure 7).
Figure 7
Total Health Expenditure per capita mirrors GDP per capita
Nigeria hosted and signed the 2001 Abuja declaration,
185
in which African governments committed to allocate at least 15% of government spending
to health. The low levels of total health expenditure to GDP ratio and public spending
on health, and the heavy burden of disease shows that it is important that overall
health expenditure is increased. Without an increase in total health expenditure to
GDP ratio, only an increase in GDP will lead to a rise in total health expenditure
(from all sources, most currently being out-of-pocket). Nigeria should concurrently
increase its GDP, the overall fiscal space, and the proportion of the budget allocated
to health as outlined further on in this Commission.
Concerted advocacy and community engagement efforts from committed and powerful national
and state-level institutions and civil society organisations could push health (including
harm-reduction and pro-health multisectoral policies) and health-care funding up the
political agenda, making it a key election issue. In subsequent elections, holding
politicians to account at the ballot box for their previous promises to improve health
and access to healthy environments, could engender sustained progress. The COVID-19
pandemic and other health security risks could present the opportunity to increase
this advocacy through political engagement. The investment case for health spending
in Nigeria is clear; health spending provides value for money and can be politically
rewarding.
The investment case
Value for money
Spending existing revenues in ways that efficiently and equitably decrease the burden
of disease to in turn reduce health-care need is crucial, as is direct investment
in multisectoral action to prevent disease (table 4) and better strategic purchasing
in the health sector to improve diagnosis and treatment.
Table 4
Multisectoral actions for health with high benefit to cost ratios by policy area
Benefits
*
Costs
†
Benefit to cost ratio
‡
186
Universal access to contraception
Around US$60 billion, given that Nigeria has around 20% of global maternal deaths,
and around 10% of global newborn deaths and estimated, not counting the reduction
in costs in maternal and newborn health services
$25 million in 2022 (of which $22 million is still required)
$120 benefits per $1 spent
Make beneficial ownership information public
An estimated $15·7 billion flows out of Nigeria illicitly each year including theft
of billions of dollars of oil revenues;
187
this money could entirely fund the aggressive scale-up of health coverage to achieve
the health SDGs as shown in table 5
Creating and maintaining online beneficial ownership registries and associated incentive
or enforcement mechanisms is likely to cost only a few million dollars (eg, a World
Bank project in Nigeria is costed at $0·5 million
188
$49 benefits per $1 spent
Reduce child malnutrition
8·7 million disability-adjusted life-years and 183 000 lives saved annually, 3 million
cases of stunted growth among children aged younger than 5 years averted
189
$837 million annually
189
$45 benefits per $1 spent
Air pollution (eg, clean transport and industry, and renewable energy rather than
fossil fuels)
2·1% GDP loss averted and 11 200 premature deaths (60% in children aged younger than
5 years) averted (according to a study in Lagos state)
190
Implement and enforce vehicle and industry emissions standards, solar cells, and battery
storage
..
Modern cooking fuels
35% reduction in disease incidence, around 1 h time savings per household per day,
and forest preservation
191
Switch to liquified petroleum gas fuel and improved stoves approximately $50 per family
per year
191
$15 benefits per $1 spent
Eliminate open defecation
Around $3·6 billion per year in lost health and time costs due to open defecation
and poor sanitation (meaning disease and subsequent time off work?)
192
Around $150 million per year government investment, supplemented by around $600 million
per year by households to construct toilets for all households that have lacked them
for 10 years or longer
192
$6 benefits returned per $1 spent
*
Annual health, social, economic, and environmental benefits.
†
Annual costs for coverage of population of Nigeria in need.
‡
Global estimates, Nigeria likely to have higher benefit to cost ratio as per the preceding
columns.
Rapidly increasing health expenditure, even by as little as $30 per capita per year
(around $6 billion per year; table 5) could substantially improve coverage of essential
health-care packages resulting in less sickness and death for millions. This increase
in health expenditure in turn would improve wellbeing and economic output via increased
individual, family, and community activity, and contribute to a rapid improvement
in the nation's wealth. Delivering such an improvement in health and wealth would
bring political dividends to national and state governments. The promise of this win-win-win
situation therefore necessitates overcoming the barriers stopping it from happening.
Table 5
Estimated programme and health system strengthening costs 2021–30 extrapolated from
the National Health Strategic Development Plan 2 (NSHDP2) (2018–22)
Moderate scale-up scenario
*
Aggressive scale-up scenario
†
NSHDP2 programme costs (billion [₦]) for moderate scenario 2021–30‡
Cost per capita (US$, 2021–30 total)§
Cost per capita, per year ($, from 2021 increasing annually to 2030§
NSHDP2 programme costs (billion [₦]) for aggressive scenario 2021–30‡
Cost per capita ($, 2021–30 total)§
Cost per capita, per year ($, from 2021 increasing annually to 2030§
Programme area
MRH
₦490 billion
$5·48
$0·50–$0·58
₦5403 billion
$57·61
$5·37–$6·07
Child health
₦181 billion
$1·94
$0·19–$0·19
₦2195 billion
$22·97
$0·86–$3·32
Immunisation
₦135 billion
$1·50
$0·11–$0·18
₦2210 billion
$23·02
$0·61–$3·57
Adolescent health
₦231 billion
$2·54
$0·11–$0·37
₦2694 billion
$28·51
$2·15–$3·46
Malaria
₦97 billion
$1·03
$0·10–$0·10
₦758 billion
$8·11
$0·81–$0·81
Tuberculosis
₦24 billion
$0·26
$0·03–$0·03
₦324 billion
$3·45
$0·31–$0·38
HIV/AIDS
₦201 billion
$2·23
$0·16–$0·27
₦2033 billion
$21·74
$2·17–$2·17
Nutrition
₦286 billion
$3·17
$0·21–$0·40
₦3179 billion
$33·72
$2·70–$3·95
WASH
₦59 billion
$0·66
$0·05–$0·08
₦529 billion
$5·63
$0·50–$0·62
Non-Communicable Diseases
₦265 billion
$2·92
$0·16–$0·40
₦2758 billion
$29·26
$2·37–$3·41
Mental health
₦85 billion
$0·94
$0·05–$0·13
₦840 billion
$8·90
$0·68–$1·07
Neglected tropical diseases
₦2 billion
$0·03
$0·003–$0·003
₦57 billion
$0·61
$0·06–$0·06
Health promotion and social determinants of health
₦5 billion
$0·05
$0·005–$0·05
₦69 billion
$0·74
$0·07–$0·07
Emergency hospital services
₦10 billion
$0·11
$0·01–$0·01
₦172 billion
$1·84
$0·18–$0·18
Public health emergencies, and preparedness and response
₦1 billion
$0·01
$0·001–$0·001
₦10 billion
$0·11
$0·01–$0·01
Total
₦2072 billion
$23
$2–$3
₦23233 billion
$246
$19–$29
Health system strengthening
Programme activity costs
₦688 billion
$7·36
$0·74–$0·74
₦999 billion
$10·68
$1·07–$1·07
Human resources
₦6317 billion
$70·54
$6·07–$7·82
₦6430 billion
$68·46
$6·10–$7·45
Infrastructure
₦1074 billion
$11·49
$1·15–$1·15
₦1080 billion
$11·54
$1·15–$1·15
Logistics
₦3623 billion
$40·12
$2·65–$5·15
₦4475 billion
$47·24
$3·11–$5·98
Medicines, commodities, and supplies
₦8320 billion
$92·10
$6·00–$11·89
₦10261 billion
$108·27
$7·00–$13·82
Health financing
₦109 billion
$1·16
$0·12–$0·12
₦149 billion
$1·60
$0·16–$0·16
Health information systems
₦48 billion
$0·52
$0·05–$0·05
₦80 billion
$0·86
$0·09–$0·09
Governance
₦72 billion
$0·77
$0·08–$0·08
₦149 billion
$1·60
$0·16–$0·16
Total
₦20 252 billion
$224
$17–$27
₦23 625 billion
$250
$19–$30
MRH=Maternal and reproductive health. WASH=Water, sanitation, and hygiene. US$=US
dollars (with an assumed exchange rate of 395 Naira per dollar).
*
Moderate scale-up scenario. NSHDP2—average coverage increase of 17·5% during 2018–22,
extrapolated to 2021–30.
†
Aggressive scale-up scenario. NSHDP2—average coverage increase of 30% during 2018–22,
extrapolated to 2020–30.
‡
2021–30, a total of 10 years of costs calculated from NSHDP2 costs by extrapolating
from 2020, 2021, and 2022 costs from Tables 54 and 55 (moderate scale-up) or Tables
56 and 57 (aggressive scale-up) of the NSHDP2
11
to get costs for each year from 2021 to 2030, and then summing up those costs. Simple
extrapolation of the trend was done by dragging cells in Excel (version 16) (assuming
continued constant rate of change). Any negative trend was removed and the projected
population increase was also accounted for so that the 2021 per capita cost was repeated
for all years to 2030 and used to calculate the total costs for 2021–30 (a flat trend
resulting from the removal of a negative trend is apparent in which the per capita
costs stay the same throughout 2021–30).
§
Population of Nigeria for years 2021–30 taken from the UN Department for Economic
and Social Affairs
1
Increasing health expenditure as outlined in table 5 only constitutes approximately
2·5 times the current $11·85 (16·3%) public spending of total health expenditure per
capita of $72·7 in 2019.
184
The true costs required, however, are likely to be much higher than these costs extrapolated
from the National Health Strategic Development Plan 2 (NSHDP2; 2018–22).
For example, given experience with the COVID-19 pandemic, far more than $0·01 per
capita per year is likely to be needed for adequate provision for the programme area
of public health emergencies, preparedness, and response. Similarly, for neglected
tropical diseases to be addressed (figure 5), far more than $0·06 per capita per year
expenditure is required. Investment in health promotion and social determinants of
health also needs increasing from $0·07 per capita per year to several dollars per
capita at least, especially considering such funding would reap many times the amount
in benefits (table 4). It is also important to note that total health expenditure
per capita has been as high as $108 in 2014,
193
even though health coverage and outcomes are poor, which is likely to be related to
the high proportion derived from out-of-pocket expenditure.
194
Therefore, it would be prudent for the government to at least double annual health
expenditure per capita to $168 or perhaps even triple it to $252, while dramatically
increasing the proportion that is public expenditure (or pooled funding) and reducing
out-of-pocket expenditure, as has been attempted in India and Ethiopia (panel 8, table
6). These increases would entail investments of ₦157 trillion to double annual health
expenditure or ₦236 trillion to triple annual health expenditure for the whole of
the 2021–30 period, or 10–15% of total GDP over the decade (2020 GDP for Nigeria was
estimated at ₦152 trillion
182
). Nigerian Governments must recognise this as an investment in a prosperous nation
rather than a cost.
212
Given the size and importance of this investment, it must also be accompanied by measures
that promote efficiency and effectiveness throughout the system, while prioritising
interventions that give the most value (ie, health) for money. To illustrate the value
of efficient spending on health, panel 9 and figure 8, show how investments in maternal,
neonatal and child health can save millions of lives in Nigeria over the next decade.
The estimated $10·5 per capita per year is slightly more than that estimated for maternal
and reproductive health ($5–6) and child health ($1–3) combined from the NHSDP2 aggressive
scale-up scenario (table 5).
Panel 8
Country case studies of reduction of out-of-pocket expenditure to increase access
to health care—India and Ethiopia
India
India, like Nigeria, is a lower-middle income country with historically low health-care
expenditure and a heavy reliance on out-of-pocket payments to finance care. Both countries
have health systems shaped by the federal structures of their countries, large populations,
and fragmented health systems with different levels of government, and complex combinations
of public and private sectors that make wide-scale reform difficult. In the past few
years, however, India has embarked on a series of reforms to extend health care and
financial protection across the population that might offer some important insights
as Nigeria pursues universal health coverage. In 2018, it was estimated that 50–60
million Indians were pushed into poverty each year as a result of health-care expenditure,
195
with the effectiveness of the multitude of insurance schemes at protecting against
catastrophic health-care expenditure limited by insufficient resourcing and coverage
gaps.196, 197, 198, 199, 200, 201, 202 In the face of this challenge, the cabinet
of the Indian Government approved the ambitious Ayushman Bharat Pradhan Mantri Jan
Arogya Yojana (AB-PMJAY) in March, 2018. The scheme aims to build on existing schemes
to provide publicly-funded health insurance cover of up to 500 000 Indian rupees (almost
US$7000) per family per year to about 100 million of the most vulnerable Indian families
(500 million people, 40% of India's population).203, 204, 205Benefits are India-wide
such that a beneficiary can access cashless care across the country; however, state
authorities are responsible for the implementation of the programme and they can choose
the operating model, either using funding to pay a private insurance provider to cover
services, provide services directly, or a mix of the two.
203
The scheme has been designed to either replace or operate alongside other state-based
initiatives.
203
Expenditure under the programme is shared between the central and state governments
in a prespecified ratio depending on legislative arrangements and the relative wealth
of the states, with the Indian government covering between 60%–100% of expenditure.
A substantially proportion of private providers have been empanelled under the scheme,
reflecting the importance of the sector to care patterns in India. Although hospital
care is covered under the scheme, AB-PMJAY is built on a substantial increase in primary
care investment across India through the establishment of over 50 000 health and wellness
centres across the country. The country has also established Health Technology Assessment
in India, a new body formed to drive cost-effectiveness through health technology
assessments of publicly-financed interventions.
206
A number of other investments have been made attempting to ensure the system can effectively
implement the programme with the establishment of new governance structures and substantial
investment in IT systems across the country for example. The programme has also taken
on substantial political importance in India, allowing the government to leverage
widespread popular support for improved health care.
207
Ethiopia
Ethiopia has made progress in provision of PHC, 208 and out-of-pocket payments expenditure
has reduced from 47% in 2011 to 35% in 2018.
209
Ethiopia's Community-Based Health Insurance scheme has improved access to care, reduced
out-of-pocket payments, and also managed to improve quality of care to some extent
via increasing health facility revenue that has then been used to reduce drug stockouts
and make other improvements that have increased patient satisfaction.
210
The Ethiopian government has committed to further reducing the effect of high out-of-pocket
payments and catastrophic health expenditure by incorporating considerations of financial
protection and equity in determining which services to fund. The Essential Health
Services Package of Ethiopia 2019
211
determines which services should be publicly funded and was devised based on seven
criteria including burden of disease, cost-effectiveness, and financial risk protection
(ie, the potential of interventions to avert catastrophic expenditure or incur financial
hardship). Another of the seven criteria is equity, which assessed the effect on specified
groups including economically poor individuals and those in remote areas, therefore
also contributing to financial protection. All interventions were ranked on their
financial risk protection potential and then this score (alongside those for the other
criteria) was used in the decision to fund or not fund specific interventions. See
Table 6 for a comparison of key health financing indicators between Nigeria, India
and Ethiopia.
Table 6
Key health-care financing indicators for 2018 for Nigeria, India and Ethiopia
Nigeria
India
Ethiopia
Gross national income per capita ($US)
2030
2120
800
Health-care expenditure as % of GDP
3·9
3·5
3·3
Health-care expenditure per capita ($US)
83·75
72·84
24·23
Proportion of health-care expenditure out-of-pocket
76·6
62·7
35·47
Out-of-pocket expenditure per person ($US)
64·16
45·64
8·59
Data are from The World Bank DataBank and WHO Global Health Expenditure database.
Panel 9
Maternal, neonatal, and child mortality in Nigeria—saving millions of lives
Although there have been improvements over the past 5–10 years, the level of maternal,
neonatal, and child deaths are extremely high in Nigeria placing an immense health
and economic burden on the population, severely curtailing economic and social development
across the country and leaving Nigeria off-track to achieve the related sustainable
development goals (panel 5). Although these rates are a national tragedy, experience
in other nations suggest that the majority can be overcome with a package of existing,
and often low-cost, interventions. To assess the potential effect of health system
investment targeting these interventions, we used the UN inter-agency developed Lives
Saved Tool (LiST) to dynamically project the health and cost effects between 2021
and 2030 of three scenarios of policy intervention: (1) baseline (no improvements
in intervention coverage); (2) moderate increased investment (defined as linear progress
to 20% increased coverage of interventions relative to baseline); and, (3) universal
coverage (defined as linear progress to 90% coverage of interventions). Further details
of the interventions included, the LiST tool, and projection methods are detailed
in the appendix.
Under the baseline scenario, the maternal mortality rate worsened slightly by 2030
(a result of demographic changes), and neonatal and under-five mortality rates were
largely stable. The results for the other scenarios are striking—figure 8 shows the
numbers of deaths averted each year for the moderate and universal coverage scenarios.
In total, over 309 000 maternal, 967 000 neonatal, and over 2·61 million child deaths
could be averted under the universal health coverage scenario by 2030 relative to
baseline. For the moderate scenario, over 160 500 maternal, 664 000 neonatal, and
almost 806 000 child deaths could be averted relative to baseline. Importantly, much
of this care is nurse, midwife, or community health worker-led (rather than doctor-led),
although the scale-up scenarios require large increases in the health workforce particularly
for these groups. Given this health impact, the costs required to implement the package
are modest and increased investment in the area is likely to be considered very cost-effective
under all commonly considered definitions.
An analysis of the estimated additional costs for these 10-year scale-up scenarios
suggests that the universal health coverage scenario provides good value for money.
Although the universal health coverage scenario is substantially more expensive than
the other options, the per capita cost (using the population projections under each
scenario) are relatively modest. Under the universal health coverage scenario for
example, a total additional expenditure per person equivalent to less than $64 (₦
26 612) per person will be required for the entire period (2021–30), comprised of
steadily rising annual costs that will reach $10·5 (₦ 4366) per person in 2030 on
top of baseline expenditure. This amount constitutes approximately a 13% increase
on 2018 health spending of $83·75 (₦34 827) per capita. In contrast, the moderate
scenario requires a total additional expenditure per person equivalent to just over
$12 per (₦ 4990) person over the 2021–30 period, but which a much smaller reduction
in maternal, neonatal and child deaths, as shown in figure 8.
Figure 8
Maternal, neonatal, child deaths, and still births averted relative to baseline scenario
UHC=universal health coverage
Table 7 and table 8 are from an analysis by Ezenwaka and colleagues (Onwujeke O, unpublished),
which detail the projected number of health workers and health facilities required
to achieve a moderate scale-up of 5% coverage of health care per year for 10 years
until 2030. This scale-up is a 63% increase in coverage, and a corresponding 63% increase
in all cadres of health workers and health facilities could be needed to deliver this
gain. Newly recruited health workers will require training, supportive supervision,
and adequate salaries and benefits. New facilities will need to be planned, constructed,
and maintained, with a key consideration being facility locations that reflect health
needs. In an analysis of health facility data, we show a clear association between
the quality of health facility infrastructure and childhood vaccination outcomes at
state level (appendix pp 15–16).
Table 7
Health workers needed for moderate scale-up scenario by 2030 (5% per year for 10 years,
63% increase over the decade; Onwujeke O, unpublished)
Number of staff in 2020
Number of staff in 2030
Health service providers
Community health officers
6227
10 144
Dental technicians
1961
3194
Dental therapists
3384
5512
Doctors
68 415
111 441
Nurses and midwives
12 836
20 908
Medical laboratory scientists
20 001
32 581
Medical laboratory technicians
8533
13 899
Nursing assistants
1560
2542
Occupational therapists
35
57
Optometrists
2784
4535
Pharmacy assistants
107
175
Pharmacy technicians
1923
3134
Physiotherapists
2932
4776
Senior community health extension workers
44 673
72 767
Junior community health extension workers
29 607
48 227
Health management and support personnel
Accountants
3762
6128
Administrative officers
7043
11 473
Catering, cooks, and stewards
1062
1730
Cleaners, labourers, and gardeners
329
537
Clerical officers
7055
11 493
Community health extension workers admins
1979
3223
Community health officer admins
566
922
Data processing officer
712
1161
Dental technician admin
240
391
Director admin
8736
14 230
Environmental health officer
6806
11 087
Health information management officer
1038
1691
Health record officer
4434
7223
Messengers
322
526
Mortuary officer
30
49
Nurse and midwives admin
2977
4850
Nurse and midwives tutor
201
328
Pharmacist admin
569
927
Pharmacy technician admin
253
413
Planning officer
553
902
Plaster technicians
40
66
Procurement officers
403
658
Senior auditors
93
152
Social worker
1013
151
Statistician
396
646
Store officers
1505
2452
Ward attendant
448
730
Watchman and security
751
1223
Works and maintenance
4696
7649
Table 8
Health facilities needed for moderate scale-up scenario by 2030 (5% per year for 10
years, 63% increase over the decade; Onwujeke O, unpublished)
Number of facilities
Average number of beds
Average occupancy bed rate (%)
Baseline year (2020)
Target year (2030)
Baseline year (2020)
Target year (2030)
Baseline year (2020)
Target year (2030)
Primary
28 202
45 938
8
14
45·2
73·6
Secondary
1327
2162
91
163
57·3
93·4
Tertiary
104
169
346
621
63·9
95·0
Specialist hospital
35
57
147
264
59·5
97·0
Federal medical centre
24
40
308
553
..
..
Federal health agency
8
13
..
..
..
..
Federal ministry of health
1
2
..
..
..
..
Regulatory agencies
13
22
..
..
..
..
Health training institute
23
38
..
..
..
..
Multisectoral action on the determinants of health will play a key role in any effort
to improve health, including those related to diet, water and sanitation, air quality,
transport, habitation, and the environment.
213
Local and state governments should also be empowered to take a place-based approach
to the health of the population. This approach would include resource prioritisation
for PHC and zoning authority to prioritise healthy environments, thereby, putting
the health-in-all policies approach
214
into action beyond words. One without the other is insufficient and simply results
in an unchecked increase in disease burden and health-care needs that cannot be adequately
addressed in PHC.
Political benefits
Targeted investments in the health sector that will improve financial and physical
access to priority public health services and consequently improve health outcomes
should markedly bolster the positive image that the citizenry have of the initiating
level of government. Examples of past programmes that have paid off politically include
the Saving One Million Lives initiative targeting maternal, newborn, and child health
interventions, the NPHCDA Primary Healthcare Centre Revitalisation strategy targeted
at ensuring there is at least one PHC in every ward across the country to promote
access, and the Primary Health Care Under One Roof strategy to integrate management
of PHCs for more efficiency, as well as the now defunct Subsidy Reinvestment and Empowerment
Programme for Maternal and Child Health (SURE-P MCH) and National Health Insurance-Millennium
Development Goals (NHIS-MDG) programmes. The branding of such special programmes is
usually effective for galvanising political support and ensuring that the beneficiaries
are aware of the sources of the interventions.
Ensuring accountability and mitigating against corruption
Corruption has been defined as the abuse of entrusted power, such that a person, group,
or organisation acquires undue benefits. These benefits might be financial, material,
or non-material.215, 216 Health systems are especially susceptible,217, 218 often
with life-threatening consequences. Yet, corruption in the health sector is often
seen as intractable.
215
Health sector corruption impedes access to health care, therefore, effective solutions
are needed to tackle them. Universal health coverage should mean action on determinants
of health and health-care provision. The Nigerian Government and commercial and industrial
interests therefore need to be held accountable for ensuring Nigeria is a healthy
country to live and grow in. Nigeria cannot achieve universal health coverage if the
system is corrupt. The most common types of corruption in the Nigerian health system,
which has to be eliminated for the country to make reasonable progress in achieving
its health goals are absenteeism, procurement-related corruption, under-the-counter
payments, health financing-related corruption, and employment-related corruption.
218
Experience from other settings shows that although the health sector plays a crucial
role in advocating for this approach, there is need for a cross-sectoral mechanism
to facilitate and coordinate measures to address corruption (eg, the office of the
governor or mayor or equivalent).219, 220 There is also a need to explicitly address
accountability, value for money, and corruption in the Nigerian health sector. Institutional
mechanisms to govern procurement, prevent informal payment, and discourage absenteeism
also need to be set-up and managed with high-level oversight and accountability. Informal
payments and employment-related corruption were most feasible to tackle. Frontline
workers and policy makers agreed that tackling corrupt practices requires both vertical
(eg, regulations and penalties) and horizontal approaches (eg, collective efforts
of health workers, local government administrators, and community groups in the locality
of health facilities and grassroots movements).
218
To improve accountability, transparency, and efficiency, and reduce corruption, it
will be important to strengthen public financial management systems within the health
sector at the federal, state, and local government levels. This process will involve
governments ensuring that expenditure tracking mechanisms are instituted and routinely
applied at all levels of government for both government and donor spending, and the
Ministries of Finance promptly transferring funds to institutions within the health
sector against approved plans. There should be capacity building of managers at national
and subnational levels on budget negotiation and management. Data systems and transparently
publishing information will allow citizens to hold public officials to account, especially
if revenue is raised primarily through taxation. Finally, given that many of the officials
that are responsible for implementing these accountability systems are often directly
or indirectly involved in the failings, we draw on the ideas of North
221
to call for action that goes beyond individuals and focuses on institutions, broadly
defined to include formal and informal processes to help in achieving accountability.
Funding the health system
Funding sources and their shortcomings
Nigeria continues to spend very little on health and health care compared with its
peers in the region and around the world (figure 9). As of 2018, the share of government
spending assigned to health care was only 5·2%, slightly above the average of 3·4%
between 1981 and 2018. The share of government spending has been as low as 0·2% (1992)
with the highest share of spending in 2011 at about 7% (appendix p 33). Compared with
the rest of Africa, Nigeria's Government spending on health care is only 0·5% of GDP,
lower than the African regional average of 2% and the world average of 3·5% as of
2017 (figure 9).
Figure 9
Health spending statistics per region, 2017
Data are from The World Bank DataBank.
Government spending in total health expenditure across four major categories (government
spending, out-of-pocket spending, external development assistance, and prepaid private
spending) is both lower and more volatile in Nigeria compared with other countries
in the sub-Saharan Africa region.
222
The share of government spending in total health expenditure was 26% on average between
1995 and 2014, lower than the sub-Saharan Africa average of 37%. Out-of-pocket spending
is a much higher share of health expenditure in Nigeria than in sub-Saharan Africa
(appendix p 34). There is a strong negative correlation between the share of government
spending in total health expenditures and the share of out-of-pocket spending in total
health spending in Nigeria at –0·92 (p<0·001), presenting a contrast with the sub-Saharan
Africa region where there is no significant correlation between the two. In Nigeria,
the share of out-of-pocket spending on health was 67% on average between 1995 and
2014, reaching 70% in 2014, which is much higher than the average of 31% in sub-Saharan
Africa over the same period. Nigerians are forced to rely on out-of-pocket expenditure
when government spending on health falls, imposing a substantial economic cost in
a country where 40% of the population, nearly 83 million people, live below the poverty
line of $382 per year according to the 2019 National Bureau of Statistics estimates.
223
The National Strategic Health Development Plan 2 (2018–2022) set a target of reducing
out-of-pocket expenditure to 35% of overall health expenditure, however the latest
available data from 2019 show that out-of-pocket expenditure has not reduced and still
accounts for over three-quarters (78%) of all health expenditure.
193
Indeed out-of-pocket expenditure has not been below 70% since 2005. The vast majority
of the burden of financing health care therefore is on the people of Nigeria, presenting
a serious barrier to care-seeking, entrenching inequality, and inducing catastrophic
health expenditure and medically-induced poverty for many Nigerians every year. The
World Bank estimates that 50% of Nigerians were at risk of catastrophic health expenditure
for surgical care in 2020, with the percentage varying from 38% to 54% between 2007
and 2020.
224
Studies in Enugu and Anambra states have shown rates of 15%
225
of actual catastrophic health expenditure in 2008 and 27%
226
in 2010, with catastrophic spending measured at a threshold of 40% of non-food expenditure.
In the past two decades, external development assistance has grown in importance,
constituting 7% as a share of total health spending in 2014.
222
Countries that effectively utilise donor funding generally have stronger health systems,
governance, and financing.
227
However, the performance of donor funding in Nigeria has been limited by weak government
coordination of donor activities, with sustainability also adversely affected by the
failure of some state governments to pay counterpart funds, lateness in payment, and
the problem of donor fatigue.
228
The final major category for health financing is prepaid health spending, largely
consisting of spending on private health insurance. Prepaid health spending has remained
extremely low over time, averaging 3% of total health expenditure between 1995 and
2014, compared with 21% for sub-Saharan Africa over the same period.
222
Although there were slight increases in the share of private health insurance in total
health expenditure between 1995 and 2002, the share has fallen and is low, falling
to near its lowest point at 0·8% in 2014 (compared with 21% for sub-Saharan Africa
in 2014).
Health financing reform will be essential if Nigeria's health system is to deliver
universal health coverage to its population, as the current spending is neither evidence
nor impact driven, with inequitable distribution of resources, dysfunctional systems
to protect individuals and households from catastrophic expenditure, and little attempt
to minimise wastage.
228
Reforms should focus on increasing government funding for health, improving resource
management through strategic purchasing, altering the National Health Insurance Scheme
(NHIS) legislation to require mandatory insurance coverage using a revised and more
robust benefit package, and establishing strong systems for oversight and regulation
of providers such as Health Maintenance Organisations.
228
Ultimately, to improve financial risk protection and the effectiveness of health financing
mechanisms such as social health insurance in Nigeria, implementation bottlenecks
must be addressed within the three health financing functions, which are revenue mobilisation,
pooling, and purchasing.
Options for revenue mobilisation
Fiscal space for increased domestic funding of health services requires increases
in overall government revenue and expenditure, and increasing share of government
resources being devoted to the health sector.
229
To increase the fiscal space, Nigeria also needs to rapidly diversify its economy—for
example, by developing the digital, global, and local services sector and manufacturing—to
ensure continued and increasing government revenues. As history has shown, the over-reliance
on oil revenue for foreign exchange exposes the country to continuous financial shocks.
Building and improving government institutions and corporate governance structures
will increase investor confidence and promote foreign investments to strengthen Nigeria's
macroeconomic foundations.
230
Panel 10 provides ideas for expanding fiscal space and optimising government health
expenditure in Nigeria.
Panel 10
Increasing fiscal space and improving government expenditure on health in Nigeria
Increasing fiscal space for health
•
Improve tax collection: link national identification numbers with government-delivered
benefits, banking, and government-issued permissions; institute automated pay as you
earn tax collection via electronic payments
•
Diversify sources of government revenue (80% of Nigeria's government revenue comes
from oil receipts)
35
•
Institute health taxes on alcohol, tobacco, gambling, sugary drinks, fatty foods,
luxury goods, flying, oil and gas profits, and telecommunications and social media
•
Impose a levy on individuals seeking foreign exchange to pay for health treatment
overseas
•
Increase GDP by diversifying economic activity and increasing investor confidence
•
Dedicate a proportion of already available VAT to social health insurance
Increasing government expenditure on health
•
Institute legally-binding government commitments to distribute ring-fenced health
funding, backed by sustained and focused lobbying from national stakeholders and the
general public for universal health coverage
•
Create incentives for fully implementing detailed costed health plans by local and
state governments
•
Incentivise delivery of programmes with rewards and promotions for health-care managers
and enforce penalties for programme failures
•
Legislate for open access to data on programme delivery and expenditure to allow scrutiny
by the public at the local and national levels
•
Institute universal government pre-paid health insurance for children, pregnant women,
and vulnerable groups
•
Improve government expenditure on health—greater health for the same resources
•
Conduct studies to understand opportunity costs of alternative options for health
expenditure to maximise health outcomes for a given amount of resources
Any consideration of fiscal space typically entails an examination of whether and
how a government could feasibly increase its expenditure in the short-to-medium term.
231
The tax-to-GDP ratio in Nigeria is very low, leaving scope for increasing domestic
resource mobilisation through tax collection. The low tax-to-GDP ratio is associated
with inadequate compliance and enforcement, weak revenue administrations, low taxpayer
morale, poor governance, and corruption.232, 233 However, a multicountry study including
Lagos state in Nigeria
232
showed that increased tax revenue led to increases in public health spending in absolute
although not necessarily real per capita terms. Indeed, the percentage of the government
budget allocated to health declined for much of the period under review due to intersectoral
competition in priority setting, fiscal federalism, Ministry of Finance perceptions
of the health sector's absorptive capacity, weak investment cases made by the Ministry
of Health, and insufficient parliamentary and civil society involvement. Ministries
of Health, including Nigeria's FMoH and state-level Ministries of Health, must therefore
strengthen their ability to negotiate for larger—and ring-fenced—allocations from
government revenue through better planning, while showing improved performance and
adequate absorptive capacity and making the case for the benefits of health investments.
Health has always been a stated national policy priority for the federal government
and some state governments, as evidenced by numerous statements and policies including
the 1995 Health Summit, the revisions of the National Health Policy in 2004 and 2016,
the Health Sector Reform Programme (2003–07), commencement of the Formal Sector Social
Health Insurance Programme of the National Health Insurance Scheme in 2005, the Office
of the Senior Special Assistant the President on MDGs (Millennium Development Goals)—National
Health Insurance Scheme Free Maternal and Child Health programme, the Midwives Service
Scheme, the Presidential Summit on universal health coverage in 2014, the enactment
of the Health Act with a dedicated amount of special funds (Basic Health Care Provision
Fund), the development of the National Health Financing Policy in 2016, and the development
of the National Strategic Health Development Plans 1 and 2, and the SURE-P MCH programme,
among other initiatives. Differing emphases and funding streams for some diseases,
such as AIDS, tuberculosis, and malaria,234, 235 or for select modes of care (medical
compared with surgical services), have nonetheless created noticeable pathology-dependent
variations in financing and access to care.
Revenue disbursement, largely from oil receipts, is extremely centralised in Nigeria.
Apart from a constitutional requirement that 13% of gross oil revenue be shared among
oil producing states in proportion to their production volumes, all revenues are remitted
to the federal government.
236
The remaining revenue is paid into a federation account, which also gathers revenues
from corporate income taxes, custom and excise duties, and notably, value-added tax
(VAT) revenue from state governments. Given the substantial share of revenues from
oil in the account, the gross amount in the account fluctuates closely with exogenous
changes in the export price of oil.
236
Revenues are then shared by the federal government among the three levels of government
according to a vertical and horizontal formula. State and local governments, including
oil-producing states, have no control over the rate of federal allocations; the only
tax revenue they directly raise and control is internally generated revenues, largely
from personal income taxes and business registration and land leasing fees.
236
States are thus heavily dependent on federal transfers for revenue; for example, between
2000 and 2016, transfers from the federal government comprised 81% of state revenues
on average, with the result that political considerations often prevailed over population
health needs in setting states' spending agendas.
236
Health spending would therefore be improved by instituting a dedicated pre-determined
budget at the federal and state levels, outside of the electoral cycle, and with mechanisms
to ensure it is spent efficiently and equitably. The budget must be made public and
subject to independent auditors to ensure equity in the distribution of resources
and setting of health priorities. An increase in states' internally generated revenues
would also lower state dependence on federal funding and refocus priorities on internal
needs in determining health spending. A transparent, public process for assigning
and using grants from international donor partners, subject to independent regular
audits, is also needed. To address some of these issues, in 2014, Nigeria established
the Basic Healthcare Provision Fund, financed by an annual federal government grant
of not less than 1% of the Consolidated Revenue Fund, grants from external donors,
and other sources. 50% of the funds gathered are to be administered by the NHIS to
provide basic health services to citizens and for subsidy payments to state insurance
agencies to provide health care to the very poor who are unable to afford premium
payments; however, more far-reaching reform is needed to reach Nigeria's goal of universal
health coverage.
Using pooling and insurance systems to manage revenues and reduce the burden on poor
Nigerians
Pooling is the health financing function whereby collected health revenues are transferred
to purchasing organisations, which manage revenues and distribute risks. Nigeria should
strive to develop large pools because having small, scattered, and uncoordinated pools
will not lead to efficient and equitable financial risk protection. However, in the
case of multiple pools, such as the various State Social Health Insurance Schemes,
the Formal Sector Social Health Insurance Programme, free programmes funded by the
budget, community-based health insurance schemes, and private health insurance, risk
equalisation can be achieved via mechanisms including a dedicated fund and health
re-insurance, under the leadership of the Federal Ministry of Finance, FMoH, the National
Council of Health, and the Nigeria Governors Forum.
To further improve pooling and management of revenue, the federal, state, and local
governments should ensure the development and institutionalising of efficient, equitable,
and transparent fund management systems. Development partners should move from their
current opaque systems to ensure the pooling of donor funds that will be transparently
managed. The government, through health and finance ministries, should ensure harmonisation
and alignment of donor funding to health with national policies, strategies, and priorities.
Third-party funds pooling agents can be public, quasi-public, or private entities
depending on the context and preferences of the different levels of government.
Furthermore, the federal government needs to amend the legislation that established
NHIS and revise the benefit package so that every citizen is covered by social health
insurance, and so that it is implemented with strict oversight and regulation of Health
Maintenance Organisations.
228
Awareness and benefits of social health insurance should be increased and should be
mandatory for all. At regular intervals, the NHIS's implementation strategy should
be reviewed to fast track and improve the level of coverage among informal and formal
sector workers, with the poorest Nigerians covered by government, with the objectives
of providing universal financial risk protection and eliminating both the high level
of out-of-pocket and the proportion of expenditure it covers. Federal and state-specific
strategies should address context-related challenges of individual states (eg, the
inability to reallocate funds into the Formal Sector Social Health Insurance Programme).
In keeping with our recommendations of localising particular aspects of health services
provision, it is important to allocate more funds at the state and local government
levels for purchasing health services, with evidence-based, strategic, and appropriately-tracked
spending
137
to ensure resources are used efficiently while removing financial barriers to access
by reducing out-of-pocket expenditure in both absolute and relative terms.
136
Innovative strategies are also needed to enable potential beneficiaries, especially
in the informal sector, to better comprehend and accept the concept of prepayment
methods of financing health care, and ensure all the formal sector employees are adequately
informed about the Formal Sector Social Health Insurance Programme of the NHIS. State
and local governments can establish a tax-based health financing mechanism targeted
at vulnerable groups, the poorest groups, and individuals working in the informal
sector of the economy to accelerate progress towards universal health coverage. Lessons
can be learned from health insurance schemes in Ghana and Anambra State about potential
strategies to expand health insurance coverage among informal sector workers (panel
11).
Panel 11
Lessons on covering informal sector workers with health insurance in Ghana and Anambra
State, Nigeria
Ghana's National Health Insurance Scheme (NHIS) has been running for 16 years, and
the Anambra State Health Insurance Scheme (ASHIS) has been in existence only since
2016. They both began in response to growing out-of-pocket health spending and stagnated
government spending on health. Each scheme is mandatory by law, with different approaches
to addressing the needs of people who are extremely poor, many of whom work in the
informal sector. In less than 3 years, Anambra state health insurance scheme had covered
over 100 000 active enrolees. Although this makes up only 2·5% of the population of
Anambra, 36% of the enrolees are in the informal sector. Ghana's NHIS covers about
41% of the population and 29·8% of NHIS members are informal sector workers.
In Anambra, people in the informal sector are expected to pay a membership premium,
but there is a Philanthropists Adoption Model that targets high-income residents of
the state to purchase annual subscriptions for low-income indigenes through a mass
campaign, enabling the scheme to capture a large chunk of the informal sector. The
NHIS in Ghana is funded through a 2·5% tax on goods and services, 2·5% deduction from
formal sector workers' social security contributions, and premiums from informal sector
workers (paid progressively based on their income level, ranging from GHS7·20 (US$1·62)
to GHS48 ($10·83) per person per year). Revenue from taxes funds about 70% of the
scheme, whereas 23% comes from social security deductions, 5% from premiums, and 2%
from sources such as donors. However, the population exempt from paying premiums is
so large—for example, children (<18 years), pregnant women, and people living in extreme
poverty—that it accounts for 65% of the total population covered by the scheme.
Anambra State's Health Insurance Agency has offices in all the state's 21 Local Government
Areas (LGAs). The roll-out of the scheme was preceded by mass sensitisation on traditional
and social media and in all health facilities, with an ongoing 24-hour call centre
(for real-time resolution of enrolee or provider challenges) and annual Town Hall
meetings with stakeholders and enrolees (to discuss and address service delivery issues).
Like Anambra state, Ghana's Health Insurance Agency has offices in all districts of
Ghana, through which people register for and engage with the public scheme, which
operates alongside private schemes. In 2012, a central funding pool was created by
combining district pools, which were too small to be sustainable and too inefficient
to operate. Premiums are paid into the central pool, and the government provides subsidies
to cover exempt groups.
Registration (including self-registration) of enrolees in the Anambra state health
insurance scheme is done electronically using a locally developed insurance information
management system equipped with biometric and facial identification features. In Ghana,
all members of the NHIS register in person at a district office and renew their membership
yearly in a process that includes an in-person interview to determine exempt status
and biometric data collection. A new mobile renewal service, which allows members
to use an SMS code and mobile money to renew their membership, has been linked to
a recent surge in enrolment—from 10·2 million in 2017 to over 12 million in 2019.
In both Ghana and Anambra, electronic platforms reduce the challenge of enrolees forgetting
renewal dates, and the costs associated with in-person registration.
Most people in Ghana and Anambra state still do not enrol and many do not renew their
membership due to the cost of premiums, challenges in belonging to the large informal
sector, and the weak administrative capability of insurance agencies. In Ghana, members
are not required to contribute any co-payments, co-insurance, or deductibles. In Anambra
state, another reason for low membership is delays in reimbursement of both enrolees'
and providers' claims, which causes dissatisfaction, particularly among poorer enrolees
who have difficulty paying out of pocket. These issues are addressed through the 24-hour
hotline for complaints and feedback, a feature which has generated much public support
and confidence in the scheme. In Ghana, client expectations are managed at the district
level through community outreach and education. Expanding the reach of insurance requires
innovations that create convenient, quality, and timely services for providers and
clients.
The government, through the FMoH, has tried to invest in improvements in health-care
access by introducing policies like the Formal Sector Social Health Insurance Programme
of the NHIS in 2005, aimed at improving health access through increasing uptake and
coverage of health insurance in the country.
237
The Formal Sector Social Health Insurance Programme is a prepaid plan in which participants
pay fixed regular amounts or premiums, which are then pooled and transferred to Health
Maintenance Organisations to cover the cost of health care. Although the objective
is to share risk, uptake of the Formal Sector Social Health Insurance Programme and
other health insurance schemes of the NHIS, like private prepaid insurance at 0·8%,
has been low, with information asymmetry on the part of both citizens and health providers,
and concerns about moral hazard and adverse selection by market providers impeding
insurance uptake.
237
Private health insurance schemes often do not cover individuals most in need, although
they can be a useful stopgap before sufficient public provision is secured. Encouraging
the use of mobile payments and apps to make and process insurance claims could reduce
barriers to insurance coverage for some individuals, especially in urban areas,
238
however, the larger barrier is poverty, meaning insufficient total premiums can be
pooled to fund sufficient services for individuals most in need.
239
The funding gap for the National Strategic Health Development Plan 2 2018–2022 moderate
coverage scenario ($6·8 billion of a total estimated cost of $19·9 billion) could
have been bridged via increasing state health insurance subscribers from 5% in 2018
to 30% in 2022,
11
however the subscriber base remained low at 5% in 2020.
240
Reducing the burden and financial risk from health-care spending for individuals,
families, and communities will therefore require a dramatic provision of and access
to pooled funding (insurance) or pre-paid government provision of health care. Alternatively,
mandatory social insurance for health could be levied, although both would need to
be done equitably to guard against increasing inequality and resulting health, social,
and economic harms. Additionally, solutions for barriers to coverage of those working
in the informal sector and individuals unemployed would need to be found.
240
Levying taxes and social insurance is also difficult as the majority of work is in
the informal sector in Nigeria. However, as has been seen in other countries such
as India and Ethiopia (panel 8), should universal health coverage become an election
issue nationally and at state level, concerted advocacy and community engagement efforts
from committed institutions and civil society organisations could provide creative
approaches to facilitate universal health coverage.
241
Using strategic health purchasing to increase efficiency
Strategic health purchasing ensures that only needed services are purchased by identifying
the most cost-effective ones with evidence of good value for money, and those essential
for achieving health-related SDGs targets, universal health coverage, and other national
priorities.
242
The objectives of strategic purchasing are to enhance equity in the distribution of
resources, increase efficiency (more health for the money), manage expenditure growth,
and promote quality in health service delivery.
243
Strategic health purchasing serves to enhance transparency and accountability of providers
and purchasers to the population, which contributes to the ultimate goals of maximised
health outcomes and equity in health gains, financial protection, and equity in financing
as well as responsiveness.243, 244
Countries at all levels of income are considering or implementing reforms to increase
the extent to which purchasing of services in the health system is strategic.
243
Strategic health purchasing helped to achieve a pro-poor utilisation of health services
in Thailand,
245
equitable and high level of use of free maternal and child health services in Nigeria,
246
and in many other health services in other countries.
247
However, it is noted that improving the purchasing function is a continuous challenge
for health system governance and require adaptations in how best to purchase services
over time.243, 245, 247
Hence, strategic health purchasing should be adopted at all levels by all public and
quasi-public purchasers, and become the main mechanism used by purchasers such as
federal and state Ministries of Health, agencies, and other third-party financiers
in the Nigerian health sector. In preparing budgets, government at all levels should
ensure the institutionalisation of the medium-term sector strategy,
248
introduced by the Budget Office in 2006, which outlines strategic objectives, activities,
and budgets in the allocation of public sector health expenditure at all levels. Although
the medium-term sector strategy is designed to achieve strategic health purchasing
and lead to more efficient, equitable, and accountable deployment of resources, its
implementation has been stalled and should become a top priority.
A broad-based, participatory medium-term sector strategy process will involve non-state
actors such as civil society organisations, the private sector, consumer groups, and
development partners to develop annual budgets and decide the use of other resources
to purchase health services. Federal and state governments should entrench strategic
health purchasing as the main mechanism for purchasing health services.
249
The institutionalisation of strategic health purchasing within Nigeria will require
strengthening the capacity of purchasing agencies and raising awareness of its benefits
among decision makers in the Ministry of Finance and various departments, agencies,
and programmes at the Ministries of Health at the federal and state levels.228, 250
One high priority strategic health purchasing intervention in Nigeria is creating
the expectation that governments at all levels should purchase free services for high-priority
life-saving public health services through increased use of government revenue, notably
the Basic Healthcare Provision Fund. Such services will include: (1) immunisation
prevention and treatment of HIV/AIDS, tuberculosis, and malaria; (2) some non-communicable
diseases; and (3) maternal, neonatal, and child health services, especially antenatal,
childbirth, and postnatal services (table 5, panel 9).
Section 6: conclusions and recommendations
With Nigeria's large and growing population, ongoing governance and security challenges,
and potential leadership role in Africa and globally, the decisions made today will
determine whether Africa's most populous country will become a success story or a
cautionary tale. A successful Nigeria will inarguably require strong investments in
health, education, and basic public services, following a central organising principle
of creating a healthy population (ie, a health-in-all-policies approach). Such an
approach is the best pathway to human flourishing, economic development, and a legacy
for the politicians who achieve it. The strength of institutions—in government, civil
society, traditional and religious authorities, and within communities—can and must
be harnessed to engender and reap the benefits of a virtuous cycle of prosperity and
good health. Institutions, including formal structures such as the constitution and
laws, and informal societal factors such as customary norms and values, are requisite
to achieving the political and social accountability that continues to elude the nation.
The alternative of business-as-usual risks a spiral of increasing poverty, inequality,
and insecurity as the growing population is blighted by the interdependent challenges
of lack of opportunity, poor education, and poor health. Delivering a health agenda
for Nigeria is thus a matter of the utmost importance for Nigeria, the subregion,
and the world.
In this Commission, we began by exploring how Nigeria's health system, writ large,
evolved from a widely accessible community health infrastructure during the pre-colonial
period, to an inegalitarian colonial inheritance, ultimately leading to a post-independence
period of an unequally distributed, unbalanced, and weak health system despite multiple
national plans over six decades. Nevertheless, the story of the Nigerian health system
presents numerous successes that can serve as lessons to build upon. The overall progress
over the past 50 years shows that most indicators have moved in the right direction,
although there is much room for improvement. Further, Nigeria effectively utilised
vertical programmes with international multilateral agency support to contain Guineaworm
disease and wild-type poliomyelitis showing that the health system can, in particular
circumstances, deliver. There is a distinct opportunity to fulfil Nigeria's constitutional
promise to ensure health care to all persons and extend this to wider preventive health
goals.
The giant of Africa—Africa's largest country in terms of population and economy—enjoys
considerable unrealised potential. The time to achieve greatness is now, with health
at the heart of the development agenda. The health system can become a positive reflection
of Nigeria—with successful health reform the catalyst to show why Nigeria matters
to Nigerians, giving good reason for patriotism, and serving as a model for wider
societal change.
Declaration of interests
FS, MNS, GA, and BLS are current heads of Nigerian Government health agencies. CI
and SHA held leadership roles in the Nigerian Government during the period of writing
of this Commission. SA is editor-in-chief of BMJ Global Health. IA was a Scientific
and Technical Adviser to the Nigerian Government Presidential Task Force on COVID-19
and ZI is chair of the Nigerian national ethics committee. All other authors declare
no competing interests.
Summary Background In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and development investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding Bill & Melinda Gates Foundation.
Summary Background Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attributable burden of disease. Methods GBD 2019 estimated attributable mortality, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 87 risk factors and combinations of risk factors, at the global level, regionally, and for 204 countries and territories. GBD uses a hierarchical list of risk factors so that specific risk factors (eg, sodium intake), and related aggregates (eg, diet quality), are both evaluated. This method has six analytical steps. (1) We included 560 risk–outcome pairs that met criteria for convincing or probable evidence on the basis of research studies. 12 risk–outcome pairs included in GBD 2017 no longer met inclusion criteria and 47 risk–outcome pairs for risks already included in GBD 2017 were added based on new evidence. (2) Relative risks were estimated as a function of exposure based on published systematic reviews, 81 systematic reviews done for GBD 2019, and meta-regression. (3) Levels of exposure in each age-sex-location-year included in the study were estimated based on all available data sources using spatiotemporal Gaussian process regression, DisMod-MR 2.1, a Bayesian meta-regression method, or alternative methods. (4) We determined, from published trials or cohort studies, the level of exposure associated with minimum risk, called the theoretical minimum risk exposure level. (5) Attributable deaths, YLLs, YLDs, and DALYs were computed by multiplying population attributable fractions (PAFs) by the relevant outcome quantity for each age-sex-location-year. (6) PAFs and attributable burden for combinations of risk factors were estimated taking into account mediation of different risk factors through other risk factors. Across all six analytical steps, 30 652 distinct data sources were used in the analysis. Uncertainty in each step of the analysis was propagated into the final estimates of attributable burden. Exposure levels for dichotomous, polytomous, and continuous risk factors were summarised with use of the summary exposure value to facilitate comparisons over time, across location, and across risks. Because the entire time series from 1990 to 2019 has been re-estimated with use of consistent data and methods, these results supersede previously published GBD estimates of attributable burden. Findings The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. Global declines also occurred for tobacco smoking and lead exposure. The largest increases in risk exposure were for ambient particulate matter pollution, drug use, high fasting plasma glucose, and high body-mass index. In 2019, the leading Level 2 risk factor globally for attributable deaths was high systolic blood pressure, which accounted for 10·8 million (95% uncertainty interval [UI] 9·51–12·1) deaths (19·2% [16·9–21·3] of all deaths in 2019), followed by tobacco (smoked, second-hand, and chewing), which accounted for 8·71 million (8·12–9·31) deaths (15·4% [14·6–16·2] of all deaths in 2019). The leading Level 2 risk factor for attributable DALYs globally in 2019 was child and maternal malnutrition, which largely affects health in the youngest age groups and accounted for 295 million (253–350) DALYs (11·6% [10·3–13·1] of all global DALYs that year). The risk factor burden varied considerably in 2019 between age groups and locations. Among children aged 0–9 years, the three leading detailed risk factors for attributable DALYs were all related to malnutrition. Iron deficiency was the leading risk factor for those aged 10–24 years, alcohol use for those aged 25–49 years, and high systolic blood pressure for those aged 50–74 years and 75 years and older. Interpretation Overall, the record for reducing exposure to harmful risks over the past three decades is poor. Success with reducing smoking and lead exposure through regulatory policy might point the way for a stronger role for public policy on other risks in addition to continued efforts to provide information on risk factor harm to the general public. Funding Bill & Melinda Gates Foundation.
Executive summary Although health outcomes have improved in low-income and middle-income countries (LMICs) in the past several decades, a new reality is at hand. Changing health needs, growing public expectations, and ambitious new health goals are raising the bar for health systems to produce better health outcomes and greater social value. But staying on current trajectory will not suffice to meet these demands. What is needed are high-quality health systems that optimise health care in each given context by consistently delivering care that improves or maintains health, by being valued and trusted by all people, and by responding to changing population needs. Quality should not be the purview of the elite or an aspiration for some distant future; it should be the DNA of all health systems. Furthermore, the human right to health is meaningless without good quality care because health systems cannot improve health without it. We propose that health systems be judged primarily on their impacts, including better health and its equitable distribution; on the confidence of people in their health system; and on their economic benefit, and processes of care, consisting of competent care and positive user experience. The foundations of high-quality health systems include the population and their health needs and expectations, governance of the health sector and partnerships across sectors, platforms for care delivery, workforce numbers and skills, and tools and resources, from medicines to data. In addition to strong foundations, health systems need to develop the capacity to measure and use data to learn. High-quality health systems should be informed by four values: they are for people, and they are equitable, resilient, and efficient. For this Commission, we examined the literature, analysed surveys, and did qualitative and quantitative research to evaluate the quality of care available to people in LMICs across a range of health needs included in the Sustainable Development Goals (SDGs). We explored the ethical dimensions of high-quality care in resource-constrained settings and reviewed available measures and improvement approaches. We reached five conclusions: The care that people receive is often inadequate, and poor-quality care is common across conditions and countries, with the most vulnerable populations faring the worst Data from a range of countries and conditions show systematic deficits in quality of care. In LMICs, mothers and children receive less than half of recommended clinical actions in a typical preventive or curative visit, less than half of suspected cases of tuberculosis are correctly managed, and fewer than one in ten people diagnosed with major depressive disorder receive minimally adequate treatment. Diagnoses are frequently incorrect for serious conditions, such as pneumonia, myocardial infarction, and newborn asphyxia. Care can be too slow for conditions that require timely action, reducing chances of survival. At the system level, we found major gaps in safety, prevention, integration, and continuity, reflected by poor patient retention and insufficient coordination across platforms of care. One in three people across LMICs cited negative experiences with their health system in the areas of attention, respect, communication, and length of visit (visits of 5 min are common); on the extreme end of these experiences were disrespectful treatment and abuse. Quality of care is worst for vulnerable groups, including the poor, the less educated, adolescents, those with stigmatised conditions, and those at the edges of health systems, such as people in prisons. Universal health coverage (UHC) can be a starting point for improving the quality of health systems. Improving quality should be a core component of UHC initiatives, alongside expanding coverage and financial protection. Governments should start by establishing a national quality guarantee for health services, specifying the level of competence and user experience that people can expect. To ensure that all people will benefit from improved services, expansion should prioritise the poor and their health needs from the start. Progress on UHC should be measured through effective (quality-corrected) coverage. High-quality health systems could save over 8 million lives each year in LMICs More than 8 million people per year in LMICs die from conditions that should be treatable by the health system. In 2015 alone, these deaths resulted in US$6 trillion in economic losses. Poor-quality care is now a bigger barrier to reducing mortality than insufficient access. 60% of deaths from conditions amenable to health care are due to poor-quality care, whereas the remaining deaths result from non-utilisation of the health system. High-quality health systems could prevent 2·5 million deaths from cardiovascular disease, 1 million newborn deaths, 900 000 deaths from tuberculosis, and half of all maternal deaths each year. Quality of care will become an even larger driver of population health as utilisation of health systems increases and as the burden of disease shifts to more complex conditions. The high mortality rates in LMICs for treatable causes, such as injuries and surgical conditions, maternal and newborn complications, cardiovascular disease, and vaccine preventable diseases, illustrate the breadth and depth of the healthcare quality challenge. Poor-quality care can lead to other adverse outcomes, including unnecessary health-related suffering, persistent symptoms, loss of function, and a lack of trust and confidence in health systems. Waste of resources and catastrophic expenditures are economic side effects of poor-quality health systems. As a result of this, only one-quarter of people in LMICs believe that their health systems work well. Health systems should measure and report what matters most to people, such as competent care, user experience, health outcomes, and confidence in the system Measurement is key to accountability and improvement, but available measures do not capture many of the processes and outcomes that matter most to people. At the same time, data systems generate many metrics that produce inadequate insight at a substantial cost in funds and health workers’ time. For example, although inputs such as medicines and equipment are commonly counted in surveys, these are weakly related to the quality of care that people receive. Indicators such as proportion of births with skilled attendants do not reflect quality of childbirth care and might lead to false complacency about progress in maternal and newborn health. This Commission calls for fewer, but better, measures of health system quality to be generated and used at national and subnational levels. Countries should report health system performance to the public annually by use of a dashboard of key metrics (eg, health outcomes, people’s confidence in the system, system competence, and user experience) along with measures of financial protection and equity. Robust vital registries and trustworthy routine health information systems are prerequisites for good performance assessment. Countries need agile new surveys and real-time measures of health facilities and populations that reflect the health systems of today and not those of the past. To generate and interpret data, countries need to invest in national institutions and professionals with strong quantitative and analytical skills. Global development partners can support the generation and testing of public goods for health system measurement (civil and vital registries, routine data systems, and routine health system surveys) and promote national and regional institutions and the training and mentoring of scientists. New research is crucial for the transformation of low-quality health systems to high-quality ones Data on care quality in LMICs do not reflect the current disease burden. In many of these countries, we know little about quality of care for respiratory diseases, cancer, mental health, injuries, and surgery, as well as the care of adolescents and elderly people. There are vast blind spots in areas such as user experience, system competence, confidence in the system, and the wellbeing of people, including patient-reported outcomes. Measuring the quality of the health system as a whole and across the care continuum is essential, but not done. Filling in these gaps will require not only better routine health information systems for monitoring, but also new research, as proposed in the research agenda of this Commission. For example, research will be needed to rigorously evaluate the effects and costs of recommended improvement approaches on health, patient experience, and financial protection. Implementation science studies can help discern the contextual factors that promote or hinder reform. New data collection and research should be explicitly designed to build national and regional research capacity. Improving quality of care will require system-wide action To address the scale and range of quality deficits we documented in this Commission, reforming the foundations of the health system is required. Because health systems are complex adaptive systems that function at multiple interconnected levels, fixes at the micro-level (ie, health-care provider or clinic) alone are unlikely to alter the underlying performance of the whole system. However, we found that interventions aimed at changing provider behaviour dominate the improvement field, even though many of these interventions have a modest effect on provider performance and are difficult to scale and sustain over time. Achieving high-quality health systems requires expanding the space for improvement to structural reforms that act on the foundations of the system. This Commission endorses four universal actions to raise quality across the health system. First, health system leaders need to govern for quality by adopting a shared vision of quality care, a clear quality strategy, strong regulation, and continuous learning. Ministries of health cannot accomplish this alone and need to partner with the private sector, civil society, and sectors outside of health care, such as education, infrastructure, communication, and transport. Second, countries should redesign service delivery to maximise health outcomes rather than geographical access to services alone. Primary care could tackle a greater range of low-acuity conditions, whereas hospitals or specialised health centres should provide care for conditions, such as births, that need advanced clinical expertise or have the risk of unexpected complications. Third, countries should transform the health workforce by adopting competency-based clinical education, introducing training in ethics and respectful care, and better supporting and respecting all workers to deliver the best care possible. Fourth, governments and civil society should ignite demand for quality in the population to empower people to hold systems accountable and actively seek high-quality care. Additional targeted actions in areas such as health financing, management, district-level learning, and others can complement these efforts. What works in one setting might not work elsewhere, and improvement efforts should be adapted for local context and monitored. Funders should align their support with system-wide strategies rather than contribute to the proliferation of micro-level efforts. In this Commission, we assert that providing health services without guaranteeing a minimum level of quality is ineffective, wasteful, and unethical. Moving to a high-quality health system—one that improves health and generates confidence and economic benefits—is primarily a political, not technical, decision. National governments need to invest in high-quality health systems for their own people and make such systems accountable to people through legislation, education about rights, regulation, transparency, and greater public participation. Countries will know that they are on the way towards a high-quality, accountable health system when health workers and policymakers choose to receive health care in their own public institutions. Introduction The past 20 years have been called a golden age for global health. 1 Fuelled by a major increase in domestic health spending and donor funding, LMICs have vastly expanded access to health determinants (eg, clean water and sanitation) and health services alike (eg, vaccination, antenatal care, and HIV treatment). 2–4 These expansions have saved the lives of millions of children, men, and women, largely by averting deaths from infectious diseases. 5 However, these past decades were not as favourable for preventing deaths from non-communicable diseases and acute conditions, such as ischaemic heart disease, stroke, diabetes, neonatal mortality, and injuries, for which mortality stagnated or increased. 6 The lowest-income countries and the poorest people within countries generally had the worst outcomes, despite considerable efforts to increase use of health care. 7 The strategy that brought big wins for child health and infectious diseases will not suffice to reach the health-related SDGs. The newly ascendant health conditions, including chronic and complex conditions, require more than a single visit or standardised pill pack; they require highly skilled, longitudinal, and integrated care. Such care is also needed to address the substantial residual mortality from maternal and child conditions and infectious diseases. In short, it is becoming clear that access to health care is not enough, and that good quality of care is needed to improve outcomes. India learned this with Janani Suraksha Yojana, a cash incentive programme for facility births, which massively increased facility delivery but did not measurably reduce maternal or newborn mortality. 8 High-quality care involves thorough assessment, detection of asymptomatic and co-existing conditions, accurate diagnosis, appropriate and timely treatment, referral when needed for hospital care and surgery, and the ability to follow the patient and adjust the treatment course as needed. Health systems should also take into account the needs, experiences, and preferences of people and their right to be treated with respect. 9 Although many consumer services make user experience a central mission, health systems—like other public sector systems—are often difficult to use, indifferent to the time and preferences of people, and reluctant to share decision-making processes. 10 Indeed, some providers are rude and even abusive—a fundamental abrogation of human rights and health system obligations. 9 At the same time, health workers might not receive the support and respect required to have a fulfilling professional life. Finally, systems can be inefficient, wasting scarce resources on unnecessary care and on low-quality clinics that people bypass, while imposing high costs on users. 11 The SDG era demands new ways of thinking about health systems. Although they are only one contributor to good health—other major contributors being social determinants of health such as education, wealth, employment, and social protections, and cross-sectoral public health actions such as tobacco taxation and improved food, water, and road and occupational safety regulations 12 —access to high-quality health care is a human right and moral imperative for every country. 13 Moreover, health systems are a powerful engine for improving survival and wellbeing and they are the focus of our report. 14,15 We endorse WHO’s definition of a health system as consisting of “all organisations, people, and actions whose primary intent is to promote, restore, or maintain health”, and we focus this Commission on the organised health sector, public and private, including community health workers. 16 Although informal providers (those with little or no formal clinical training) also provide care in some countries, there are—with a few notable exceptions—insufficient data on the quality of care offered by these providers, and we do not cover them in this Commission. Addressing quality of care is particularly pertinent as countries begin to implement UHC. 17 UHC represents a substantial new investment of national resources—one that embodies new concrete commitments about the type of care that people have a right to expect. Newly transparent benefit packages can, in turn, create public expectations that governments will be under pressure to fulfil. Furthermore, new investments in health care will face scrutiny from finance ministers, who will demand efficient use of resources and better results measured in longer lifespans, restored physical and mental functions, user satisfaction, and economic productivity. What should a high-quality health system look like in countries with resource constraints and competing health priorities that aspire to reach the SDGs? The Lancet Global Health Commission on High-Quality Health Systems in the SDG Era, comprised of 30 academics, policy makers, and health system experts from 18 countries, seeks to answer this question. 18 In this Commission, we propose new ways to define, measure, and improve the performance of health systems. We review evidence of past approaches and look for strategies that can change the trajectory of health systems in LMICs. Our work is informed by several principles. First, the principle that health systems are for people. Health systems need to work with people not only to improve health outcomes, but also to generate non-health-related value, such as trust and economic benefit for all people, including the poor and vulnerable. Second, the principle that people should be able to receive good quality, respectful care for any health concern that can be tackled within their country’s resource capacity. Third, the principle that high-quality care should be the raison d’être of the health system, rather than a peripheral activity in ministries of health. Finally, the principle that fundamental change should be prioritised over piecemeal approaches. We recognise that health systems are complex adaptive systems that resist change and can be impervious to isolated interventions; indeed, multiple small-scale efforts can be deleterious. Quality of care is an emergent property that requires shared aims among all health system actors, favourable health system foundations, and is honed through iterative efforts to improve and learn from successes and failures. These considerations guided our analysis. We are also aware of other major efforts on quality of care at the time of the writing of this Commission. WHO convened the Quality of Care Network to facilitate joint learning, accelerate scale-up of quality maternal, newborn, and child services, and strengthen the evidence for cost-effective approaches. WHO, the World Bank, and the Organisation for Economic Co-operation and Development (OECD) published a global report on quality of health care earlier in 2018. 19 The US National Academy of Medicine has begun a study on improving the quality of health care across the globe. There is also new interest in stronger primary care that can promote health, prevent illness, identify the sick from the healthy, and efficiently manage the needs of those with chronic disease. 20 The Primary Health Care Performance Initiative, a multistakeholder effort, is focusing on measuring and comparing the functioning of primary health-care systems and identifying pathways for improvement. 21 Primary care has been a main platform for provision of health care in low-income countries, but there—as elsewhere—the changing disease burden, urbanisation, and rising demand for advanced services and excellent user experience are challenging this current model of care. Our work was substantially strengthened with input from nine National High-Quality Health Systems Commissions that were formed to explore quality of care in their local contexts alongside the global Commission. To ensure that our work reflects the needs of people and communities, we have sought input from a people’s voice advisory board and we obtained advice and policy perspectives from an external advisory council. Our intended audiences for the report are people, national leaders, health and finance ministers, policy makers, managers, providers, global partners (bilateral and multilateral institutions and foundations), advocates, civil society, and academics. This report is arranged in the following manner: in section 1, we propose a new definition for high-quality health systems; in section 2, we describe the state of health system quality in LMICs, bringing together multiple national and cross-national data on quality of care for the first time; in section 3, we tackle the ethics of good quality of care and propose mechanisms for ensuring that the poor and vulnerable benefit from improvement; in section 4, we review the current status of quality measurements and propose how to measure better and more efficiently; in section 5, we reassess the available options for improvement and recommend new structural solutions; in section 6, we conclude with a summary of our key messages, our recommendations, and a research agenda. We recognise that the level of ambition implied in our recommendations might be daunting to low-income countries that are struggling to put in place the basics of health care. In this Commission, we are describing a new aspiration for health systems that can guide policies and investments now. Regardless of starting point, every country has opportunities to get started on the path to high-quality health systems. Section 1: Redefining high-quality health systems The systematic examination of health-care quality began with the work of Avedis Donabedian, whose 1966 article 22 proposed a framework for quality of care assessment that described quality along the dimensions of structure, process, and outcomes of care. At the turn of the 21st century, the Committee on Quality of Health Care in America of the Institute of Medicine (IOM) produced two influential quality reports 23,24 that galvanised the examination of quality in the US health system and prompted similar investigations in other industrialised countries. The IOM Committee defined quality of care as “the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge”. 23 The committee noted that 21st century health systems should seek to improve performance on six dimensions of quality of care: safety, effectiveness, patient-centredness, timeliness, efficiency, and equity. The committee also observed that “the current care systems cannot do the job. Trying harder will not work. Changing systems of care will.” 23 In 2010, Michael Porter proposed 25 that health systems be fundamentally accountable for producing value, which should be defined around the user. International organisations, such as WHO, and many low-income and high-income countries have relied on the IOM definition of quality and its core dimensions. WHO has also separately defined integrated people-centred health systems as systems where “all people have equal access to quality health services that are coproduced in a way that meets their life course needs”. 26 Building on this and other work, this section sets out our rationale for an updated definition of high-quality health systems and a conceptual framework ready for the health challenges, patient expectations, and rising ambitions of today. 27,28 The improvement of health outcomes is the sine qua non of health systems; these outcomes include longer lives, better quality of life, and improved capacity to function. In addition to better health, people derive security and confidence from having a trusted source of care when illness renders them most vulnerable. In this way, health systems also function as key social institutions, both deriving from and shaping social norms and able to promote or corrode public trust. 29,30 Finally, health systems cannot be static and must adapt to changing societal needs. This Commission defines a high-quality health system as the following: A high-quality health system is one that optimises health care in a given context by consistently delivering care that improves or maintains health outcomes, by being valued and trusted by all people, and by responding to changing population needs. Context is paramount in this definition; health systems have been shaped by different histories and, as a result, function differently across LMICs. High-quality health systems are underpinned by four values: high-quality health systems are for people and are equitable, resilient, and efficient. A focus on people begins with the self-evident observation that health systems must reach people—access is a prerequisite for benefiting from health care. However, this focus also signifies that people are not just beneficiaries of health services, but have a right to health care and have agency over their health and health-care decisions. Therefore, people become accountability agents, able to hold health system actors to account. The emphasis on people-centredness is especially crucial in health care because of the asymmetry of power and information between provider and patient. The focus on people works not only as a moral imperative to protect against the adverse effects of this power imbalance, but also as a corrective action that reduces the imbalance through patient empowerment and better accountability. Health systems must also treat well the people that work within them, who deserve a supportive work environment (safe working conditions, efficient and supportive management, and appropriate role assignment) and are themselves health-care users. Demotivated providers cannot contribute to a high-quality health system. A focus on equity means that high-quality health care needs to be available and affordable for all people, regardless of underlying social disadvantages. Measures of quality need to be disaggregated by stratifiers of social power—such as wealth, gender, or ethnicity—and quality improvements should explicitly include poor and vulnerable people to redress existing inequities. Health systems in LMICs have been slow to change from their legacy functions focused on infectious diseases and maternal and child health, but health needs and expectations are shifting, sometimes quickly. Health crises, such as the Ebola epidemic, acutely illustrate the need for resilient systems, defined as systems that can prepare for and effectively respond to crises while maintaining core functions and reorganising if needed. 31 High-quality health systems also need everyday resilience to respond to routine challenges, and this requires accountable leaders who respect and motivate their front-line staff. 32 Lastly, health systems must be efficient: although spending on health systems is tightly associated with income and therefore varies greatly across LMICs, all health systems should aim to avoid waste and achieve the maximum possible improvement in health outcomes with the investment received. We propose a new conceptual framework for high-quality health systems with three key domains: foundations, processes of care, and quality impacts (figure 1). This framework stems from our definition of high-quality health systems and is informed by past frameworks in the fields of health systems and quality improvement, including Donabedian’s framework, 22 WHO’s building blocks 16 and maternal quality of care 27 frameworks, Judith Bruce’s family planning quality framework, 28 Getting Health Reform Right, 33 the Juran trilogy, and the Deming quality cycle. 34 Figure 1 High-quality health system framework Our high-quality health system framework focuses on health system function, user experience, and how people benefit from health care. This Commission believes that the quality of health systems should be primarily measured by these processes and impacts rather than by inputs. Facilities staffed by health workers and equipped with running water, electricity, and medicines are essential for good quality care, but the presence of these inputs is not itself a measure of high-quality care. Empirical work shows that the quantity of such inputs does not predict the care that people receive and whether their health will improve—poor care often happens in the presence of adequate tools. 35 Table 1 summarises the components of the three framework domains (quality impacts, processes of care, and foundations). The quality impacts begin with better health, including reduced mortality and morbidity, and positive health markers such as quality of life, function and wellbeing, and absence of serious health-related suffering. 36 These health outcomes should also encompass patient-reported measures. Another impact of high-quality health systems is confidence in the system, including trust in health workers and appropriate care uptake. Confidence goes beyond the more traditional measure of satisfaction with care; it is the extent to which people trust and are willing to use health care. Trust is essential for maximising outcomes because it can motivate active participation in care—ie, adherence to recommendations and uptake of services, including in emergencies. 37 Trust is also essential for the success of UHC, because financing for UHC will be primarily domestic and people are unlikely to agree to contribute taxes or pay premiums for health services that they do not value. Finally, although good quality of care might require additional investment in many health systems of LMICs, high-quality health systems have the potential to generate economic benefits. First, by reducing premature mortality and improving people’s health, ability to work, and ability to attend school, high-quality health systems can foster economic productivity. Second, high-quality health systems can reduce waste from unnecessary, ineffective, and harmful care and prevent inappropriate hospital admissions and the bypassing of cost-effective options, such as primary care. Additionally, high-quality health systems with appropriate financing mechanisms, particularly mandatory insurance, can reduce the incidence of catastrophic or impoverishing health expenditures. Therefore, financing that provides people with financial protection and promotes high-quality, efficient care is an integral foundation of a high-quality health system. Table 1 High-quality health system framework components Components Quality impacts Better health Level and distribution of patient-reported outcomes: function, symptoms, pain, wellbeing, quality of life, and avoiding serious health-related suffering Confidence in system Satisfaction, recommendation, trust, and care uptake and retention Economic benefit Ability to work or attend school, economic growth, reduction in health system waste, and financial risk protection Processes of care Competent care and systems Evidence-based, effective care: systematic assessment, correct diagnosis, appropriate treatment, counselling, and referral; capable systems: safety, prevention and detection, continuity and integration, timely action, and population health management Positive user experience Respect: dignity, privacy, non-discrimination, autonomy, confidentiality, and clear communication; user focus: choice of provider, short wait times, patient voice and values, affordability, and ease of use Foundations Population Individuals, families, and communities as citizens, producers of better health outcomes, and system users: health needs, knowledge, health literacy, preferences, and cultural norms Governance Leadership: political commitment, change management; policies: regulations, standards, norms, and policies for the public and private sector, institutions for accountability, supportive behavioural architecture, and public health functions; financing: funding, fund pooling, insurance and purchasing, provider contracting and payment; learning and improvement: institutions for evaluation, measurement, and improvement, learning communities, and trustworthy data; intersectoral: roads, transport, water and sanitation, electric grid, and higher education Platforms Assets: number and distribution of facilities, public and private mix, service mix, and geographic access to facilities; care organisation: roles and organisation of community care, primary care, secondary and tertiary care, and engagement of private providers; connective systems: emergency medical services, referral systems, and facility community outreach Workforce Health workers, laboratory workers, planners, managers: number and distribution, skills and skill mix, training in ethics and people-centred care, supportive environment, education, team work, and retention Tools Hardware: equipment, supplies, medicines, and information systems; software: culture of quality, use of data, supervision, and feedback The processes of care include competent care and user experience, which we consider to be complementary elements of quality. These elements must be present in both the health system as a whole and in individual care visits. Competent systems provide people and communities with health promotion and prevention when healthy and effective and timely care when sick. People should be able to count on their conditions being detected and managed in an integrated manner. Systems should also be user-focused: easy to navigate, with short wait times and attention to people’s values and preferences—this is the definition of people-centredness. When people visit providers, they should expect to receive evidence-based care, including careful assessment, correct diagnosis, and appropriate treatment and counselling. And providers should treat all people with dignity, communicate clearly, and provide autonomy and confidentiality. Disrespectful and discriminatory behaviours are crucial quality failures, as are work environments that demean or disempower providers. The foundations of high-quality health systems begin with the populations that they serve: individuals, families, and communities. People are necessary partners in providing health care and improving health outcomes; they are not only the core beneficiaries of the health system, but also the agents who can hold these systems to account. The health needs, knowledge, and preferences of people should shape the health system response. High-quality health systems require strong governance, and financing, to promote the desired outcomes and policies to regulate providers, organise care, and institutionalise accountability to citizens. However, regulation will not be enough; health system leaders will need to inspire and sustain the values of professionalism and excellence that underpin high-quality health care. In most countries, health care is provided by three platforms: community health, primary care, and hospital care. An appropriate facility and provider mix, quality-centred service delivery models, and functioning connections between levels of care (eg, referral, prehospital transport) will be required to ensure that the whole system maximises outcomes and the efficient use of resources. Providers, from health workers to managers, are fundamental for health systems, and require adequate numbers, preparation, professionalism, and motivation. Providers need high-quality, competency-focused clinical education, with training in ethics, and a supportive environment for achieving the desired performance. Finally, health systems require not only physical tools, such as equipment, medicines, and supplies, but also new attitudes, skills, and behaviours, including quality mindsets, supervision and feedback, and the ability and willingness to learn from data. The foundations alone will not create good care, and the system will not be able to adapt to new challenges without built-in mechanisms for learning and improvement, including having timely information on performance, assessment of new ideas, and the means to retire ineffective approaches. This framework can be used to measure health systems over time on elements that matter to people (through processes and impacts) and to guide opportunities for improvement (through shoring up or rethinking foundations). Section 2: What quality of care are people receiving in LMICs today? In this section, we describe the current state of healthcare quality in LMICs. We compiled data from multiple sources to present the most comprehensive and detailed picture of health system quality. We analysed data from health facility, household, telephone, and internet surveys collected in the past 10 years, and summarised findings from global estimates, systematic reviews, and individual studies (data sources are listed in appendix 1 and a comparison of methods used to collect the data can be found in appendix 2). Within the constraints of the available data, we describe quality across all health conditions addressed by the SDGs (list of conditions in appendix 1) and across health system platforms (community outreach, primary and hospital care, and the linkages between them: referral systems and emergency medical services). Following the Commission’s framework, we describe the current situation with regard to provision of evidence-based care, competent health systems, and user experience and we present available evidence on the links between quality and health, confidence, and economic benefits. Our focus is on describing the processes of care and their impacts. Foundations—the facilities, people, and tools required for care—are crucial to high-quality health systems, but their availability does not guarantee quality care. Lastly, we explore why some population groups are more vulnerable to poor-quality care. Where multicountry medians are presented throughout the section, country-specific data are included in appendix 2. Key findings are shown in panel 1. Panel 1: Section 2 key findings Poor-quality health systems result in more than 8 million deaths per year in LMICs, leading to economic welfare losses of $6 trillion. Health providers in low-income and middle-income countries (LMICs) often do less than half of recommended evidence-based care actions. For example, only two in five women who delivered in a facility were examined within 1 h after birth. Approximately one third of patients experience disrespectful care, short consultations, poor communication, or long wait times. Inadequate integration across platforms and weak referral systems undermine the ability of health systems to care for complex and emerging conditions. Less than one quarter of people in LMICs believe that their health system works well, compared with half of people in high-income countries. Clinics and providers with good performance can be found in every country and studying them can inform country-wide efforts for improvement. High-quality health care is inequitably distributed in many countries, with poor and vulnerable groups having worse quality care—both in terms of competent care and user experience. People can be especially vulnerable to poor-quality care on the basis of particular settings of care, health conditions, and demographic factors. Processes of care Evidence-based care Evidence-based care includes systematic patient assessments, accurate diagnoses, provision of appropriate treatments, and proper patient counselling. In this section, we assess how these aspects are being followed, across selected SDG conditions. Data from direct observations of clinical consultations allowed us to measure the quality of reproductive, maternal, and child health services. Using guidelines from WHO, we identified essential elements of reproductive, maternal, and child health care and built quality indices (appendix 1). On the basis of these indices, data from observations of 81856 consultations in 18 countries showed that adherence to evidence-based guidelines is low (figure 2A). On average, providers fulfilled only 47% of recommended care—with median performance ranging from 44% for family planning consultations to 64% for labour and delivery care (appendix 2). However, median figures can mask important variations within countries (appendix 2). These large variations in performance across providers suggest that better quality of care is possible in these countries. Identifying and replicating local best practices might be valuable to inform improvement strategies. 38 Figure 2 Adherence to evidence-based guidelines and diagnostic accuracy Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes delineate the IQR. Indicator definitions are shown in appendix 1, and country specific means are shown in appendix 2. (A) Data are from Service Provision Assessment (SPA) surveys done in ten countries (Ethiopia 2014, Haiti 2013, Kenya 2010, Malawi 2013, Namibia 2009, Nepal 2015, Rwanda 2007, Senegal 2015–16, Tanzania 2015, and Uganda 2007) and baseline facility surveys of Results-based Financing impact evaluations (RBF) in eight countries (Burkina Faso 2013, Central African Republic 2012, Cameroon 2011, Republic of the Congo 2014, Democratic Republic of the Congo 2015, Kyrgyzstan 2012–13, Nigeria 2013, and Tajikistan 2014–15). (B) Data are from clinical vignettes from the Service Delivery Indicators surveys done by the World Bank, in cooperation with the African Economic Research Consortium and the African Development Bank in Kenya (2012), Nigeria (2013), Tanzania (2014), Togo (2013), and Uganda (2013) and from the Service Provision Assessment survey in Ethiopia (2014). Other studies have also shown that providers often fail to adhere to clinical guidelines. In Uttar Pradesh, India, facility-based birth attendants did only 40% of items on the WHO safe childbirth checklist in a typical birth. 39 Across 12 countries, only 50% of diarrhoea cases were correctly managed in health-care facilities according to WHO and UNICEF recommendations. 40 In standardised patient studies in China 41 and Kenya, 42 only 13–45% of suspected tuberculosis cases were correctly managed by primary care providers according to the International Standards for Tuberculosis Care guidelines. A systematic patient assessment involves gathering clinically relevant information by asking appropriate medical history questions and doing recommended examinations and tests. Data from LMICs showed that systematic patient assessments are not always done. For example, after giving birth, women should be assessed for abnormal bleeding, perineal tears, signs of infections, and high blood pressure. 43 However, in many countries, few women reported receiving any postpartum check-up after giving birth in a health-care facility, including only 27% of women in Swaziland and 44% in Ethiopia, Burundi, and Rwanda (appendix 2). Similarly, during antenatal care, monitoring of blood pressure and urine and blood sample analyses are crucial to detect pre-eclampsia, nutritional deficiencies, infections, and other pregnancy risks. 44 Across 91 countries, only 73% of women attending antenatal care with a skilled provider reported receiving these elements of care—ranging from an average of 54% in 30 low-income countries to 94% in 27 upper-middle-income countries (appendix 2). 45 Poor availability of laboratory facilities and diagnostic equipment are also barriers to patient assessment and diagnosis, even when providers are aware of the necessary tests. For example, pathology service coverage in sub-Saharan Africa is approximately one-tenth of that in high-income countries. 46 Even simple tests are often unavailable: studies showed that blood glucose meters and urine strips were available in only 18–61% of facilities across Mali, Mozambique, and Zambia. 47 A study of ten countries found that only 2% of health-care facilities had the eight diagnostic tests defined as essential for basic service readiness by WHO. 48 Incorrect diagnoses have deleterious consequences on health and contribute to treatment delays and antimicrobial resistance. For example, diagnostic uncertainty about undifferentiated fever often leads to overprescription of antimicrobial therapy. 49 Our analyses of data from clinical vignettes done in LMICs revealed wide variations in diagnostic accuracy. In six sub-Saharan African countries, correct diagnoses ranged from 0 providers in Togo identifying malaria with anaemia to 94% of providers in Kenya diagnosing post-partum haemorrhage (figure 2B, appendix 2). Other work has shown that, across six eastern European and central Asian countries, acute myocardial infarctions were correctly diagnosed by only 33% of providers. 50 Performance in practice is also likely to be worse than on vignettes: diagnostic accuracy ranging from only 8% to 20% has been reported for childhood pneumonia in Malawi 51 and for a range of primary care conditions in India. 52 Poor quality of laboratory testing and a heavy reliance on outdated diagnostic technologies can also contribute to misdiagnoses. For example, an external quality assessment 53 in the Democratic Republic of the Congo found that only 4% of laboratories correctly identified the parasites that cause malaria and human African trypanosomiasis on all slides analysed. Similarly, studies 54 in Latin America have reported Pap smear sensitivity as low as 20–25% and lower than expected rates of HER2 (human epidermal growth factor receptor 2) positivity in women with early breast cancer. For tuberculosis, uptake of newer diagnostics has been slow and many countries continue to rely on often inaccurate smear microscopy. 55 In high-burden countries, nine sputum smears are done for every gold standard test (Xpert MTB/RIF) used. 55 Poor-quality care also includes the underuse 56 of effective care and the overuse 11 of unnecessary care. Our analyses of survey data revealed that individuals in LMICs often do not receive appropriate treatments during consultations, including preventive interventions during skilled antenatal care, oral rehydration therapy for children with diarrhoea, or antibiotics for those with symptoms of pneumonia (figure 3, appendix 2). Similarly, another study 57 in Malawi reported that only 38·7% of patients with non-severe pneumonia confirmed on re-examination were correctly prescribed first-line antibiotics during consultation. Additionally, despite being diagnosed, many patients are untreated or undertreated for conditions such as HIV, tuberculosis, hypertension, diabetes, and depression. 58–63 In LMICs where data are available, only 68% of people aware of their HIV status are on antiretroviral therapy, and only 5% of people with a diagnosis of major depressive disorder receive minimally adequate treatment (figure 3, appendix 2). Individuals in severe pain are also systematically undertreated in LMICs. 36 Of the 298·5 metric tonnes of morphine-equivalent opioids distributed in the world every year, only 0·03% of that is distributed in low-income countries, leading to a 98% unmet need for morphine. 36 A study 64 showed that, among patients with ST-segment elevation myocardial infarctions admitted to Chinese hospitals, only half of ideal candidates for reperfusion therapy received the treatment. Other treatments that reduce mortality in patients were also underused, with only 58% of eligible patients receiving β blockers and 66% receiving angiotensin-converting-enzyme inhibitors. 64 All these reports represent major missed opportunities to improve outcomes among people already using the health system. Figure 3 Proportion of individuals receiving appropriate treatments among those who seek care in 112 low-income and middle-income countries Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes delineate the IQR. Data sources for tetanus injections and iron during antenatal care were Demographic and Health surveys (DHS) and Multiple Indicator Cluster surveys in 75 countries; for oral rehydration therapy (ORT) were DHS in 54 countries; for antibiotics for pneumonia were DHS and Multiple Indicator Cluster surveys in 63 countries; for antiretroviral therapy among those aware of their HIV status were UNAIDS estimates in 78 countries; and for minimally adequate depression treatment were World Mental Health Surveys in 8 countries. Indicators are defined in appendix 1; country specific means are shown in appendix 2. Overuse of unnecessary or ineffective care has also been documented in LMICs. In the previously mentioned study 64 in China, almost a third of patients received magnesium sulphate—a treatment that is ineffective—on admission and more than half of patients were given traditional Chinese medicine, despite little evidence of its efficacy and safety. 64 Other instances of inappropriate care in LMICs include unnecessary use of antibiotics for diarrhoea, inappropriate cardiac interventions, overuse of steroids, and unnecessary hysterectomies. 11,65,66 Although many women still do not have access to needed caesarean sections, rates of unnecessary caesarean sections have been increasing in LMICs. 11,67 Inappropriate use and overprescription of antimicrobials, combined with poor sanitation, inadequate access to diagnostic tools, and low diagnostic accuracy, have fuelled antimicrobial resistance throughout LMICs. 68 A 2018 study 69 assessed the quality of antimicrobial prescribing for hospital inpatients in 53 countries, including 25 LMICs. Inappropriate antibiotic prescribing practices included prescriptions for unknown diagnoses, prescriptions without stop or review dates (to avoid unnecessarily long antibiotic courses), and prolonged surgical prophylaxis. Proper counselling and health education are essential elements of evidence-based care. We found that during antenatal care, many skilled providers do not advise women on the signs of pregnancy complications or how to prevent HIV infections, and, when prescribing contraceptives, many providers fail to discuss their potential side-effects (appendix 2). Similarly, providers often do not state their diagnosis during the consultation. 52 In observations of sick child consultations in 17 countries, only 43% of providers informed caregivers about the diagnosis of their child (appendix 2). Counselling is particularly important for chronic disease management. Tobacco use, excess weight, unhealthy diets, and physical inactivity are the leading risk factors for non-communicable diseases. Data from the WHO STEPS survey in seven LMICs showed that providers did not counsel many patients diagnosed with cardiometabolic diseases: only 16% of patients were counselled on tobacco, 29% on exercise, and 55% on dietary changes (appendix 2). In six Latin American and Caribbean countries, only 56% of patients diagnosed with at least one chronic condition reported receiving advice on diet and exercise from primary care providers (appendix 2). 70 Competent systems Beyond the content of the health-care visit, competent care requires the whole health system to function for the patient. Here, we describe current evidence on four elements of competent health systems: safety, prevention and detection, continuity and integration, and timely care. The literature documents a range of safety problems in health care, including adverse drug events, adverse events and injuries due to medical devices, injuries due to surgical and anaesthesia errors (including wrong-site surgery), health-care-associated infections, improper transfusion and injection practices, falls, burns, and pressure ulcers. 71 Despite lower health-care use rates, LMICs bear the majority of the global burden of adverse events from unsafe care. 72 Surgical site infections, the most common type of health-care-associated infection, are markedly higher in LMICs than in high-income countries. 73 Patient safety literature has been largely focused on inpatient care, but adverse events also occur to outpatients, including medication errors, infections resulting from poor hand hygiene, unsafe injections, blood samples, or reusable equipment. LMICs are estimated to have rates of medication-related adverse events similar to those of high-income countries, but they result in twice as many years of healthy life lost because more younger patients are affected in LMICs. 72 One study found that, across 54 LMICs, 35% of healthcare facilities do not have water and soap for handwashing and 19% do not have improved sanitation. 74 This absence of services compromises efforts to improve hygiene behaviours and reduce health-care-associated infections. However, although water and sanitation are necessary, handwashing does not necessarily associate with their presence: low adherence to hand hygiene was found even in facilities with available supplies. 75 Beyond their costs to human lives and disability, adverse events from unsafe care are also costly in terms of loss of trust in the health system. The prevention and early detection of diseases, including through recommended screenings, is an important function of high-quality health systems. Across six Latin American and Caribbean countries, less than half of adults reported having had their blood pressure checked in the past year and their cholesterol checked in the past 5 years. 76 Rates of cervical and breast cancer screening also vary widely. 54 Across six LMICs surveyed by the WHO study on global ageing and adult health (SAGE), mammogram coverage averaged 20% of all women of screening age and was as low as 1% in India and 2% in Ghana (appendix 2). 63 Across nine countries in the Americas, average Pap smear coverage was 36% of women in need, ranging from 10% in Nicaragua to 97% in Panama. 77 Even people in the health system might not receive the needed screening or early detection. In countries with HIV prevalence higher than 5%, WHO recommends that all pregnant women be tested for HIV. 78 In five of nine high-prevalence countries, more than 95% of pregnant women attending antenatal care were tested for HIV. However, despite a HIV prevalence of 27% in Swaziland and 12% in Mozambique, only 56% of women in Swaziland and 69% in Mozambique are tested during antenatal care (appendix 2). Continuity of care is reflected by the ability of the health system to retain people in care and by the patient’s ability to see a clinician familiar with their medical history. Integration is the extent to which health services are delivered in a complementary and coherent manner. These two dimensions are important for the management of non-communicable diseases and other chronic conditions, such as HIV, that require continuous patient support after diagnosis and a comprehensive treatment approach. 58 Across services including antenatal care, child vaccination, antiretroviral therapy, and mental health care, retention rates ranged from 87% for diphtheria-tetanus-pertussis (DTP3) vaccination in 83 LMICs to only 55% retention for mental health care in 12 LMICs (appendix 2). 79,80 Similarly, lapses in the follow-up of test results have also been reported and pose severe challenges for infectious conditions such as HIV and tuberculosis. 59,71 A systematic review 81 estimated patient losses to the system between diagnosis and treatment for tuberculosis to be as high as 18% in Africa and 13% in Asia. Regarding integration, all tuberculosis patients should be tested for HIV, because of risk factors shared between the two infections. 78 In the WHO African Region, where the burden of HIV-associated tuberculosis is highest, 82% of patients with tuberculosis were tested for HIV. 82 For people with life-threatening emergencies, such as labour complications, trauma, and stroke, treatment delays substantially increase mortality risk. Timeliness is also central for other conditions that can be cured if treated early—including many cancers—and conditions such as tuberculosis or diabetes, in which early treatment prevents transmission or disease progression. Time intervals from admission to surgery for traumatic fractures of the femur were found to be substantially longer in LMIC hospitals than in high-income country hospitals. 83 Numerous studies have described the delays that occur during labour complications in women deciding to seek care and in reaching health facilities—the so-called first and second delays. However, the third delay—in providing high-quality care once women reach health-care facilities—is emerging as an important contributor to maternal and newborn child mortality. 84 For example, a study 85 in India found that attending to women within 10 min of their arrival to the facility could have prevented 37% of recorded stillbirths. Additionally, the absence of immediate postpartum care can lead to serious obstetric complications being missed. Across 41 countries with a demographic and health survey, we found that only 41% of women delivering in a health-care facility reported someone checking on their health within 1 h of delivery (appendix 2). For infectious diseases, such as tuberculosis, making a timely diagnosis is crucial for interrupting transmission and optimising treatment outcomes. A review 86 of studies done in LMICs found that an average of 28·4 days passed between the first contact of patients with the health system and the date of tuberculosis diagnosis, ranging from 2 days in China to 87 days in Pakistan. Regarding cancer care, delays caused by both patient and health system contribute to advanced disease at presentation and high cancer mortality rates in LMICs. Studies 54,87,88 from Brazil, Ghana, Mexico, Peru, and Rwanda reported delays of up to 28 weeks between presentation to a doctor and definitive diagnoses of cervical or breast cancer. Data from the Mexican Institute of Social Security, the largest health system in Mexico, revealed that 51% of women with breast cancer waited more than 30 days between mammography and diagnosis, and 44% of women with cervical cancer waited more than 30 days between Pap smear and diagnosis. 89 Delays in initiating treatments further affected the prognosis of patients. According to the Mexican Institute of Social Security, as many as 70% of women with breast cancer and 61% of women with cervical cancer waited more than 21 days between receiving the diagnosis and beginning therapy. 89 Similarly, a study 90 done in Buenos Aires hospitals, Argentina, found that the median time elapsed between diagnosis of breast cancer and treatment with chemotherapy was 76 days in public hospitals and 60 days in private hospitals. These delays are concerning because waiting more than 5 weeks before starting definitive treatment can worsen survival for cervical cancer, and delays in diagnosis longer than 12 weeks are considered suboptimal for breast cancer. 54,87 User experience Competent care and competent health systems are necessary for achieving high-quality care, but a positive user experience is also important. In addition to having an intrinsic value, positive user experience can improve retention in care, adherence to treatments, and, ultimately, confidence in health systems. 91 Additionally, some studies have found that positive user experience is linked to better technical quality. 91,92 To address insufficient cross-national data on user experience, this Commission did an internet survey on user experience in 12 countries in Africa, Latin America, Asia, and the Middle East. Full results will be presented in forthcoming papers, but some of the key results of this survey are shown in figure 4, along with indicators from four other surveys done in 49 LMICs and 11 high-income countries (appendix 2). 70 We found that an average of 34% of people in LMICs reported poor user experience, citing a lack of attention or respect from facility staff (41%), long wait times (37%), poor communication (21%), or short time spent with providers (37%). This result on the short time spent with providers was echoed by a 2017 review 93 that found that primary care consultations lasted fewer than 5 min on average in LMICs. Figure 4 User experience in 49 low-income and middle-income countries (LMICs) and 11 high-income countries Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes delineate the IQR. High-income countries do not contribute to the illustrated medians. Data are from the surveys indicated. AFRO=Afrobarometer survey done in 34 African LMICs (2011–13). HQSS=Commission-led internet survey done in 12 LMICs (2017). IDB=nationally representative phone survey on primary care access, use, and quality done by the Inter-American Development Bank in six Latin-American and Caribbean LMICs (2013). SPA=Service Provision assessment surveys done in ten LMICs (2007–16). CWF=International Health Policy Survey done by the Commonwealth Fund in 11 high-income countries (2013). Indicators are defined in appendix 1; country specific means are shown in appendix 2. Panel 2: Beyond the numbers—experiences in the health system* Interviews with patients help to paint a more comprehensive picture of their experiences within the health system. The Word Bank’s landmark publication, Voices of the Poor,A1 in 2000 shared the narratives of individuals across the world and described the challenges that the poor face in not only accessing health care but also successfully navigating the health system. Since then, several qualitative studies have further illuminated the ways in which people receive differential treatment while seeking care. We did a rapid review of these studies (methods are described in appendix 1). The stories described in these studies highlight disparities in both competent care and user experience. Patients across a wide range of low-income and middle-income countries have described the lack of competent care and health systems. In Egypt, a woman said that “at the hospital, they do nothing to people unless they are staff relatives, or rich people that have power or authority.”A1 A focus group participant in TanzaniaA2 stated that “they are very often saying that medicines are available or not available. When someone tells you they aren’t, it’s her siri (secret). She is the only one who knows. She decides when she sees you coming. … This really upsets us…. The obstacles are like these ones of medicines even if there are no medicines what makes me feel bad is the game.” Patients also reported improper examinations and care. A focus group participant in EthiopiaA3 described her delivery care: “they left the placenta inside me. Because they are impatient, they did not examine me. After I gave birth, I rested there for 5 h but no one came and asked me whether I was bleeding… After 3 days, my face got swollen… I almost died.” Studies also highlight poor user experience, including verbal abuse and neglect from health-care workers. According to a patient in Russia, “the hospital is like a prison”.A1 A person in GhanaA4 recounted that “people always say that the nurses are shouting too much, and saying bad things to them, and maybe they don’t want to treat them. They only care for those big people who have money to give them.” Poor patients, such as this respondent in Timor Leste,A5 also frequently report disrespectful, discriminatory treatment from health-care workers: “Health workers yell at us like a slave… they give priority to the important people, rich and intellectual and neglecting the poor, no money, stupid and dirty…That is the reason why people do not want to go to the hospital although they have a letter of referral.” *Panel references can be found in appendix 1. Some differences across surveys are worth noting. In Afrobarometer survey countries, 42% of respondents reported never experiencing a lack of attention or respect, whereas in the internet survey, 75% of respondents reported respectful care at their last visit. Differences in countries and income groups (our survey was done in more middle-income countries than those of Afrobarometer), wording (“never experienced” was used in Afrobarometer surveys), time frames (past year vs last visit), and survey sampling (internet users have a higher average socioeconomic status than household respondents) might explain these differences. Differing expectations of quality can also influence the perception of user experience. No benchmarks exist for what constitutes good user experience. However, user ratings of communication and time spent with providers were consistently higher in high-income countries than in LMICs (figure 4), with only 11% of respondents reporting poor communication and 17% reporting insufficient time with providers (compared with 74% and 60% on average in the six Latin American and Caribbean countries surveyed by the Inter-American Development Bank). Disrespect and abuse of women during childbirth has been widely reported in LMICs, 9 including documented instances of physical abuse, non-consented clinical care, no confidentiality and dignity, discrimination, abandonment, and detention in facilities. A review 9 of studies showed a range of 19–98% of women reporting mistreatment during childbirth across LMICs, with 3–36% reporting physical abuse. Beyond being an indicator of poor-quality care, disrespect and abuse should be unacceptable in any health system. Nonetheless, these numbers can only tell part of the story. The quality of the processes of care, particularly of the user experience, is also reflected in the patient voices in panel 2. Quality impacts High-quality care—both competent care and positive user experience—can have an effect on people’s health, their confidence and trust in health systems, and economic outcomes. In this section, we present available evidence on morbidity and mortality linked to poor quality care. We also synthesise data on people’s confidence in health systems, and we address the potential economic benefits of high-quality care. Health Although the causes of death are often multifactorial, and are not solely influenced by health care, deaths from some conditions are highly dependent on quality of care and are regarded as sensitive indicators of how well a health system is functioning. For this Commission, we did an analysis of the mortality burden of poor-quality care across health conditions relevant to SDGs. 94 We compared mortality for conditions amenable to health care between LMICs and countries with well performing health systems, to estimate the mortality that can be attributed to poor-quality health systems. We estimated that 8·6 million deaths per year (uncertainty interval [UI] 8·5–8·8 million) in 137 LMICs are due to inadequate access to quality care. Of these, 3·6 million (UI 3·5–3·7 million) are people who did not access the health system, whereas 5·0 million (UI 4·9–5·2 million) are people who sought care but received poor-quality care. Poor-quality care resulted in 82 deaths per 100 000 people in LMICs—an annual mortality rate equivalent to that from cerebrovascular disease globally. 94 Cardiovascular deaths make up 33% of deaths amenable to health care (figure 5). 94 Ischaemic heart disease is the largest contributor to amenable cardiovascular disease deaths, with 1·4 million deaths due to poor-quality care and 260 000 due to non-utilisation of health systems. Of the 2 million deaths from neonatal conditions and tuberculosis that are amenable to health care, 56% occurred in people who used the health system, but did not receive good quality care. Across several other health priorities for which coverage is still low, including chronic respiratory disease, cancer, mental health, and diabetes, non-utilisation of health systems plays a larger role than poor-quality care, but this will change as access increases. Our results highlight that health systems could be more effective in saving lives across a spectrum of conditions by improving quality of care along with expanding coverage. An analysis done with similar methods for a shorter list of conditions found that, globally, 8·0 million deaths could be averted with access to high-quality care. 95 Figure 5 Deaths from Sustainable Development Goal conditions due to poor-quality care and non-utilisation in 137 low-income and middle-income countries External factor deaths are those due to poisonings and adverse medical events. Other infectious diseases deaths are those due to diarrhoeal diseases, intestinal infections, malaria, and upper and lower respiratory infections. Maternal and newborn deaths are a particularly sensitive measure of health system quality, because many deaths stemming from labour complications can be averted with appropriate treatment. 96 Figure 6 shows the comparison of rates of maternal and newborn deaths in countries with similar, high coverage of skilled attendants during birth (80–90% of births). Countries were grouped by income to reduce the influence of social and economic determinants. Across countries with similar coverage, large disparities in maternal and neonatal mortality are apparent. The ratio of worst to best performing country for maternal mortality was 2·1 in low-income, 12·2 in lower-middle-income, and 5·7 in upper-middle-income countries; for neonatal mortality it was 1·4, 3·7, and 2·9, respectively, suggesting differences in quality of care. Figure 6 Differences in maternal and neonatal mortality rates across low-income and middle-income countries with 80–90% skilled birth attendance coverage Mortality estimates are from WHO, using 2015 modelled estimates. Skilled birth attendance is from the World Bank World Development Indicators, using the most recent data available in the past 10 years. Horizontal lines indicate Sustainable Development Goal targets. Few deaths in these countries are recorded in complete vital registration systems; global estimates must account for missing and unreliable data. Mortality estimates should be interpreted with caution because of uncertainty from measurement error. References can be found in appendix 1. The frequency of stillbirths can also be reduced with high-quality care. 97 An analysis done for this Commission—with use of the Lives Saved Tool—in 81 countries that are the focus of the Countdown to 2030 collaboration, estimated that 520 000 stillbirths could be prevented and 670 000 neonatal and 86 000 maternal lives could be saved in these countries by 2020 if adequate quality of care is provided at current levels of health system use (appendix 1). Because quality was measured by use of inputs to care rather than by processes of care, these figures might underestimate actual mortality. An older analysis that used different methods found similar effects on stillbirths, but more maternal and newborn lives saved. 98 In addition to improving the quality of labour and delivery care, improving the quality of antenatal care and family planning is crucial to reducing stillbirths. 97 Population-based cancer survival is also an indicator of overall health system effectiveness. 99 Using cancer registries from 71 countries, a 2018 study 99 found varying rates of cancer survival between countries and for different cancers. For example, most countries reported an increasing trend in 5-year net survival from breast cancer since 1995, but survival did not always increase in countries such as India, Thailand, and several eastern European countries. 99 More broadly, hospital mortality can be useful for gauging the quality of care in facilities, when adjusted for disease severity and underlying risk, and can provide useful insight on the quality of secondary care in a region or country, when aggregated. Delivering high-quality hospital care requires well functioning facility systems that include appropriate triage in emergency departments, rapid decision making for very sick patients, close inpatient monitoring, and rigorous infection prevention practices, among other elements. Studies in LMICs have revealed high institutional maternal, perioperative, and emergency department mortality rates and high in-hospital mortality rates in patients admitted for acute myocardial infarctions. For example, the WHO multicountry survey 100 on maternal and newborn health found intrahospital maternal mortality ratios that were 2–3 times higher than expected on the basis of case severity. High rates of perioperative and anaesthetic-related mortality were also found in LMIC hospitals, reflecting gaps in surgical and hospital care quality. 101–104 The African surgical outcomes study 101 found that patients in Africa were twice as likely to die after surgery compared with the global average, despite being younger, with a lower surgical risk profile, and undergoing less complex surgeries. Most of the deaths occurred post surgery, suggesting that many lives could be saved by effective surveillance for physiological deterioration in patients who have developed complications. Similarly, although the quality of emergency and trauma care in LMICs is understudied, one study found that mortality recorded in emergency departments in LMICs is many times higher than that generally reported in high-income countries, pointing to gaps in the quality and appropriateness of services being provided in these emergency departments. 105 In patients admitted with ST-segment elevation myocardial infarction in China, in-hospital mortality did not significantly change between 2001 and 2011, suggesting a need for improvements in quality. 64 Mortality alone does not capture the full burden of poor-quality care. People accessing poor-quality care can develop morbidities, including physical sequelae, persistent symptoms, reduced function, pain, and poor quality of life. For example, for many people in LMICs, access to health care does not result in control of manageable conditions such as hypertension, diabetes, HIV, tuberculosis, chronic lung diseases, and depression. Poor quality of care during childbirth can also result in morbidities with lifelong consequences. A study 106 of 1·7 million adults in China found that only 24% of patients under treatment for hypertension had achieved blood pressure control. A nationally representative study, 107 also from China, found that among patients receiving treatment for diabetes, only 40% had achieved adequate glycaemic control. Complications of diabetes such as blindness, kidney failure, and lower limb amputation can be largely averted through high-quality primary care. However, in 2016, the Mexican Social Security Institute reported 4518 major lower limb amputations in patients with diabetes, for an incidence of 120 per 100 000 patients. This continues a previously documented trend of increasing incidence of diabetic amputations and is higher than the comparable incidence in most, but not all, OECD countries. 89,108 According to 2017 UNAIDS estimates, 79 only 71% of people on antiretroviral therapy in LMICs have achieved viral suppression, and only ten countries have reached the 90% viral suppression target. Tuberculosis treatment success rates are also reflective of the quality of care, and only eight of the 30 countries with high tuberculosis burden have reached 90% first-line treatment success rate. 109 In countries with high drug-resistant tuberculosis burden, treatment success rates range between 50% and 85%. 109 These figures show a need for better follow-up, treatment, and counselling of patients with manageable conditions in LMICs. Obstetric fistula is a highly debilitating condition with severe social and health consequences. Women with fistula have leakage of urine or stool through the vagina and are ostracised because of this in some regions. 110 Fistulas typically develop in women with prolonged obstructed labour. Although cultural factors, such as child marriage, increase the risk of obstructed labour, the existence of fistulas on a wide scale, as documented in studies, is an indicator of poor quality obstetric care and a broader health system failure. 111 Using data from demographic and health surveys in 25 countries, we estimated the proportion of women who suffered from symptoms of an obstetric fistula among those whose last birth was attended by a skilled provider. In women whose last delivery was done with a skilled attendant, ten per 1000 women reported symptoms of an obstetric fistula, ranging from 0·54 per 1000 in Burkina Faso to 32 per 1000 in Pakistan (appendix 2). By contrast, obstetric fistulas have been almost eliminated in high-income countries. Another goal of treatment is remission or reduction of symptoms. In the WHO SAGE, only 50% of patients receiving treatment for chronic lung disease and only 7% receiving treatment for depression reported having no symptoms from the two diseases in the preceding 2 weeks (appendix 2). The Lancet Commission 36 on palliative care and pain relief quantified the global burden of serious health-related suffering and found that more than 80% of the global 61 million patients affected by serious health-related suffering live in LMICs. Confidence in the system The quality of care that people receive also has important consequences for their confidence and trust in their government and health system, which can affect their decisions of when and where to seek care. Figure 7 shows varying degrees of confidence and trust in health systems across 45 LMICs. Only 24% of people stated that they believe that their health system worked “pretty well” and that only minor changes were necessary to make it work better. 112 In comparison, 47% of respondents agreed with the same statement in 11 high-income countries, ranging from 24% in the USA to 61% in the UK (appendix 2). 113 Differences in survey sampling and indicator wording might account for some of the variation across surveys. For example, increased confidence in the ability to receive the care needed present in the internet survey led by this Commission might be explained partly by a higher socioeconomic status of internet users. Gallup World polls 114 also showed large gaps in satisfaction between low-income and high-income countries: in sub-Saharan Africa, northern Africa, and the Middle East, only 42–49% of respondents were satisfied with the availability of high-quality care near them, compared with 86% in northern Europe. Nonetheless, patient satisfaction should be interpreted with caution as a measure of quality (panel 3). Figure 7 Confidence and trust in health systems in 45 low-income and middle-income countries (LMICs) and 11 high-income countries Dots represent country-specific means, vertical bars indicate median performance across countries, and boxes delineate the IQR. High-income countries do not contribute to the illustrated medians. Data are from the surveys indicated. AFRO=Afrobarometer survey done in 34 African countries (2011–13). HQSS=Commission-led internet survey done in 12 LMICs (2017). IDB=nationally representative phone survey on primary care access, use, and quality done by the Inter-American Development Bank in six Latin-American and Caribbean LMICs (2013). CWF=International Health Policy Survey done by the Commonwealth Fund in 11 high-income countries (2013). Indicators are defined in appendix 1; country specific means are shown in appendix 2. Panel 3: Why are people satisfied with poor quality?* Perhaps paradoxically, because of the prevalence of poor-quality health care, patients in low-income and middle-income countries tend to report high satisfaction with the care received. Across eight low-income countries, 79% of patients and caregivers reported being very satisfied with the care received during consultations in which providers did less than half of essential clinical actions (results in appendix 2). This percentage ranged from 75% for care of sick children to 85% for family planning (appendix 2). High satisfaction with health care is common across low-income and middle-income country surveys, but patient satisfaction as a measure of quality should be carefully interpreted. Although satisfaction is influenced by the quality of care, it is also influenced by care accessibility, costs, health status, expectations, immediate outcomes of care, and gratitude.A9 Additionally, satisfaction measures can be subject to substantial survey bias.A10 In the Commission’s internet survey of patient experience, we tested one factor thought to be influential in generating high satisfaction: low expectations for quality of care. Respondents were asked to rate the quality of care on the basis of short vignettes. A vignette that described a nurse changing the medication of a patient with hypertension without measuring blood pressure or asking about symptoms was rated as good to excellent quality of care by an average of 53% of 17 966 respondents across 12 countries, and as high as 62% of 1292 respondents in Senegal, suggesting a low threshold for what is considered to be good care (appendix 2). Low expectations of what constitutes good quality might be a consequence of the prevailing poor-quality care, low agency, and inadequate functioning mechanisms to hold systems accountable. Other studies have also shown that patient satisfaction surveys are influenced by acquiescence bias. Surveys framing statements in a positive way and inviting patients to agree or disagree will lead to positive responses much more frequently than surveys with more neutral statements.A10 More discussion on the utility of patient satisfaction as a measure of health system quality can be found in Section 4. *Panel references can be found in appendix 1. Other research has found that increased technical quality of health services, combined with responsive service delivery, fair treatment, better health outcomes, and financial risk protection, was associated with an increase in the probability of having trust in government. 29 Similarly, a better user experience (communication and time spent with providers) was associated with better trust in health systems in Latin America and the Caribbean. 112 Research suggests that quality, particularly that perceived by the patient, might have an effect on healthcare utilisation patterns, retention in care, and people’s decision to bypass facilities. 115,116 In the internet survey led by this Commission, more than half of patients who decided not to seek care in the preceding year (despite needing medical attention) stated that their decision was made for quality reasons (eg, poor provider knowledge, long wait times, or disrespect), as opposed to cost of care or distance to facilities. The highest proportion of patients was in Mexico, where 73% cited quality reasons for not seeking care. Similarly, a study 117 in Haiti found that higher quality primary care facilities were associated with higher utilisation. Perceived poor quality of care can also lead people to bypass certain facilities. Households might choose to travel further distances or pay more out of pocket to seek better quality care. 118,119 In India, many patients choose to seek care from the private sector, which is viewed as more competent than public facilities. India’s District Level Household and Facility Survey found that 51% of households bypassed their nearby public facility for their usual care; of these, 80% cited at least one quality concern as a reason (figure 8, appendix 1). Some people might also choose to bypass primary care facilities and seek care at hospitals or higher-level facilities for conditions that could be treated in primary care. 120 A survey 121 in China found that poor quality of care and lack of trust in primary care institutions were among the most common reasons for bypassing primary care and going directly to hospitals. Primary care is the cornerstone of a high-quality health system, serving as the main entry point for most concerns and playing a crucial role in coordinating care and ensuring continuity across health system platforms. Nonetheless, primary care facilities often fail to fulfil their role. Using facility surveys from nine countries, we built a primary care quality score based on three domains of quality—evidence-based care, competent systems, and user experience—and found an average score of only 0·41 out of 1, ranging from 0·32 on average in Ethiopia to 0·46 in Namibia (appendix 2). By contrast, some studies 122 have not found a relation between utilisation and measures of quality, such as doctors’ competence, probably because of information asymmetry. A crucial area for future research will be to estimate the demand response to higher quality of care, focusing on the role of information and perception of quality in influencing utilisation patterns. Figure 8 Proportion of households that report quality concerns as reason for bypassing public facilities in districts in India Data are from the fourth cycle of the District Level Household and Facility Survey done by the International Institute of Population Sciences from 2012 to 2014, in 21 states of India. A quality concern was defined as mentioning any of the following as a reason for bypassing government facilities: inadequate infrastructure, doctor not available, absent health workers, poor quality, drugs not available, inconvenient hours, long wait time, or distrust. In darker coloured districts, a higher proportion of households cited quality concerns. Economic benefit Improving health system quality can be justified on ethical, epidemiological, and economic grounds. Little evidence exists on the link between levels of quality of care and economic outcomes. Here, we describe three types of economic consequences that could be averted by high-quality health systems: macroeconomic effects of premature mortality, health system waste, and catastrophic or impoverishing health expenditures faced by households. A 2018 analysis 95 estimated the macroeconomic effect of mortality that could be prevented with access to high-quality care in LMICs. The analysis was done by use of two distinct approaches to quantify economic losses from preventable mortality. The first approach projected gross domestic product (GDP) losses over 15 years due to the consequences of mortality on labour force and physical capital accumulation. In 91 LMICs, amenable deaths due to insufficient good quality care would result in a projected cumulative loss of US$11·2 trillion (UI 8·6–15·2 trillion) between 2015 and 2030. This economic output loss was greatest in low-income countries, costing 2·6% of their GDP compared with 0·9% in upper-middle-income countries. 95 The second approach estimated the current value of total economic welfare losses on the basis of the concept of a statistical life, which attempts to capture the value placed on good health in and of itself. In 2015 alone, poor access to quality care resulted in an estimated $6·0 trillion of losses in 130 LMICs. 95 Upper-middle-income regions lost the least, whereas losses in sub-Saharan Africa accounted for more than 15% of GDP. This analysis shows that poor-quality care can result in a great macroeconomic burden that is inequitably distributed across countries. Beyond the economic losses from premature mortality, poor-quality care can also lead to important waste and inefficiency. Waste in health care has been defined as any “health-care spending that can be eliminated without reducing the quality of care”. 123 Health-care waste includes the overuse of unnecessary care or ineffective approaches, medical errors, unsafe care, incoordination of care, misuse (including inappropriate hospital admissions and bypassing), fraud, and abuse. There have been few measurements of health-care waste attributable to poor-quality care in LMICs. However, evidence from high-income settings suggests that averting these costs could help LMICs make better use of scarce resources. For example, the annual costs of extra hospital stays and readmissions for treatments of surgical site infections were estimated to range between $3·5 billion and $10 billion in the USA and between €1·47 billion to €19·1 billion in Europe. 73 Similarly, the global economic effects of antimicrobial resistance remain largely unknown, but in the USA alone, its yearly cost to the health system is estimated to range between $21 billion and $34 billion. 124 Lastly, the global cost of unnecessary caesarean sections done each year is estimated to be $2·32 billion, which far surpasses the cost of needed caesarean sections. 125 Because care delivered in hospitals has a greater risk of complications and is more costly, inappropriate hospital admissions also represent a substantial burden to the health system. High-quality primary care can prevent the need for hospital admissions for several health conditions called ambulatory care-sensitive. 11 In the USA, $31 billion are spent annually on hospital admissions for these conditions. 123 Better perceived quality and greater trust in health systems can also improve care-seeking patterns and reduce the bypassing of primary care facilities for overcrowded hospitals in LMICs. Finally, people living in countries with poorly functioning health systems, without appropriate financing mechanisms and insurance, risk suffering from catastrophic or impoverishing expenditures when seeking care. Out-of-pocket payments (ie, health spending made by patients themselves at the point of care) as a share of household consumption have been increasing worldwide. 126 In 2010, 808 million people (11·7% of the world’s population) incurred catastrophic health expenditures—ie, exceeding 10% of household consumption. 17 Catastrophic spending increased by 2 percentage points since 2000 and was associated with economic growth and per capita health spending. Nearly 100 million people are pushed into extreme poverty each year because of out-of-pocket expenses. 17 For poorer households, out-of-pocket payments often mean choosing between paying for health and paying for other necessities, such as food or rent, straining their day-to-day survival capacity and affecting their physical, social, and economic wellbeing. 127 High-quality health systems with appropriate financing mechanisms can enable facilities and providers to give affordable care to the population. To help reduce impoverishing and catastrophic expenditures, prepaid health expenditures should replace out-of-pocket payments. A study 128 published in 2018, found that the proportion of the population covered by health insurance schemes or by national or subnational health services was not associated with financial protection. Conversely, increased shares of prepayment in total health expenditure, typically achieved through taxes and mandatory contributions, were important for protecting people against catastrophic spending. 128 The economic consequences we have described could be attenuated or averted in high-quality health systems. However, improving health system quality will require additional investments in many countries. Analyses have suggested that these will be substantial but affordable in most settings, excepting the poorest countries. In 2017, WHO published 129 an estimation of the cost of interventions and health-system strengthening strategies required for reaching all SDG-related health goals in 67 LMICs. WHO estimated additional annual costs of $263 billion, which would save 97 million lives from 2016 to 2030. The estimated total costs per person ranged from $112 in low-income countries to $536 in upper-middle-income countries. The Disease Control Priorities Project 14,130 estimated the costs for reaching 80% effective coverage for 218 interventions, to meet UHC targets, in 83 LMICs and found that an additional $260 billion per year would be required. This represents $76 per person in low-income countries and $110 in lower-middle-income countries; this investment would result in 6·2 million deaths averted by 2030. Further research is needed to measure the costs of specific quality improvement strategies, including those advanced by this Commission. A health systems view must also be used to understand quality. This section addressed health care that is delivered at different levels of the health system, including through community outreach, primary care, and hospital care, and the linkages between them—referral systems and emergency medical services. Figure 9 summarises evidence on quality across these key health system platforms. Figure 9 Quality of care across health system platforms in low-income and middle-income countries (LMICs) DALYs=disability-adjusted life-years. HDI=Human Development Index. References can be found in appendix 1. Equity of high-quality care We have thus far reviewed the available evidence on quality of care at a national or multinational level. However, these estimates mask important variations within countries. Equitable distribution of high-quality health care is essential to make the gains in health set out by the SDGs and ultimately contribute towards the realisation of the right to health. We now explore why some groups are more vulnerable to poor-quality care than others and who receives worse quality care. Defining equity in the quality of health care Braveman and Gruskin 131 defined health equity as “the absence of systematic disparities in health (or in the major social determinants of health) between groups with different levels of underlying social advantage/disadvantage—that is, wealth, power, or prestige”. This definition emphasises equitable health outcomes. The health-care system is one major determinant of health, and equitable access to the system is, therefore, important. But equitable access will not result in more equitable health outcomes unless all people—not just the privileged—are able to access high-quality services. Equity in the quality of health care can be defined as the absence of disparities in the quality of health services between individuals and groups with different levels of underlying social disadvantage. Groups vulnerable to poor quality of care In 1971, Julian Tudor Hart 132 stated that “the availability of good medical care tends to vary inversely with the need for it in the population served.” There is evidence of this inverse care law in many health systems—LMICs and high-income countries alike. For instance, tuberculosis has a strong socioeconomic gradient between countries, within countries, and within communities. 133 Drug resistance arises in areas with poor tuberculosis control programmes and among subpopulations that face barriers to quality treatment. Similarly, a systematic review 134 focused on diabetes showed that low individual socioeconomic status and deprivation in the residential area are associated with worse process indicators and intermediate outcomes, resulting in higher risks of microvascular and macrovascular complications. The 2030 agenda for sustainable development is built on principles of universality and aims to ensure that no one is systematically left behind. 135,136 This commitment is echoed in the World Health Assembly resolution number 69·11, 137 which calls for “health system strengthening for UHC, with a special emphasis on the poor, vulnerable, and marginalised segments of the population”. Therefore, an effective implementation demands the defining and targeting of those most vulnerable. 136 WHO’s definition of vulnerability encompasses the effects of “marginalisation, exclusion, and discrimination that contribute to poor health outcomes”. 138 Vulnerability can vary substantially, change over time, and be multidimensional. 139 Factors such as gender, ethnicity, displacement, disability, and health status can increase vulnerability of both individuals and communities. These factors are often fluid and have intersecting points, presenting serious obstacles to individuals in accessing high-quality health services. 139 However, many countries fail to recognise the existence and impact of intersecting discrimination. As a result, the experiences and needs of these populations are not integrated into national health strategies, further entrenching the discrimination and disadvantage that they face. In this Commission, we highlight three dimensions that might make people especially vulnerable to poor-quality care: settings of care, conditions, and demographic factors (figure 10). Within settings of care, vulnerability is greater for individuals on the margins of mainstream services or displaced from home, such as those who are in a humanitarian crisis or in refugee camps, internally displaced, living in informal settlements, prisoners, and migrant populations. People with stigmatised conditions can face worse treatment in the health system than others; these conditions can include HIV and AIDS, mental health and substance abuse disorders, and some reproductive health services such as abortion. Finally, previously recognised social and demographic factors that indicate asymmetric power, such as gender, age, sexual orientation, ethnic group, disability, and insurance coverage, can predispose people to experiencing poor-quality care. Figure 10 Dimensions of vulnerability to poor-quality care Reasons for poor-quality care in these three dimensions include the collapse of health services, insufficient financial and human resources, low patient empowerment, barriers to continuity of care, insufficient legislative controls, and breakdown in trust between patient and system. These dimensions of vulnerability, along with an understanding of why these groups could receive poor-quality care and suffer worse health outcomes than others, can inform policies and programmes that target specific vulnerability factors. Panel 4: Why quality of maternal mental health care might suffer for vulnerable groups: perinatal depression care in primary care setting in Nigeria* Women with perinatal depression can experience stigma associated with mental illness in some low-income and middle-income countries. People with mental disorders are often victims of discrimination and denial of basic rights.A37 They can also internalise shame, anticipate rejection and discrimination, and accept diminished expectations from others. These two forms of stigma, enacted and felt, have the effect of exposing individuals with mental disorders to poor and inequitable quality of care. Therefore, in the context of perinatal depression, stigma would increase the likelihood that those suffering are denied access to the basic and often rudimentary services available. A formative study done as part of the project Scaling up Care for Perinatal Depression for Improving Maternal and Infant Health in Nigeria, assessed the factors that might promote or hinder the delivery of quality services to women with perinatal depression (appendix 1). All 23 facilities sampled had the lowest level of institutional support for continuous care for depression. Of the 218 patients who screened positive for perinatal depression by use of a validated tool, only three were identified by primary health-care workers. The treatment offered to these three patients was non-existent or grossly inadequate. None were provided with structured psychosocial interventions or offered specific follow-up to address their depression. However, 96% of the women in all sampled facilities reported that the quality of care provided in the clinics was good and of sufficient quality, and 98% reported that they were satisfied with the care they had received. The low capacity of all the sampled facilities to provide quality care for depression, and the extremely low detection rates of depression by primary health-care workers recorded in the study showed important gaps in both the organisational structures and the manpower capacity of the front-line facilities to respond to common perinatal mental health conditions in a fully functional integrated chronic care model. Despite the objectively rated poor quality of service being provided, the women using these facilities still rated them high regarding quality of care and personal satisfaction with the level of service provided. This paradox is an important indicator of the existing inequity in the system: people who have never experienced high-quality services set their expectations low and do not know how to demand higher-quality health care. Source: Olatunde Ayinde and Oye Gureje. *Panel references can be found in appendix 1. Panel 4 and panel 5 illustrate how conditions (eg, mental health) and settings of care (eg, humanitarian crisis or refugee camps) can exacerbate poor-quality care and what might be done to address these inequalities. Who receives worse quality care? The monitoring and tracking of equity in health intervention coverage has been the focus of major international efforts. 140 Many studies 61,140,141 have shown that some population groups are systematically less likely to have access to or use health services for several conditions. However, there has been less work done on equity in the quality of care. As described earlier in this section, quality of care varies between and within countries. Quality of care can also vary between certain population groups and across conditions in the same area. For example, a study 142 in Kenya showed that the quality of labour and delivery care was generally low, but care available to the poor was substantially worse than that for wealthier people. Similarly, it was found that in Madhya Pradesh, India, poor people living in poor communities received especially poor-quality care. 143 Additionally, poor people throughout the world live and die with little to no palliative care or pain relief. 36 We disaggregated several indicators of quality in maternal and child health presented earlier in this section by wealth, urban and rural residence, maternal age, gender, and education (appendix 1); we also assessed variation in quality between the public and private sector. We found evidence that quality care is inequitably distributed across these stratifiers. Regarding evidence-based care, figure 11A shows the proportion of women and caregivers reporting different elements of antenatal and child health care by wealth quintiles. We found evidence of a wealth gradient across most of these indicators. Among women attending antenatal care with a skilled provider, wealthier women were more likely to report receiving antenatal care assessments and appropriate preventive treatments and more likely to be retained in care until the fourth antenatal care visit. For example, among women attending antenatal care, we found that the wealthiest were four times more likely to report blood pressure measurements and urine and blood tests than the poorest women in their country (relative index of inequality 4·0, 95% CI 3·9–4·1). 45 When seeking care at facilities for pneumonia, children in the wealthiest quintiles in low-income countries were more likely to receive antibiotics than those in the lowest; among all children who received the first diphtheria, tetanus, and pertussis vaccine dose, those from wealthier families were more likely to complete the vaccination series (receiving the third dose by age 1 year) than children from poorer families. These inequities tended to be larger in low-income countries than in lower-middle-income and upper-middle-income countries. Figure 11 Equity in maternal and child health-care quality and in user experience in low-income and middle-income countries (LMICs) (A) Data are from Demographic and Health Surveys and Multiple Indicator Cluster Surveys done in 90 LMICs (2007–16); wealth quintiles are pooled across countries and sampling weights are adjusted to weigh countries equally. (B) Data are from Demographic and Health Surveys and Multiple Indicator Cluster Surveys done in 91 LMICs (2007–16) and are weighted using individual-level survey weights. (C) Data from Commission-led internet survey in 12 LMICs (2017); proportion of respondents who classified their experience for each indicator as “good”, “very good”, or “excellent” (vs “fair” or “poor”) for their last outpatient visit within the prior 12 months; education levels are pooled across country. Indicators are defined in appendix 1. ORT=oral rehydration therapy. DTP=diphtheria tetanus pertussis vaccine. Panel 5: Quality of humanitarian health services for populations affected by armed conflict and natural disasters* During 2016, there were 49 active armed conflicts with about 170 million people affected, including 60 million refugees and internally displaced people throughout the world.A38–A40 Additionally, an estimated 200 million people are affected by natural disasters annually.A41 These crises cause excess morbidity and mortality through multiple pathways.A42 One of these is the disruption of what are often already weak public health systems. In most crises, the health system undergoes substantial degradation and fragmentation, with the void left by reduced government activities often filled by faith-based, private, and informal providers.A43 There are logistical, safety, and practical difficulties in undertaking research during times of conflict that have led to insufficient data on the quality of health services being provided in these situations.A44 However, methods that have been used to assess the quality of care showed low levels of competent care and user experience, issues with staff motivation, and less complicated conditions receiving better quality care than patients who were seriously ill.A45 During the past two decades, humanitarian actors have undertaken various, largely normative, initiatives to promote health-care quality. However, accountability and enforcement remains low, and few humanitarian agencies have implemented health governance systems. Here, we discuss several challenges that need to be tackled to advance the quality agenda in the humanitarian health sector. First, the pursuit of quality remains weak and needs to be incentivised. For example, donors of humanitarian activities should place greater emphasis and funding on strengthening the use and reporting of quality standards and performance metrics. Failure to collect and report these data should have consequences for agencies, such as removal of permission to operate and loss of funding. Second, quality is impeded by insufficient capacity within the humanitarian health workforce. Efforts to professionalise the humanitarian health workforce need to be scaled up through training and updated technical standards and competency frameworks. Third, existing coordination mechanisms need to evolve into technical leadership arrangements, whereby, in exchange for the benefits of taking part in coordination (eg, access to specific funding pools), actors agree to operate according to a standard package of care and specific service quality standards. Fourth, governments need to explicitly consider crisis areas when implanting health interview and population surveys. The actors in these areas should collect data in a way that matches the quality indicators defined by the public health information systems, including assessment of confidence in the system. Lastly, health governance in the humanitarian systems remains weak. Robust governance arrangements, ideally interagency, need to be established to develop concrete accountability and liability in the humanitarian health sector. Source: Bayard Roberts and Francesco Checchi. *Panel references can be found in appendix 1. We also found important urban–rural differences in several of these quality indicators, whereby women and caregivers in urban areas were significantly more likely to report better maternal and child health-care quality than those in rural settings (figure 11B). These urban–rural differences were also largest in low-income countries. In terms of user experience, this Commission’s 12-country internet survey also showed that people with some primary education consistently rated their user experience as worse than did those with secondary education or higher (figure 11C). The largest gap was found in the rating of the overall quality of the last outpatient visit, for which people with primary education or less reported significantly lower quality than did those with more education. A total of 34% of respondents reported that staff had treated them poorly because of their identity and, of those, 10% attributed this to their poverty (appendix 1). These inequalities could be underestimated because studies have shown that less educated people tend to be more accepting of the care they receive. 144,145 Additionally, adolescent women seeking maternal and child health care can also face particular stigma and poorer quality care (appendix 2). Among women attending antenatal care and delivering in health-care facilities, young adolescents were less likely to report receiving different elements of care than women aged 20–35 years. Younger mothers were less likely than others to receive post-partum checkups before discharge after giving birth in a health-care facility. The youngest adolescents (15-year-olds) appeared to be substantially less likely to receive all four recommended antenatal care visits, and their children were less likely to complete the diphtheria, tetanus, and pertussis vaccination series. An analysis of data from the STEPS survey on receipt of lifestyle advice from health-care providers among adults diagnosed with diabetes, hypertension, or hypercholesterolaemia found that women were less likely to receive advice about tobacco use and physical activity than men, and overall, those with no formal schooling were more likely to receive advice about tobacco use and dietary change than those with primary or secondary schooling. Individuals with secondary schooling were more likely to receive advice about physical activity, maintaining a healthy bodyweight, or losing weight than those with primary or no schooling. Additionally, evidence from the Prospective Urban Rural Epidemiology study 146 found that the use of medication for secondary prevention of coronary heart disease was extremely low, with people in the poorest countries having the lowest rates of use. Within countries, women and rural dwellers had lower use than men and urban dwellers; less educated patients were less likely to use antiplatelet drugs and statins than more educated patients. Quality can also differ between public and private facilities, but these differences vary across contexts. Such differences also depend on the types of provider included in the definition of private sector. In terms of evidence-based care and competent systems in the Democratic Republic of the Congo, Kenya, Rwanda, and Uganda, adherence to WHO guidelines for sick child care was higher in private facilities than in public ones. Additionally, adherence to checklists was higher among private providers than among public ones in a standardised patient study 52 in India. However, an analysis 147 of household surveys in 46 countries found that public and private sectors did similarly in terms of antenatal care quality. By contrast, a systematic review 148 in LMICs found that private sector providers (including unlicensed and uncertified providers) were less likely to follow medical standards of practice, had poorer patient outcomes, and reported lower efficiency than public sector providers, resulting partly from perverse incentives for unnecessary testing and treatment. For user experience, public providers did worse in terms of timeliness and hospitality to patients than private providers. 148 Nonetheless, quality can vary considerably within the same sector in a country. Additionally, country differences were found to be more influential than all other subnational factors combined in explaining variation in the quality of primary care services and labour and delivery care. 38 This finding might point to the importance of structural factors in producing quality. Panel 6: Section 3 key findings Previous right-to-health discussions did not sufficiently elaborate on the quality of health services promised to people Spending scarce resources on expanding access to services without ensuring quality is wasteful and inefficient; as countries embark on universal health coverage, services should be accompanied by a national guarantee of quality Quality improvement efforts should start in areas with the greatest quality deficits, with a focus on care received by disadvantaged populations There are concrete mechanisms available to improve health system accountability; this lies at the core of realising the right to the highest attainable standard of health for all people Section 2 conclusion The epidemic of poor-quality care described in this section casts doubt on the ability of legacy health systems to achieve the SDG health targets. Poor-quality care in LMICs is reflected by inadequate adherence to evidence-based care, negative patient experiences, unequal treatment and access to health services, and by deficiencies in safety, prevention, continuity, and timeliness, leading to poor health, adverse economic outcomes, and loss of trust and confidence in health systems. Additionally, poor and vulnerable groups appear to experience worse quality care. Despite the breadth of the evidence presented in this section, there were still many gaps in the availability of data on quality of care (appendix 2). Poor-quality care has been attributed to the poor knowledge and competence of providers and to fatigued or unmotivated health workers. However, the scale and range of the problem across countries, settings, and health conditions suggests that it is a manifestation of a broader systems failure. LMIC health facilities are underequipped, overcrowded, and frequently understaffed. Pre-service education and specialty trainings are inadequate. Processes are inefficient or inexistent, including financial incentives and remuneration of providers, referral networks, and triage in emergency departments. These fragmented health-care systems are unable to support health workers in providing high-quality care. Section 3: The ethical basis of high-quality health systems The core principle of this Commission is that health systems are for people. This section asks: are they for all people? We review the right to high-quality care and provide insights into steps that national governments and communities can take to address the issue of equity and build a strong high-quality health system that targets the poor and vulnerable groups. The key findings of this section are shown in panel 6. Implementing the right to high-quality care through a national quality guarantee What is the right to quality care in settings with few resources? The health and human rights agenda has been essential to motivating investments and actions to improve health in LMICs, as well as globally. This agenda historically emphasised inputs and access to care, but did not specify the quality of services provided. In 2000, 13 the UN Committee on Economic, Social, and Cultural Rights adopted general comment 14, which states that the right to the highest attainable standard of health includes availability, accessibility, acceptability, and quality. In a review for this Commission 149 of global health policy milestones since 2000, we found that the global discourse has been focused on access to care and foundations of quality, but not enough appears on processes of care or quality-specific impacts, such as trust or satisfaction. However, with the implementation of the 2007 WHO framework for action on strengthening health systems to improve health outcomes and the 2016 WHO framework on integrated, people-centred health services, the trend is moving in the direction of patient-centred care and measures of quality focused on processes of care. Health systems should communicate the right to health through a national health plan, initiatives to ensure that the public knows its entitlements and how to realise them, and data on health system quality. 30 Are there ethical trade-offs between improving quality and expanding access? One reason that quality has lagged behind access in global health discussions is the perceived trade-off between expanding coverage and improving quality. A trade-off is a compromise between two or more desirable, but competing considerations and, thus, involves a sacrifice made in one dimension to obtain benefits or ensure respect for rights in other dimensions. 150 There was (and still is in many low-income countries) an understandable sense of urgency to expand essential services to the population at any cost—without an explicit focus on quality. This finding can be interpreted as the result of a trade-off made by decision makers: equitable access for all is better than access to high-quality services for some. Quality is essential to the equity agenda. We recognise that on the high end of care, such as expensive advanced technologies and medicines, provision of cheaper and somewhat less effective treatments can be an appropriate option in low-resource settings. One example is the use of the visual inspection with acetic acid method for cervical cancer screening instead of the more expensive and time consuming Papanicolaou smear and human papillomavirus co-testing. 151 However, we believe that a concern for equity implies access to a minimally assured level of quality for all. There are two reasons for this: ethical achievement of health outcomes and efficient use of resources. First, increased access will not translate to better health outcomes for disadvantaged people unless all people have access to high-quality services. Second, spending scarce resources to expand access without quality is wasteful and inefficient. Countries can build on their achievements in expanding coverage by improving the quality of services offered to meet the minimum quality level. They can then consider further expansion of quality services. As countries pursue UHC, approaches such as progressive universalism—a determination to include people who are poor from the beginning—have proven to be effective ways to target poor and vulnerable groups of society. 152,153 Brazil’s Family Health programme 154 and Mexico’s Seguro Popular initiative 155 are two examples of programmes designed to increase coverage first among disadvantaged groups. This Commission endorses this approach. Defining a national quality guarantee Many countries recognise the need to be accountable for the health care of the population. One clear manifestation of this is patients’ rights charters that outline a country’s approach to patient care and provide an ethical basis for care. Although these charters contain many of the same basic principles, such as legal and human rights guarantees, they vary substantially in length, scope, and detail. Patients’ rights charters are well intentioned, but not operational. South Africa is attempting to make its promises actionable through its National Health Insurance Policy, which underpins the establishment of a unified health system based on the principles of social solidarity, progressive universalism, equity, and health as a public good and a social investment (appendix 2). This Commission recommends that countries adopt a national quality guarantee—ie, quality sufficient to consistently produce a health benefit. This would be concrete and operational for covered services. What are the elements of such a guarantee? First, clearly poor-quality services, providing more harm or risks than benefits, fall below the thresholds of a guarantee. Second, the quality of services must be sufficient to generate health benefits. For example, a rural clinic should specify to the patient the level of services that it is competent in providing. Third, services must be provided in a respectful people-centred manner. An integral aspect of people-centred health systems is the relationship between provider and patient. Patient–provider relationships are shaped by societal norms and are susceptible to power imbalances. Pre-service and in-service training on respectful care is one way to improve the ethical competence of providers in low-income settings. 156 However, to end the poor treatment of patients and greatly improve health care, people-centred and patient-driven approaches that shift the power from the health-care system and providers to the patients are needed. 157 The quality guarantee should accompany any efforts to expand service coverage; in many countries, the movement to UHC is an excellent starting point. National standards for conditions covered by a UHC benefit package might include descriptions of adequate assessment and diagnosis, treatment and care, assurance of continuum of care, and referral. This is a corrective to the current UHC discussion that revolves around the pooling of funds to expand the coverage of populations and services while decreasing the cost. Without building in quality, the increased coverage will not result in health gains for people. Although many countries can do more to provide quality health services with existing funds, others will require additional funds. Data from WHO 4 show that global government spending on health as a percentage of all government expenditures rose by an average of 10% between 2000 and 2015; however, it was flat in lower-middle-income countries, and fell substantially in low-income countries—the very countries struggling with poor-quality care. Beyond these general considerations, countries need to undertake analyses and open discussions to specify their national standards. National guarantees should start with the reality of social norms and health system functions and be context-specific. 158 Guarantees will depend on budget, setting, disease type, intervention, and delivery platform. Current national standards are often defined and implemented through standard operating procedures or clinical practice guidelines. Standards included in the national quality guarantee should be developed by health policymakers and professionals, in collaboration with users and national regulatory agencies, to ensure that upholding the guarantee does not fall solely on providers. The guarantee is not intended to be punitive against individual providers; any redress mechanisms should be targeted to the appropriate level of the health system. Improving accountability for quality Over the past three decades, the concept of accountability in provision of health care has gained increased attention. However, accountability for quality in health care has been less explored. In this subsection, we refer to Brinkerhoff’s definition 159 of accountability, which encompasses both answerability and enforceability. The three general categories of accountability are financial, performance, and political or democratic. In this section, we use elements of financial and political or democratic accountability to discuss legal and social mechanisms. Performance accountability is discussed in the subsequent sections. For accountability to function, there must be actors responsible for activities, standards to define what actors should deliver, agents to hold actors to account, and tools or methods to do so. A review done for this Commission on the accountability ecosystem and its relation to the delivery of quality care (methods in appendix 1) supported the notion that accountability mechanisms can serve as a catalyst to initiate and sustain improvements in quality and advance the progressive realisation of the human right to health and quality health care. The review found that multiple accountability tools have been used, and documented in the peer-reviewed literature, to improve access to essential and effective health care (appendix 1). A key finding of the review was that single interventions do not have the power to induce large-scale change. Additionally, governance and coordination must be strengthened, resources must be planned and budgeted, and a performance monitoring system must make the information collected available. Therefore, to improve quality, countries need to devise accountability strategies that encompass elements of legal and social accountability. Legal accountability National governments are the primary agents for accountability. Human rights conventions can provide the basis for legislation that recognises the right to health and health care, and can be an essential and minimum foundation for approaches to improve access and quality of care. Meaningful legislation should not only recognise the right to health and health care, but also cater for the right to meaningful public participation, freedom of civil society, and freedom of information. Where such legislation exists, it can be used for accelerating action. Quasijudicial mechanisms exist in many LMICs, such as the ombudsman in South Africa tasked with addressing the system failures that led to the deaths of 94 mental health-care users. 160 Also in South Africa, the Treatment Action Campaign defeated the Government in the constitutional court to increase access to HIV treatment to mothers and newborn babies. A high court in Kenya awarded a woman 2·5 million Kenyan shillings for mistreatment and abuse during childbirth, which was caught on film. 161 Additionally, in Malawi and Mozambique, human rights concerns and entitlements were used by civil society organisations to expand national policy for maternal, newborn, and child health. 162 Social accountability Social accountability refers to approaches that involve communities, citizens, and service users directly; these approaches include attempts to increase community involvement, awareness, and demand generation for high-quality care. 163 A 2004 World Development Report 164 suggested that social accountability tools could be used to increase transparency and accountability, shortening the long route of democratic accountability between citizens and politicians. Multiple tools are available to foster social accountability. They include citizen report cards, community monitoring, social audits, participatory budgeting, citizen charters, and health committees. Mechanisms for creating and acting on such tools exist in LMICs today. Institutions tasked with reporting on quality-related indicators include the Health Data Advisory and Coordinating Committee in South Africa and the General Directorate for Quality Healthcare and Education in Mexico. 165 There are licensing and assessment activities with internal and occasionally public reporting, such as the Ideal Clinic in South Africa, Big Results Now project in Tanzania, and the Kenya Patient Safety Impact Evaluation. 166–168 Finally, direct public reporting of local progress can be effective, such as Imihigo, 169 the televised reporting of progress on commitments by local leaders in Rwanda, including maternal health outcomes. These social accountability mechanisms should be seen as complementary rather than substitutes to the legal approaches previously discussed. Panel 7: Actions to support legal and social accountability A literature review done for this Commission aimed to present findings on the accountability–quality relationship and explore how accountability mechanisms contribute to improvements in quality of care. The review focused on legal and social accountability mechanisms pertaining to reproductive, maternal, and child health. The key findings were synthesised and the following actions were identified as important for effective and transparent accountability: Adopt and enact legislation that recognises the right to health and quality health care Invest in rights awareness and education at all levels, including among policy makers, parliamentarians, programme managers, service providers, and the public Share information on health system performance with the public and promote transparency of quality measurements Institutionalise mechanisms for remedy and redress, such as ombudsperson or tribunals Develop multipronged strategies for accountability for quality of care that combine legal, performance, and social accountability tools Methods are described in appendix 1. Source: David Clarke, Rajat Khosla, Blerta Maliqi, Marcus Stahlhofer, and Bernadette Daelmans. Panel 7 synthesises the key findings from the review on legal and social accountability and proposes actions to support effective and transparent accountability at the national level. Section 3 conclusion Health systems should give priority to poor and vulnerable groups of society to reduce inequities and expand the right to quality health care through progressive universalism. A movement towards UHC offers countries the opportunity to start on this path by expanding coverage tied to a national quality guarantee. Legal and social accountability mechanisms can assist in upholding these quality standards. Enacting accountability is predicated on insight into current health system quality. In the next section, we assess the purpose, status, and promise of health system quality measurement. Section 4: Measuring health system quality The key findings of this section are shown in panel 8. Why measure health system quality? Valid and reliable information is a necessary input to a high-quality health system. 170,171 Multiple national, international, and global efforts are underway to identify measures to improve care delivery and amplify patient voices. These efforts include the National Quality Forum in the USA, the Health Data Collaborative, and initiatives undertaken by OECD, the Inter-American Development Bank, and the China Joint Study Partnership. 70,76,172–175 These efforts show that the measurement of health-care quality is a concern of populations and governments around the world; high-income settings, in particular, have invested in institutions to strengthen health system performance through measurement. Although some efforts, such as the Health Metrics Network, have included LMICs, country ownership of this agenda has been inconsistent, and progress on health system measurement remains incomplete. Panel 8: Section 4 key findings Accountability and action are the guiding purposes of quality measurement; measurement not used for these purposes can burden the health system. Current quality measurement is fragmented by disease, focused on inputs rather than outcomes, and poorly aligned to population health needs. Decision makers do not have timely information that provides a picture of the health system as a whole. National and global actors should seize three opportunities to improve measurement of health system quality: (1) measure effective coverage—use quality-corrected coverage metrics to track progress towards UHC; (2) adopt fewer, but better measures by shedding inefficient indicators and prioritising measures of system competence, user experience, and outcomes, including clinical and patient-reported health, confidence in the system, and economic benefit; (3) invest in country-led quality measurement, including strengthening national capacity for data use and policy translation, releasing an annual health system quality dashboard, and disaggregating results for vulnerable populations. Indeed, the findings described in Section 2 on healthcare quality in LMICs reveal crucial measurement gaps. Existing data on quality of care have largely been generated within vertical programmes, resulting in measures that have not been combined in ways that could illustrate quality of the health system as a whole, whether at local or national levels. 176 Systematic data on the performance of health system platforms (such as primary care) or on user experience, population confidence, and patient-reported health outcomes are scarce. Moreover, research on health system quality—including the policy and implementation research urgently needed to bring effective interventions to scale—has not kept pace with the magnitude of the challenge, reflecting inadequacies in measurement approaches and data use. A bibliometric search for quality-related research between 2000, and 2016, revealed that, although this type of research is increasing in LMICs, it remains overwhelmingly located in high-income countries (appendix 2). The demands made of health systems are growing: the burden of disease is shifting towards non-communicable diseases and injuries, 6 health emergencies are rising, 177 countries are actively moving towards UHC, 17 and people are demanding better services and outcomes. 119 The health priorities of the SDG 178 era—with ambitious targets of improved survival and quality of life for all—demand new approaches that promote accountability and action to drive broad health system improvements. To meet these challenges, measurement approaches need to be responsive to new health system demands, relevant to people, and efficient. At the heart of this reframing is the question: why measure and for whom? This Commission proposes two main purposes for the measurement of health system quality: accountability and action. Accountability requires the provision of information when questioned, whether for routine monitoring or detailed justification, paired with a mechanism for oversight. 159 This section focuses on measurement for performance accountability—how the health system delivers on its intentions—and social accountability—whether it is responsive to society. 159 The measurement of performance accountability should show results against benchmarks, support crossnational or subnational comparisons, disaggregate evidence for vulnerable subpopulations, and do this in or near real time. For both performance and social accountability, data will typically need to be representative of the target population, comparable, and systematic. Measurement should further include elements that are of high value to people; for example, they should include not only health outcomes such as survival, but also function, pain, and processes such as respectful treatment (panel 9). Panel 9: What different measures tell us about health system quality* Measures of health system quality have usually been organised into inputs (eg, workforce, tools, facilities), processes of care (eg, adherence to guidelines, communication), and outcomes (eg, morbidity, mortality).A46 In low-income and middle-income countries, many quality measurement and improvement efforts have emphasised inputs to health services. Inputs are foundational to health-care provision and are easily measured, but they provide narrow insight into quality of care. Studies have found weak associations between input measures and care competence,A47 particularly when facility size is considered.A25 The relation between input availability and the quality of care received can differ over the course of care delivery,A48 underscoring the need for motivated and competent providers and supportive systems for good care delivery. Similarly, multiple studiesA49,A50 attest to the know–do gap: the deficit between provider knowledge and the clinical care provided. These issues do not mean that input measures are unimportant; indeed, timely and specific information on inputs, such as stock levels and equipment functionality, is crucial for health service planning and operation and should be collected by health systems. However, these measures should not be used as indicators that health systems are providing high-quality care. Process measures can play an important role in illuminating the quality of care provided. These measures are immediate and relevant at the point of care, and they provide direct insight on care provision without risk adjustment, which makes them particularly valuable in assessing gaps or disparities in care for vulnerable subpopulations.A51 A judicious selection of process measures is essential, emphasising measures validated against the outcomes that matter to patients,A52,A53 whereas overmeasurement can divert provider time and weaken the quality and usefulness of data. The proliferation of process measures in high-income countries, for example, has increased the burden of measurement and resulted in unintended consequences, including fixation on the measure rather than the intent, reallocation of efforts towards meeting measurement targets and away from other essential tasks, and gaming (manipulation of the quality assessment system).A54,A55 Health outcome measures attest to the central goal of a health system—maintaining or improving health and wellbeing.A56,A57 However, these measures can be challenging to attribute directly to health system performance because of the involvement of multiple factors. Baseline risk information is required for valid comparisons of health outcomes over time or between facilities.A58 Despite this complexity, there is global recognition of the crucial need for health-system-sensitive and patient-focused outcome measurements, even in very low-income settings.A56 Health-system-sensitive outcomes include perioperative mortality, inpatient suicide, 5-year cancer survival, obstetric fistula, caesarean section, unsuppressed HIV viral load, uncontrolled blood pressure, lower extremity amputation in patients with diabetes, and hospitalisation due to ambulatory care-sensitive conditions. High-income settings are increasingly turning to patient-reported outcomes (PRO) as a means of realigning health care with patient values.A59 PRO measures have been used to improve monitoring, decision making, and patient–provider communication,A60 with evidence suggesting that the use of these measures improved patient perceptions of careA61 and led to better health outcomes for some conditions,A62 although their usefulness in aggregate has yet to be fully demonstrated.A63 Routine measurement and the use of health-system-sensitive outcome data and PRO are integral to achieving patient-centred health systems. *Panel references can be found in appendix 1. Measurement for action is at the heart of learning health systems. These measures should provide decision makers with answers to specific questions about the functioning of the health system and the quality of care delivered, help identify the targets and interventions for improvement, and monitor the results of the changes implemented. Quantitative data should be complemented by so-called soft intelligence, the insight on the context and processes of care delivery, to help inform action. 179 The focus of measurement for action is likely to differ in a complex adaptive system: acting directly at the level of the process indicator (eg, attempting to address poor adherence to guidelines with printed reminders) might not yield expected effects if the indicator merely signals a deeper quality deficit at the health-system foundation level. 158,179 Measurement for action is discussed further in Section 5. Fulfilling either purpose of measurement—ie, for accountability or action—requires valid and reliable measures, transparency in information exchange, and an entity with the power to demand a response. Panel 10 outlines conditions required for measurement to induce change. To meet the SDG targets and improve health system quality by 2030, countries will need to embark on a measurement agenda that will take time and investment to fulfil. This agenda starts by knowing what is currently being measured. What is—and is not—measured in LMIC health systems today Multiple strategies have been used to capture the range of information needed to assess health system quality, including measuring population health needs, health outcomes, and health system performance. Table 2 describes the platforms in use and their best application; given the multiplicity of tools, central organisation and triangulation are needed to gain insight and act on these data. We, and others, have found that health system data collection is often costly, uncoordinated, and disconnected from decision making. 173,180 Tools and indicators are fragmented by disease and funding source, with inadequate harmonisation and few national plans for coordination and data use. 180,181 For example, 26 different bilateral, multilateral, governmental, and non-governmental organisations fund health information systems in Kenya, resulting in duplication of efforts and uneven distribution of resources within the country. 182 120 distinct digital health-related information systems operate in Tanzania. 173 More than 1000 indicators are collected at the national level across the three major public health systems in Mexico, but only 27 overlap at least two health systems, preventing comparison and standardisation. Table 2 Platforms for health system measurement Frequency Level of collection Relevant quality subdomains (Commission framework) Best uses in measuring high-quality health systems Administrative data (eg, HMIS) Routine Individual level data aggregated by condition within facilities and then by geographical unit Population (care seeking), competent care and systems, and health outcomes Monitor facility and clinician performance; monitor health status at the community and district level Electronic health records Routine Individual patient Population (care seeking), competent care and systems, and health outcomes Inform clinical care; monitor facility and clinician performance; monitor health status at the community and district level Population surveys Periodic or continuous * Population Population (care seeking), user experience, selected health outcomes, confidence, and economic benefit Represent both users and non-users of the health system; permit analysis of equity for subpopulations; have potential to be adapted for innovations in measurement, such as patient experience and patient-reported outcomes Facility assessmentst Periodic or continuous * Health system Workforce, tools; with observation or exit interviews: competent care, user experience, and confidence Generate a representative assessment of health systems for subnational and national benchmarking; allow for assessment of user perspectives Patient registries Routine Individual Health outcomes, user experience, confidence Monitor patient-reported experience and outcomes measurement over time Vital and civic registries Routine Population Health outcomes Monitor population health status; form basis for policy guidance, projections, and planning HMIS=health management information system. Commission framework is depicted in figure 1. * Continuous household and facility survey methods that permit regular data synthesis, review, and health programme decision making have been proposed as an alternative to one-off surveys,A83 tested subnationally,A84 and adopted, for example by Peru since 2004, and by Senegal in 2012. tFacility assessments can include audits of structural inputs, interviews with health-care workers, direct observation of care, and exit interviews. References can be found in appendix 1. Panel 10: From measurement to action* Measurement alone will not ensure health system quality. Actionable information must reach agents capable and empowered to use it to effect change in the health system. Freedom of information—the right to access information held by public bodies—was enshrined in the 1948 Universal Declaration of Human Rights and has been adopted into law by more than 90 countries.A64,A65 Applied to health systems, freedom of information demands transparency of data within the system and to the public.A66,A67 High-quality health systems are not automatically produced by governments. A regulatory system that engages an array of actors should hold the system to account for high-quality care. This system includes formal mechanisms such as audits, ombudsmen, and courts and informal actors such as patients, the press, professional organisations, and civil society.A67,A68 A range of barriers can inhibit the flow of information about health systems. Power differentials can stymie communication, restricting the transmission of and responsiveness to local knowledge;A69–A71 hierarchical norms and fear of reprisal can inhibit incident reporting about health-care failures;A72 and, ironically, a surfeit of indicators in routine measurement systems can prevent the ready understanding and use of locally relevant information.A69,A72–A74 Although governments often claim to want to reach users through open government initiatives, scant attention to how people understand and use information has led to an abundance of information but a minimal effect on care seeking and other outcomes.A75–A77 Countries have the opportunity to take better advantage of increasing health system data by building trust in data, promoting learning cultures within the health system, and ensuring freedom of information. Obligatory reporting with data audit trails or data quality assurance institutions can bolster confidence in the indicators generated.A74,A79 A culture of information and learning within and across health facilities can lead to greater transparency and action.A69,A80 For instance, facility audits and licensing exercises should include clear criteria for improvement and result in non-punitive responses, such as support for addressing deficiencies.A81,A82 To ensure freedom of information, formal protection for whistle-blowers is an important guarantee, although a culture of secrecy and professional protectionism should also be addressed.A72 The free operation of traditional and social media can provide external accountability levers.A67,A69 Open government initiatives are an initial step, but their success should be judged on the basis of information use, not on quantity of data released. One path to fulfilling these opportunities is the development of a national body for monitoring health system quality, informing the public, and identifying and responding to failures, to serve as a locus for measurement, accountability, and action. *Panel references can be found in appendix 1. The proliferation of indicators burdens health-care workers and systems. In sub-Saharan Africa, an estimated one-third of health-care providers’ time is spent on recording and reporting. 173 Health facility assessments cost a minimum of $100 000 per national survey and typically many times that amount, 183 but are rarely used for national planning. Furthermore, fragmentation of these and other data sources prevents the coherent assessment of health system performance, to say nothing of actions in response to the data. To understand how well this plethora of tools measures health system quality, we analysed multicountry health system indicator sets or surveys and sample national indicator sets from LMICs against this Commission’s quality framework (figure 1; appendix 1). Quality frameworks do not imply a need for equal measurement of each subdomain for all health services and conditions, but they do make apparent the multiple aspects of quality and highlight duplication and gaps. Measurement sets focused on the foundations of care, with global sets devoting 47% of indicators to this domain, crossnational sets devoting 70%, and national sets devoting 44% (figure 12). Inputs, such as tools and workforce, were the most commonly assessed subdomains and formed the entirety or bulk of the Service Availability and Readiness Assessment (SARA), Service Delivery Indicators, and Service Provision Assessments; our findings were consistent with existing research on the predominance of input measures in health system survey tools. 184 All assessed sets, except SARA, addressed competent care processes, particularly care delivered, such as oral rehydration solution for children with diarrhoea. Although global and national measurement sets included population health outcomes such as neonatal mortality rate, user experience and non-health effects were sparsely measured across all sets. Figure 12 Representation of quality subdomains in global, crossnational, and national measurement sets We mapped indicators against domains of the high-quality health systems framework (figure 1), identifying the single domain most relevant for each indicator. We additionally classified indicators as patient-reported if the data were collected with individual self-reports. Full methods are detailed in appendix 1. Cells are coloured by greatest number of indicators per row (source), with red indicating 0, orange and yellow the midrange, and green the maximum number observed for that measurement set. DHIS2=District Health Information System 2. DHS=Demographic and Health Surveys. HIS=Health Information System. HMIS=Health Management Information System. IMSS=Instituto Mexicano del Seguro Social. IPCHS=Integrated People-Centred Health System. ISSSTE=Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. OECD=Organisation for Economic Co-operation and Development. SARA=Service Availability and Readiness Assessment. SDG=Sustainable Development Goals. SDI=Service Delivery Indicator Survey—health. SPA=Service Provision Assessment. * Population, governance, platforms, workforce, and tools. The extensive collection of input measures is problematic. When collected through surveys, input data are quickly out of date and thus lose usefulness for supply planning. Moreover, our analysis found that readiness metrics are only weakly connected to the content of care delivered. 35 Although the outcome indicators identified in this analysis are valuable for monitoring population health, we found few health-system-sensitive outcomes and almost no patient-reported outcomes. The remaining measures in global sets pertained to competent care and, to a lesser extent, systems. Much of this measurement is focused on a subset of conditions, mainly maternal and child health and infectious diseases. Even in these areas, the validity of indicators collected raised concerns: for example, household surveys are not well suited for identifying children who truly have pneumonia to estimate appropriate treatment, and maternal morbidity and mortality in hospitals greatly exceeded the estimated rates based on documented administration of essential interventions. 100,185 The validity of tools measuring clinical care is discussed in appendix 2. In summary, the available measures do not promote accountability for high-quality health systems. Globally funded facility surveys overmeasure inputs that provide inadequate value for accountability. At the national and global levels, health system measurement is insufficient to assess performance of the health system as a whole and inadequate for holding the system accountable to people for the user experience provided or the effect on impacts—health and non-health—that matter to patients. Data quality Data must be of adequate quality to be used for accountability or action. 186 Efforts in the past few years have identified dimensions of data quality such as completeness and timeliness, internal consistency, external consistency, and external comparisons, although assessment tools focus mainly on completeness and accuracy. 186 Routine health information systems, whether individual-level electronic health records or aggregate reporting such as the District Health Information System (DHIS) 2, provide information on the use and content of care that, if the data are of adequate quality, should form a crucial element of health system measurement for accountability. 187 34 LMICs—chiefly upper-middle-income, but including 13 low-income and lower-middle-income countries—had adopted national electronic health records systems by 2015· 188 41 LMICs, including 23 low-income countries, use DHIS2 at a national scale for aggregate reporting from electronic or paper registers in facilities. 189 Notably, private sector facilities can be included under national health management information systems, although their participation and data completion are often low. 148 Barriers to robust implementation and use of electronic health records and DHIS include restricted ownership by end users, scarce training on data skills, lack of motivation and engagement by overburdened health workers, large numbers of indicators required, and inadequate functionality of electronic platforms. 181,190 As a result, data quality in routine health information systems is poor, with vertical programme assessments often identifying high prevalence of missing or inaccurate data. 181,191 New evidence from Kenya, Nigeria, and Mexico suggests that such deficiencies in data quality also pertain to indicators of health system quality (appendix 2). Moving forward: three opportunities to measure better Opportunity 1: Measure effective coverage Countries should incorporate measures of quality within a broader health system assessment to appropriately track the value of the health system. The geographic availability of facilities overstates health system performance: reduced mortality due to acute abdominal conditions was associated with proximity to well resourced hospitals in India, but not with access to lower-quality hospitals. 192 New analysis suggests that this relation also occurs for obstetric conditions, acute surgical conditions, and time-critical adult infections in India, but less certainly for myocardial infarction (appendix 2). Even basic process indicators provide greater insight into hospital capacity than the availability of a facility or equipment. Service coverage monitoring that does not explicitly include quality will similarly overestimate health system performance and will do so substantially in many cases because of quality deficits. Achieving UHC requires effective coverage, such that “people who need health services obtain them in a timely manner and at a level of quality necessary to obtain the desired effect and potential health gains.” 193 The current monitoring of UHC does not reflect this. Figure 13 lists the current coverage indicators for monitoring UHC specifically and the health-related SDGs more broadly. Only one of these indicators (effective treatment coverage for tuberculosis) captures the health system effect on population outcomes. Calculating effective coverage requires defining the population in need, access to care, and receipt of quality care. 194 In figure 13 we also provide illustrative effective coverage indicators to suggest directions for future monitoring, and indicators for additional conditions are in appendix 2. Research is ongoing to identify standard indicators for many SDG conditions. Some indicators are available but need to be better implemented (eg, HIV), others need to be refined by selecting the best indicators and determining efficient methods of collection (eg, maternal health), and others still need to be developed de novo or validated for use at scale in low-resource contexts (eg, substance use). Figure 13 Illustrative indicators for advancing Sustainable Development Goal (SDG) monitoring from coverage towards effective coverage Tier 1=priority action is implementation (routine or targeted, as for immunisation). Tier 2=priority action is determining efficiency in indicators and data collection. Tier 3=priority action is development of valid indicators for use at scale. IMCI=Integrated Management of Childhood Illness. *Excludes health indicators focusing on population outcomes alone. †Six indicators not shown: two primarily measuring determinants outside the health system (tobacco use and access to basic household sanitation) and four service capacity and access indicators. References can be found in appendix 1. Care cascades are an extension of the concept of effective coverage: instead of a single number, cascades break performance along the continuum of care to allow analysis of health system function. 195 Cascade steps typically follow a patient population from health need through diagnosis, timely treatment, disease control, wellbeing, and survival. With each step conditional on the previous one, cascades illustrate health system failures in functions such as diagnosis, retention, and evidence-based care, while linking system performance to patient outcomes. Although specific indicators can vary across conditions (for example, disease control could be measured by viral load for HIV, blood pressure for hypertension, symptom-free days for major depressive disorder, and years without recurrence for breast cancer), the drop-offs in a disease-specific cascade can illustrate system-wide deficits: low rates of screening suggest failures in primary care as a first contact service, whereas poor outcomes among those on treatment implicate inadequate coordinated and continuous care. We provide examples and discussion in appendix 2. Opportunity 2: Fewer, better metrics For effective measurement of accountability and action, health system assessments must be reoriented away from measures that are poorly fit for purpose and towards people. A people-centred measurement means thinking about individuals across the life course and the total sum of their health system experiences rather than discrete services. 196 Panel 11: Innovation in patient experience and outcome measurement* The examples in this panel describe proof-of-principle testing of patient-reported indicators in low-income and middle-income countries. Shared investment, innovation, and learning will be needed to validate and define the use at scale of patient-reported measures for action and accountability. Measuring maternal care experience: companion of choice The Quality of Care Network for maternal and newborn health is leading efforts to standardise measures of childbirth care experience. Labour companion of choice is one of the quality measures for emotional support and is recommended in four WHO guidelines to date.A86,A87 Evidence shows that women who received continuous labour support might be more likely to give birth vaginally, be satisfied with their birth experience, and be less likely to have caesarean birth or use pain medication.A88 Labour companions can also play a role in the prevention of mistreatment of the woman during childbirth by serving as an advocate, witness, and safeguard. A process indicator would be the proportion of women who wanted and had a companion supporting them during labour, childbirth, and immediate post-partum period in a health facility, based on observation or facility or population survey. Currently, nine countries in the network are in the process of including and testing different mechanisms for three common experience of care indicators (including labour companion) as part of large-scale quality improvement efforts for maternal and newborn health.A89 Measuring patient-reported outcome measures (PROMs) for pregnancy and childbirth in Nairobi, Kenya The objective was to understand the application of value-based health-care principles in a low-resource setting; specifically, to test a model for collecting PROMs in pregnancy and childbirth in a low-resource setting, to determine feasibility and scalability of using mobile platforms to measure PROMs, and to identify how to engage patients in collecting PROMs and motivate health-care providers to measure outcomes. Outcome variables to pilot were selected from the pregnancy and childbirth standard set of the International Consortium for Health Outcomes Measurement, on the basis of importance, feasibility, acceptability (cultural and social), and literacy. Patient-reported outcomes included health status (incontinence, pain with intercourse), breastfeeding (success with breastfeeding), mental health (ante-partum or postpartum depression), and satisfaction with care during pregnancy, labour, and after birth. Five facilities providing antenatal, delivery, and postnatal care services were involved and patient liaison officers were trained to support patient enrolment, maintain engagement, and oversee follow-up. Real-time collection of medical and financial data was done with M-TIBA, a mobile health wallet that tracks patients through the health system. PROM items were administered using text messages through mSurvey. 173 of 200 women enrolled, with survey completion rates near 90% through 6 weeks post delivery. See appendix 1 for full methods. Sources: Özge Tunçalp and Meghan Bohren; Ishtar Al-Shammari and David Ljungman. *Panel references can be found in appendix 1. Processes of care and quality impacts must be better measured to have health systems that are truly for people, with three areas for improved measurement: positive user experience, patient-reported outcomes, and non-health effects of care. OECD countries are moving towards standard crosscutting measures of patient experience, particularly communication and patient voice. 175 Wide adaptation and validation of these measures would enable global comparisons. Other areas of user focus and respect pose more challenges for measurement, such as dignity, privacy, and non-discrimination. Vertical programmes with long experience in measuring such domains, including family planning, maternal care, and HIV care, can offer insight. 9,197,198 Similar efforts to make patient-reported outcome measures more broadly useful are underway, including a focus of the OECD on population outcome measures such as quality of life. 175 The International Consortium for Health Outcomes Measurement released a standard set of outcomes (including patient-reported outcomes) for hypertension, with an explicit focus on LMICs. 199 Standard sets of patient-reported outcome measures for general adult and paediatric health are in development. The enhanced use of these measures will require clarity about minimum supporting data, such as risk factors. 200 Panel 11 highlights efforts to adapt and apply patient-reported measures in LMICs. Available measurements of confidence or trust in health systems fall short of the importance of this domain in shaping population behaviour and health outcomes. Satisfaction with health care or the health system is a commonly used measure and, from a legal and rights perspective, it reflects the ultimate judgment of the consumer. 201 Satisfaction is associated with objective measures of process quality (eg, clinician competence) and with health outcomes (eg, mortality). 92,202 However, satisfaction is also strongly influenced by a host of other factors, including user demographics and health, past care experiences, expectations, and potentially courtesy bias. 202 This might explain some of the counterintuitive findings on user satisfaction. For example, satisfaction is often high for demonstrably poor-quality services, particularly for users with lower education or less experience with high-quality health care (panel 3). Conversely, people might express dissatisfaction when they expect, but do not receive services that are not indicated, such as antibiotics for the common cold. Improved health literacy can reduce this mismatch. Although user satisfaction gives an important perspective, other measures should be considered that might capture people’s confidence more directly. These could include trust in the health system, confidence that people can get the care they need, endorsement of the system as is (vs requiring major reform), and metrics that reveal preference, such as bypassing and loss to follow-up. 37 The development and validation of measures for trust in the health system relevant for LMICs should be part of the global research agenda. The links between health system quality and economic gains were detailed previously. The effects of health system quality on economic gains are largely mediated by health status (eg, incidence of surgical site infection or antibiotic-resistant disease and ability to function for work or school) and confidence in the health system. Measurement should focus on health and confidence themselves, while research quantifying links between these outcomes and economic impact is undertaken. Direct pathways include affordability that shapes individual costs of care and low system competence generating wasteful, unnecessary procedures. Measurement of cost has advanced notably in the SDG era: catastrophic out-of-pocket spending on health-care costs is the indicator for SDG 3.8.2, financial protection within UHC, 126,128 and medical impoverishment provides an indication of how well financial protection for health services has been linked with poverty alleviation. 126,128 Indicators of health system waste, such as excess caesarean sections, might signal poor system quality, although few measures have been defined for this with adequate benchmarks for national assessment in LMICs to date. Measures of system competence are a key area for innovation, both in identification of essential indicators and in use of these to produce a coherent view of system function. Elements of system competence include safety, prevention and detection, continuity and integration, timely action, and population health management. Platforms within the health system—community outreach, primary care, hospital care, emergency medical services, and referral systems—can similarly be assessed for overall functionality. Work published in 2016 from the Institute for Healthcare Improvement 203 proposed system measures for consideration in high-income settings. These measures include childhood immunisations, timely ambulatory care, preventable hospitalisations, hospital-acquired conditions, and serious reportable events (serious harm or death of a patient due to a healthcare error). In lower-income countries, consistent and accurate measurement of hospital mortality for selected services would be an important advance. 204 One approach for system competence measurement is to consider conditions or procedures that require functional integration within a health-care platform and identify process or outcome measures therein as tracer indicators. For example, indicators such as blood transfusion delay, surgical site infection, and perioperative mortality rate provide insight into hospital care quality as a whole. 73,102,205 Although perioperative mortality rates are collectable in countries of all income levels, virtually no LMICs have outcome surveillance in place. A focus on bellwether procedures and definition of standard methods in collection and reporting of both perioperative mortality rates and surgical site infections would reduce heterogeneity in measurements and facilitate their uptake into existing health system measurement. 73,104 Similarly, timely trauma care is an indicator of prehospital care, such as emergency medical services and hospital functioning. Multiple studies have assessed time from injury to admission or admission to surgery, but measurement remains heterogeneous. 83 Efforts to improve measures of system competence should include their potential use for accountability and triggering action. Opportunity 3: Invest for country-led quality measurement The current fragmented approach to health system measurement results in substantial efforts and investments expended for little data use. 176,206,207 Progress on the measurement challenges and proposals described will require a shift to country-led quality measurement. 208 This Commission calls on global, regional, and national donors to invest in national institutions for health system quality measurement. Such national bodies should be tasked with assessing available measurement against national priorities for health system quality, refining the measurement toolkit to better address the full high-quality health system needs, creating an annual public dashboard of health system quality performance, and assisting with policy translation of the results. Building such an institution or arrangement requires enriching human capacity at all levels of the health system and concentrating advanced capacity in data science at the national level. Without improved numeracy at local levels and data management capacity at district or subnational levels, data quality will not be sufficient to support the activities of the national institution. Building more advanced measurement capacity—including more masters-level and doctoral-level researchers—within such a national institution will be necessary to address the current challenges of health system measurement and future ones, as population health and health systems evolve. Investing in a central institution with the authority to translate a national policy on health system quality into priorities for measurement and to both centralise data and disseminate findings is crucial to make measurements responsive, relevant, and efficient, particularly for countries with increasingly decentralised health systems. Having a single source of knowledge of quality deficits can also provide a clear basis for accountability of system failures and patient safety lapses. 209 A truly national view of health system quality requires measurement from the private sector. The exclusion of private providers restricts health system assessments, particularly in countries with substantial private sectors, such as India. For example, an analysis of population coverage of first-level hospitals in Karnataka state, India, found that 45% of the population had access to at least one public hospital within a 25 km catchment area, whereas 91% had access when private hospitals 210 were included in the analysis (two-step floating catchment area method; appendix 2). Nonetheless, information on the capacity and quality of private facilities—or even their number and location—is scarce. 204 Some health system assessments, such as the District Level Household Survey 4 in India, are restricted to public facilities, and routine health information systems can be compulsory for public providers only. A review done for this Commission identified multiple mechanisms for measuring private sector quality, including regulation, national information systems and surveys; purchaser-driven, consumer-driven, or network-driven measurement; and voluntary external assessments. Private-sector providers sometimes express a willingness to share data, but without strong mechanisms and incentives, little sharing occurs in practice. 211 Future research on models for integrating data across the public and private sectors to enhance efficiency, transparency, and accountability is warranted. The development of a national policy and strategy for health system quality is a prerequisite to country-led measurement and is discussed further in the next section. 212 Assessing measurement approaches against the standards defined in the national strategy will provide insight on gaps and inefficiencies in measuring quality. Another responsibility of a national institution for health system measurement is the development of the quality measurement toolkit. The toolkit can differ by context and resource availability, but should include three tiers: foundational systems, routine data, and targeted studies. The first tier consists of vital registries to track population births and deaths, supply chain management, and human resources information systems, including provider payment tracking. These elements are fundamental for a sound understanding of the population and the capacity of the health system. The second tier is routine data collection through electronic health records or health information systems; many measures for effective coverage and system competence can be derived from routine health information systems. Accuracy and parsimony are essential to these measurements, because of not only their importance, but also their high potential burden. The third tier consists of targeted health system studies, which include health facility and population surveys and patient registries to probe more deeply into health needs and system performance. Facility assessments must be more agile and responsive to national priorities, with increased emphasis on measures that might be hard to capture in a routine system, including timeliness and accuracy of care delivery and patient experience. Patient registries can be developed as a subset of facility assessments to provide information on health outcomes and patient perspectives over time for priority groups or conditions. 213 Population surveys, ideally linked to health facility assessments or routine health system data, can be broadened to address the range of conditions reflected in the SDG agenda and to provide the voice of users and non-users on their needs and outcomes. These surveys will continue to be instrumental in providing data for equity assessment, particularly in lower-income countries. When optimised, the combination of these data sources has powerful potential to advance the quality of health systems. The matrix of tools will differ by context, because one of the aims of the SDG era is for all countries to own their data systems and to define their data needs within a common framework. National ownership of tools at all tiers is important for the results to be integrated and used. 208 Regional and global partners can facilitate and catalyse this work by providing public goods of centralised evidence and tools. These can include repositories for available indicators, evidence and guidance on the role of measurement platforms and methods for triangulating across them (eg, in effective coverage estimation), and tools for synthesising insight for dissemination. Regional collaborations might prove beneficial for sharing learning and avoiding duplication of efforts, particularly for small countries. Initiatives such as the Quality of Care Network and the Health Data Collaborative are important steps in this direction. Finally, this Commission recommends that countries compile an open-access health system dashboard for monitoring progress towards a high-quality health system. The dashboard would track health system quality with use of data from multiple sources. The dashboard would be people-facing and should reflect what matters most to people: health and wellbeing, user experience, system competence, confidence, and economic benefit. An example dashboard is shown in figure 14, featuring these recommended areas and illustrative indicators of each domain to show how such information might be presented. Effective coverage indicators can signal areas of underperformance by geography, condition, or vulnerability, whereas care cascades for conditions that illustrate overall system functioning can be used to identify strengths and failure points. Indicators should be selected and adapted to each country as described previously. The dashboard should evolve to reflect changing health and health system priorities. Efforts are already under way to contribute elements to such a dashboard, from real-time views of staff absenteeism in facilities in India 214 to open data platforms in Kenya. 215 Providing information is not in and of itself sufficient; information must be accompanied by appropriate context for public consumption and clear mechanisms for engagement and response by all people, whether they are members of the public, the press, or health system actors, such as medical associations. 216 Figure 14 Sample high-quality health system dashboard with illustrative indicators Countries should present overall dashboard results and results disaggregated by subnational regions and dimensions of vulnerability (settings of care, disease type, or demographics, as discussed in Section 3), as well as results for public and private sectors. This Commission recommends that the dashboard be released from 2021 onwards. It could reflect gaps in data availability and quality particularly early in its usage, before measurement platforms are realigned to provide a full system perspective. Missing information should not prevent the public release of what is available as input into mechanisms of social accountability. Public release of health system quality information is an important way of building trust in health system transparency, in addition to providing means for self-scrutiny by health system agents. 217 A high-quality health system dashboard is an essential step in a cycle of accountability and a trigger towards universal action for improvement. Section 5: Improving health systems at scale The key findings of this section are shown in panel 12. Expanding the solution space Despite some impressive health gains in LMICs in the past several decades, this Commission’s analysis showed that health systems are beset by poor-quality care. The pervasiveness of poor quality suggests that the cause is not a few weak providers or clinics, but rather that whole health systems are underperforming. To successfully address the endemic nature of poor-quality care and to give providers the right support to deliver the competent and respectful care that people deserve, this Commission calls for an ambitious improvement agenda that moves beyond targeting the manifestations of poor quality and aims to transform health systems. However, strategies for quality improvement in LMICs have generally focused on a narrow set of solutions, such as increasing health system inputs and changing people’s behaviours and routines at the point of care—ie, the lowest (micro) level of the health system. A 2018 review of primary care quality found that, globally, 72% of strategies targeted the micro level (figure 15; appendix 1). Although interventions aimed directly at facilities and staff can be motivational and promote local commitment to quality, 218 people tend to revert to entrenched ways of doing things, especially when surrounding systems do not support transformation. 23 The application of multiple micro-level interventions might lead to deleterious effects, with interventions clashing at the point of care because implementing them consumes a large amount of attention from managers, potentially detracting from other priorities. 219,220 This raises the challenge of how to situate micro-level efforts as part of broader reforms that will improve health systems. Figure 15 Types of interventions and levels targeted to improve quality of primary health care according to published literature from 2008 to 2017 Panel 12: Section 5 key findings Addressing the quality deficits in many countries today will require expanding the solution space— the feasible set of solutions that satisfy the constraints of the problems—for improvement to include macro-level, meso-level, and micro-level interventions. Countries should invest in the foundations of high-quality health systems by considering four universal actions: governing for quality, redesigning service delivery to maximise quality; transforming the health workforce to provide high-quality, respectful care; and igniting people’s demand for high-quality care. Several commonly used approaches, such as accreditation and performance-based financing, have not been consistently effective in improving quality. District-led collaborative learning has the potential to foster improved quality through better system functioning and communication, but more research on most effective models is needed. Research on strategies to directly improve health worker and facility performance found that most micro-level solutions have modest effect sizes. Studies tend to be small and brief, limiting conclusions about sustainability and effects at scale. This Commission recommends that selected meso-level and micro-level interventions be implemented alongside efforts to improve the foundations of health systems. Development partners should support health system reforms that improve the foundations of high-quality care. Monitoring and evaluation of the impact of all improvement efforts at national and subnational level is needed to drive learning and improvement. A transformative quality improvement agenda is based on the recognition that health systems are complex adaptive systems, defined as systems in which many component parts interact in unexpected ways and often produce unanticipated results. 221,222 Complex adaptive systems are resistant to change, and diffuse and isolated interventions, especially at the micro-level, are unlikely to result in large-scale improvements. 221,223 An example of this is the proliferation of point-of-care technologies for health, few of which have been taken to scale or shown to have had an effect on health in LMICs. At the same time, evidence 23 from health and other sectors shows that complex adaptive systems can thrive if actors within the system have a shared vision, clear rules, and space to allow evolution and learning. Research 224 in behavioural economics noted that successful systems create a choice architecture that supports intended goals and reduces harmful variation. Choice architecture comprises the elements of a system that influence choices and behaviour, including information flow, incentives, presentation of choices, and decision-making contexts. 224 Nudging, or steering people in a particular direction while preserving their choice, is a common behavioural economics strategy, but the broader notion is to align motivations, incentives, oversight, and management across levels to promote the best actions. We propose a new improvement approach that addresses the scope of the quality challenge and recognises the complex adaptive nature of health systems. This approach emphasises macro-level reforms—what we call universal actions—that can not only establish and cascade systemic change across all levels of the health system, but also include a role for targeted meso-level and micro-level strategies. Macro-level strategies are best able to directly tackle the social, political, economic, and organisational structures that shape a health system. Meso-level (subnational) interventions address quality of care through the coordination and management of a network of facilities and communities. Interventions at this level are also well positioned to improve communication and learning between facilities and across levels of the health system. Micro-level interventions aim to directly influence the performance of the staff or the operations of a facility. Appendix 2 includes examples of interventions at the three levels of the health system. System-wide improvements in quality of care will require effort from providers, health system administrators, and communities, but they begin with a political commitment from heads of state and ministers. Global development partners can and should assist, but they should not drive this agenda. Contributions from across the health system, including the private sector, and from sectors outside of health will be crucial. Early gains in quality are likely to be visible within a few years, though meaningful improvement might take longer. People everywhere have a right to receive effective and respectful care—the time to get started is now. Universal actions for improving quality This Commission recommends four universal actions to improve health system quality: governing for quality, redesigning service delivery to optimise quality, transforming the health workforce, and igniting people’s demand for quality (figure 16). These actions are based on successes and failures from all countries, best practices from high-performing health systems, research and evaluation, and the experience and deliberation of the Commissioners. This Commission sees these universal actions as the start of a paradigm shift towards a more ambitious health system improvement agenda. Beyond the universal actions, countries can select additional targeted opportunities that fit their needs and context. All universal and targeted actions are predicated on having adequate health system inputs, such as staff, medication, and equipment. The optimal composition, design, and implementation of the improvement agenda will vary by country, because approaches that work in one setting might not work in another. Countries need to monitor the implementation of this agenda to permit adaptation and assess the effects on health and other valued outcomes. Figure 16 Universal actions for improving quality of care Universal action 1: Govern for quality Health-system-wide change demands that the improvement and maintenance of quality be woven into the fabric of a health system. Governing for quality means reframing the pursuit of quality health care from a peripheral activity to the mandate of a health system, and making sure that a commitment to quality is actually translated from paper to actions that improve the health of people. 225,226 Governing for quality includes several elements: adopting a national quality policy and strategy, improving capacity for management at all levels of the health system, strengthening regulation and accountability, and collecting and learning from health system data. Governing for quality requires high-level political commitment to a shared vision for improving quality of care and translating this commitment into action across the health system (panel 13). Well aligned policies and strategies should be based on this vision, locally accepted definitions of quality, and national goals for improved outcomes. 212 In response to requests from countries for guidance on how to design and implement these healthcare policies and strategies, WHO produced the National Quality Policy and Strategy Handbook. 212 The handbook outlines eight elements of the strategy and argues that quality must be elevated nationally and become a priority across sectors. These policies, and the strategy linked to them, should ideally outline the roles and responsibilities of the organisational bodies and actors that participate in sustaining and improving quality of care. A plan for coordinating these elements is also needed, so that quality improvement programmes are harmonised to maximise learning and results at the system level. 227 For example, an analysis 228 of surveys from 310 health system leaders in Mexico identified insufficient coordination of quality improvement agendas and an unclear system of roles and responsibilities as key barriers to the translation of federal policies into improved quality of care. The successful development of shared vision, policies, strategy, coordination, and implementation are needed to design a choice architecture for health systems that directs patients and providers towards decisions that produce quality care and good health outcomes. Improving the quality of the health system requires action from multiple sectors and stakeholders. Governing for quality includes managing these relationships and convening stakeholders under the shared vision of making large-scale sustainable improvements in quality and health outcomes. 229 Inclusive processes that bring a diversity of voices together to solve problems are complex and difficult to manage, but they help to make action on quality possible, they foster innovation, and they lead to more comprehensive solutions. 230 Building partnerships means aligning all stakeholders, including international donors, with national needs and priorities, which is a challenging goal. For example, in 2016, only 16% of development assistance for health went to the strengthening of health systems, despite evidence showing that condition-specific funding can compromise overall quality of health care and crowd out existing health services. 231–233 Adopting a national quality policy and strategy, and engaging stakeholders around it, requires not only strong leadership skills, but also good management at all levels of the health system to effectively use available resources to realise the vision of high-quality health care. 234 Middle management at the district or regional level could play an important role at the intersection of policy and implementation, although management capacity interventions at all levels have been linked to better health sector performance. 235,236 Although the literature consistently points towards the importance of good management across health system levels, insufficient attention has been paid to creating the capacity for health-care management in LMICs. 235,236 Data from multiple LMIC settings showed that management is a key factor that differentiates between high-performing and low-performing facilities. 237,238 Bradley and colleagues 235 outlined eight key management competencies and recommended designing training programmes for management professionals to achieve them. These key management competencies are: strategic thinking and problem solving, human resource management, financial management, operations management, performance management and accountability, governance and leadership, political analysis and dialogue, and community and user assessment and engagement. Examples of effective training programmes 239,240 exist in various settings, including Ethiopia, 239 where hospital performance improved under the management of graduates of the Masters in hospital and health care administration programme. Panel 13: Governing for quality: lessons from Nepal and Argentina* Absence of multistakeholder commitment leads to minimal quality improvement in Nepal In 2007, Nepal endorsed the Policy on Quality Assurance in Health-care Services, with the objective of ensuring “quality of services provided by governmental, non-governmental, and private sector according to set standards” and to establish an “autonomous body to ensure impartial decision regarding health services.” 11 years later, the success of this policy remains mixed. Why did the policy have low impact? The policy was created without a shared vision and buy-in from stakeholders, including the Ministry of Health. Important partners, such as the Ministry of Education, did not provide critical inputs. The policy designers also did not create consensus on a definition of quality or agree on indicators against which to measure progress. A centrepiece of the policy—to establish an autonomous body for quality of care— never materialised. A quality assurance section was established in the Department of Health Services, but it has little leverage over other units in the Ministry. The absence of a political commitment and involvement of all stakeholders has meant that the objectives of the Policy on Quality Assurance in Health-care Services have been largely unrealised, and health institutions continue to deliver subpar care quality.A90 Governing for quality through strong accountability in Argentina In 2005, Argentina implemented a public supplementary insurance program, SUMAR, designed to increase access to quality health care for uninsured children and pregnant women and to address large disparities in infant and maternal mortality rates.A91,A92 The programme is credited with decreasing the probability of low birthweight among beneficiaries by 19%.A91 In the setting of Argentina’s national decentralised health system, SUMAR’s success was dependent on high-level political commitments, buy-in from provincial governments, and well designed reporting pathways to ensure accountability. A presidential decree established the programme and provincial governments confirmed it under a collaborative agreement with their respective providers. The agreement is renewed yearly with review of procedures for expenditures and goals to be achieved. Federal commitments and provincial implementations were aligned through clear standards, and multidisciplinary oversight bodies monitored performance. A provincial level programmatic office regularly reported to the federal level. Local accountability was increased through the centralised monitoring of transferred funds to the provinces. The provinces were then responsible for enrolling beneficiaries, organising the provision of services, and paying providers. Source: Amit Aryal and Franziska Fuerst. Source: Programme SUMAR, Argentina. *Panel references can be found in appendix 1. To improve and guarantee quality care, good leadership and management competences must be buttressed by regulatory structures that create accountability. Strong regulatory mechanisms, ie, so-called regulation with teeth—and transparency through good monitoring, measurement, and reporting practices—support accountability both internally within the health sector and externally with civil society and citizens. 225,241 The accountability mechanisms, in turn, should be operated by leadership and management that can pull together a complex array of regulatory domains (eg, workforce, facilities, products, and service delivery) that might be administered by multiple institutions. Lessons from the regulation of medicines suggest that multipronged collaborative approaches that include a suite of regulations, mechanisms for legal redress, and training of inspectors in the public and private sector are most likely to be effective in mixed health systems. 242 These accountability mechanisms should also include monitoring of the flow of providers between private and public practice. 243 Two first steps that are yet to be taken in many LMICs are gathering accurate descriptive data about private health care (see Section 4) and maintaining the capacity for ongoing monitoring. Local regulations that apply to private health care vary considerably and need to be explored in detail. Finally, regulatory bodies that can enforce compliance across public and private sector institutions are often severely under-resourced, do not have basic capacity, and will need to be strengthened. 244 Governing for quality also means recognising the importance of, and making space for, civil society in regulating the quality of care. Professional organisations that regulate their members have an important role to play in health system quality by promoting high-quality performance of their members and by sanctioning them when they fail to meet minimum standards. Self-regulation is underused in LMICs, where professional organisations mainly advocate for their membership. Experience in high-income health systems has shown that the privilege and responsibility of self-regulation promotes professionalism, the sense of accountability among professionals to people, and reduces transaction costs for governments. For example, in Canada, 245 physicians successfully self-govern all aspects of the profession, from setting nationally uniform entrance exams to monitoring and remediating substandard clinical practice among practising physicians. However, self-regulation is not without its challenges, as exemplified by the UK, 246 which has moved towards joint government–professional oversight because of a series of widely publicised physician scandals. When professional groups have primary fiduciary responsibility, care should be taken to involve both practising clinicians and citizens in governance and to avoid unnecessary fragmentation of regulatory responsibilities. 247 Professional organisations can also promote quality through continuing medical education and engaging directly with governments to address quality concerns. For example, the Philippine Medical Association has more than a century of experience in agitating for improvements in medical education, health facility infrastructure, and the regulation of pharmaceuticals. 248 Social participation in health care, especially for the most marginalised, has intrinsic value as a human right and instrumental value in improving health care and keeping systems accountable. 249 People and communities are experts in their local experience and, with skilled support, can wield this knowledge to help create highly valued solutions to health-care problems. 250,251 Social participation can also increase the uptake and sustainability of services. 252,253 Although the composition of civil society varies by country, it is their diversity of perspectives, the opportunities for participation and action, and the availability of accurate and understandable information that will make this sector effective in holding governments accountable for high-quality health care. 243,249,252,253 Civil society can be particularly powerful when adopting a human rights framework for advocacy. 253 For example, in Uganda, 254 the Center for Health, Human Rights, and Development regularly uses legal avenues to challenge policy makers on issues such as essential medicines, safe and respectful maternity care, and fair treatment of patients with disabilities. Institutional accreditation uses external evaluators to assess facility performance against health-care standards. Although frequently cited as a quality accountability mechanism, a scoping review of reviews done by this Commission found that the direct effect of institutional accreditation on quality of care is uncertain (appendix 1). In a systematic review of improvement strategies, median effect sizes for institutional accreditation were modest: 7·1 percentage point improvements in quality outcomes were reported (appendix 1). 255 However, accreditation can indirectly affect quality through improved management, professional development, and capacity of facilities to promote change. 256 Improvement entails the continuous production of relevant data, which measures performance and outcomes, and the translation of those data into action—a learning system. 226,257 This learning system facilitates the development of programmes and reforms based on the best available evidence (whether global, regional, or local data) and best practices. New initiatives should embed measurement, evaluation, and plans for how the results could be disseminated effectively to the people responsible for ongoing data use to inform adaptation of services. Learning systems should also identify best performers, as discussed in Section 2, and determine the basis for their success. This set of intentional processes for actively learning and improving the health system is a goal that should be articulated and demonstrated first by the actions of senior leadership and subsequently echoed by middle management and the front-line staff. This system goal should become the primary guiding principle that creates the motivation for system improvement over time and for which health system actors hold themselves accountable. 258 Planners should design better systems on the basis of lessons learned and then link back to system managers, supervisors, and front-line staff to support improvement. Developing well functioning learning systems is especially important because of the imperfect evidence base for quality improvement interventions and the large variation in effect sizes found between studies and contexts. Learning systems ensure that planners can make course corrections based on context-specific data. A meso-level strategy that illustrates this approach is the quality improvement collaborative, which we describe in the following subsection. An analysis done by this Commission regarding five country experiences on governing for quality revealed practical lessons for operationalising the described principles (methods are described in appendix 1). District and facility-level health workers might be unaware of national quality policies and strategies or might not understand the implications of those on their daily work. The dissemination and translation of policies and strategies needs to be formally assigned, built into the job descriptions of public sector administrators, and included in performance reviews of these individuals. Additionally, the workforce might experience distracting and overwhelming policy crowding, with poorly coordinated and sometimes conflicting mandates. Countries are encouraged to review all policies affecting front-line workers; overlapping or conflicting policies can then be pruned, leaving a policy set that is coherent from the perspective of the service provider. For example, a nurse in primary care seeing a patient with diabetes and latent tuberculosis would benefit from having a single quality policy, not separate documents on diabetes and tuberculosis. Informants from all levels of the health system discussed the challenges of good system-wide data use in the Commission analysis. Data generation and translation must start at the local level, but for system-wide improvements to occur, these data need to be coordinated centrally. We suggest the creation of planned spaces for information exchange, such as district-led meetings to learn from the evidence generated. Success stories of improvements made possible by accurate data collection and skilled data translation can be shared with front-line health workers to motivate continued quality care and improvement. Universal action 2: Redesign service delivery to optimise quality Most LMIC health systems were originally designed to provide basic episodic care, especially for infectious diseases. Many systems have not adapted to the changing landscape and challenges of caring for people with chronic diseases, mental health conditions, and more complex injuries and illnesses. 20 Hospitals and healthcare facilities with advanced diagnostic and treatment capabilities are overcrowded with stable patients who could be treated in primary care facilities, whereas many first-level health clinics are expected to handle cases that are beyond their scope, with slow or non-functioning referral for emergencies. 259,260 Poorly organised health systems lose lives, waste scarce resources, and squander the good will of populations. To address this, this Commission calls for a quality-focused service delivery redesign: a reorganisation of services within the health system to efficiently maximise health outcomes and user confidence, rather than only geographic access to clinics. Service delivery redesign capitalises on existing health system assets to provide services at the appropriate level and achieve the highest quality of care possible. First, some services should be shifted to primary care. Reflecting the core principles of continuity, coordination, comprehensiveness, and first contact, competent primary care is ideal for treatment of chronic and stable conditions that require sustained engagement with the health system (eg, non-communicable diseases and stable HIV or tuberculosis infection), preventive care (eg, immunisation, antenatal or routine child care, and growth monitoring), and low acuity and algorithmic services (eg, care of minor child and adult illnesses and injuries). 20,36 Palliative care can also be expertly delivered close to home by primary care and in partnership with families, community caregivers, and spiritual supporters. 36 Examples of the partial implementation of quality-focused service delivery in LMICs reveal the benefits of shifting these services to primary levels. In HIV care, stable patients are managed in primary care clinics with impressive results, and new patients can initiate treatment in their own communities. 261 As a result, centralised specialty centres are less crowded, allowing higher-skilled providers to focus on more complicated cases, such as HIV treatment failures. 260 A multicountry meta-analysis 262 of 39 090 patients with HIV showed that patients in primary care were half as likely to be lost to follow-up than patients treated at a centralised HIV clinic. In tuberculosis care, community-based models are also substantially less costly to implement. 263 Uncomplicated non-communicable diseases are especially well suited for care at the primary level, where providers can more effectively monitor chronic disease over time and build relationships that form the foundation for effective communication and counselling regarding crucial lifestyle modifications. 20 An important caveat is that current primary care models in many LMICs are outdated and ill-suited for these new tasks. New thinking is needed on primary care functions, capacities, and connections with specialised services, especially in urban settings. 20,264 For example, experience from high-income settings suggests that non-visit care, in the form of virtual or phone visits, has the potential to extend the reach of primary care for low-acuity conditions. 265 Acute or chronic conditions with higher risk of mortality or severe morbidity are best assessed at a hospital with emergency capacity. The correct health system level for some surgeries should be determined on the basis of availability of specific technical skills, laboratory, imaging, and intensive care infrastructure, acuity of the condition and projected procedure volume. Complex or rare conditions are ideally managed in tertiary, highly specialised, care centres. Childbirth is one situation that benefits from care at hospitals with surgical and specialised newborn care services, because complications can arise without warning and require rapid, highly skilled care. 266 However, in low-income countries, a substantial proportion of obstetric and newborn care is provided in primary care facilities without adequate expertise or surgical capacity. 267 For women and newborn babies who develop complications in primary care clinics, poorly functioning referral and transport to a higher level facility mean a much greater risk of morbidity and mortality. 267,268 Guided by this logic, many high-income and middle-income countries mandate that all women deliver in, or next to, hospitals with surgical and advanced newborn care services. 269 The structural deficits in highly skilled health workers and surgery at primary care levels might explain why the Better Birth trial, 39,270 a large randomised controlled study, found that implementing a safe childbirth checklist and coaching for nurses and midwives at primary care centres in India did not reduce maternal and newborn morbidity or mortality. We examined the practical implications of shifting delivery care to hospitals in a geographic modelling that linked facilities with pregnant women in six LMICs (Malawi, Haiti, Tanzania, Kenya, Namibia, and Nepal; methods are described in appendix 1). We found that delivery care redesign would result in substantial gains in technical quality for care of pregnant women without reducing interpersonal quality and with minimal reductions in 2 h access to care. For example, in Tanzania, hospitals score twice as high as primary care facilities on a basic measure of childbirth quality and, therefore, quality of care would improve by moving all deliveries to hospitals. Although this would increase the average distance from a delivery facility for rural dwellers, only 27% of pregnant women would live more than 2 h away from a delivery facility in Tanzania, compared with a current 17%. In the remaining countries, 1% to 7% of women lost 2 h access to care. This redesign can also produce efficiency gains because resources could be redirected from providing obstetric care in thousands of facilities to improving quality in fewer hospitals, promoting care integration across facilities, working with communities, and enabling transport to hospitals. Strong interfacility communication and referral networks are crucial to the success of quality-focused redesign, along with investments and participation from non-health-care sectors. Tools to facilitate redesign that warrant consideration include improved transportation (eg, community taxi services and ambulances), 271 communication (district-led learning, discussed in the following subsection), measures to reduce access barriers to high-quality facilities (eg, vouchers and maternity waiting homes), 272,273 and public education to enhance population understanding of the right place for care. 274 Local context, with a focus on facilitating access to high-quality care for the most marginalised subpopulations, should drive the mix of interventions and incentives. Planning for quality-focused service delivery redesign in any country would require analyses of patient volumes, bed and surgical capacity, provider competence in existing hospital facilities, and potential upgrades to existing health-care centres to permit high-quality care, as well as attention to transport, costs, and building community demand. 275 Universal action 3: Transform the health workforce The data in Section 2 showed that providers often do less than half of recommended evidence-based care measures and that rates of diagnostic accuracy are low across health conditions and countries. A Commission analysis showed that this is also true of providers in their first 3 years of practice, suggesting a probable role of poor preservice education in provider performance (appendix 1). 276 Low knowledge and competence of the health workforce is at risk of worsening over the coming years because of the rapid expansion of health workforce training institutions, resulting in dilution of already insufficient faculty and curricular resources. 277,278 Despite this threat to health-care quality in LMICs, improving the education of health-care professionals has not been a central part of the improvement discourse. 279 In the previously mentioned review of primary care quality improvement, only 16 of 379 articles addressed the preservice education of health professionals (figure 15). Fixing these gaps through in-service training is not an effective antidote, 280 and reforms in professional education are required to adequately equip these professionals to provide high-quality care. The Lancet commissions 277,281 on health professionals for a new century and on the future of health in sub-Saharan Africa highlighted key steps to address the quality gap of the health-care workforce. First, the education of health professionals should focus on achieving competence through active learning, early clinical exposure, and problem-based learning. Competency should be defined by the gaps and needs of each individual country and include domains beyond the technical skills of providers. Ethical, respectful, and compassionate care, and the fundamentals of systems thinking and quality improvement should be additional core competencies. Dysfunctional systems will continue unless the workforce is prepared to improve them. Second, the chronic understaffing of many health-care professional schools in LMICs must be addressed, along with support of high-quality teaching, for the quality of clinical education to improve. 278 Possible solutions include increasing salaries, expanding professional development opportunities, using state policy levers to require practising clinicians to teach trainees, and providing small incentives, such as free housing or telecommunications. 278 Finally, health education institutions should establish student recruitment and retention policies to increase the representativeness of the student population. 252,282,283 Evidence has shown that care interactions between providers and patients who are racially, culturally, ethnically, or linguistically similar are associated with higher perceived quality of care, satisfaction, and improved medical communication. 284,285 These changes within institutions of higher learning must be supported by good governance and quality-informed policy making. Intersectoral coordination between ministries of health and education would create a more direct link between the production of a health workforce and the needs of the health system. 281 Third, health-care providers also need a work environment in which they can succeed beyond graduation. Many health-care providers face challenging conditions, including inadequate and delayed salaries, heavy workloads, ambiguous responsibilities, no opportunities for growth, and poor treatment by colleagues and patients. 276,286,287 Not only do these conditions result in burnout, mental distress, and poor retention for providers, but they also result in poorer quality care. 287–289 Motivated providers are less likely to make poor decisions or medical errors and are more likely to be empathic towards patients. 290 Good working conditions, regular pay, clinical support, and opportunities to learn and grow are essential to maintain a workforce that is motivated and committed to providing high-quality care. 286,291,292 WHO recommended a set 293 of decent employment policies to support providers, including ensuring occupational health and safety, fair terms for workers, merit-based career development, and a positive practice environment. In addition to broader policies, a review 294 published in 2017 recommended a set of steps for facilities to foster joy and engagement in their own workforce. These include an initial process of inquiry to understand workforce priorities, followed by identifying and removing the primary annoyances, initiating simple fixes, and using improvement science methods to spur larger-scale change to create a fundamentally more satisfying and happier work environment. Although early reports suggest that sense of purpose can be strengthened through these approaches, much of this work has started in the past few years and the effectiveness of these interventions on improving quality of care in LMICs remains to be determined. Universal action 4: Ignite population demand for high-quality care High-quality health systems respond to people’s expectations, but if those expectations have been dampened by a history of disempowerment and poor-quality care, that response will not translate into better health care. 295 Section 2 shows that when expectations are low, quality ratings of objectively poor care are high. This discrepancy lets health systems disregard issues of quality. Beyond putting pressure on systems to improve, generating demand for quality through information sharing would increase health system accountability (see universal action 1) and has an ethical foundation: for patients to be autonomous decision makers, they must have access to usable information about the quality of their care. 296 This is imperative because of the information and power asymmetry that exists between patients and providers. Finally, this Commission’s recommendation is based on evidence that people who already demand higher quality in LMICs and actively make decisions can extract higher quality care from their health systems. 118,119,297,298 National quality improvement strategists are encouraged to explore demand-side approaches that raise people’s expectations of quality. Very few improvement programmes are explicitly designed to raise demand for quality care. We used those few programmes to draw lessons on this understudied improvement opportunity. Participatory women’s groups are a well documented 299 example, and improved outcomes for women and children in communities with these groups are believed to be partly due to participants demanding better care, such as safe hygienic practices during childbirth. Community monitoring programmes can generate demand for quality, although few high-quality studies exploring this outcome exist (see Section 3). 300 A programme 301,302 in rural Uganda, for example, combined information sharing about quality care at local facilities with community participation and found reductions in neonatal deaths and improvements in measures of facility process quality 4 years after implementation. A study 303 in Uttar Pradesh, India, showed that quality during prenatal visits was improved by sharing information about health and social service entitlements with pregnant women. A preliminary body of qualitative research 304 also suggested that demand generation for quality might be especially well suited to improving user experience. Panel 14 includes examples of the use of advocacy to generate demand for high-quality care from the White Ribbon Alliance. These interventions are based on sharing information with people and treating them as active agents in the health system. They are unlikely to work without system-level support that encourages patient-centredness, power-sharing, communication, and inclusion. 300 Importantly, this supporting of people to be active agents should be done with careful attention to marginalised populations. The intersection of multiple sources of vulnerability is likely to make some groups less able and prepared to act on quality information than others. To prevent the exacerbation of existing disparities, particular attention must be paid to rural, less educated, and impoverished populations (see Section 3). Interventions that might raise expectations and demand for quality often include social interaction through groups, committees, or meetings; this component is supported by social network science and evidence showing that people learn about quality from each other. 305,306 This insight from social network science also suggests that demand generation interventions might take advantage of the increasing presence of interactive social media platforms in LMICs. Figure 14 gives an example of a people-facing dashboard that can be used to share information with populations. More country examples of improvement through the four universal actions can be found in appendix 2. Targeted opportunities In conjunction with system-wide reform through the universal actions just described, countries will likely require additional context-specific interventions, which we call targeted opportunities. Beyond increasing health system inputs, this subsection reviews the most commonly used quality improvement interventions, but does not aim to present a comprehensive list. As mentioned in Section 2, the cost of interventions is not addressed in this report. We used several sources, including the Health Care Provider Performance Review (HCPPR)—a systematic review of health worker performance improvement strategies in LMICs (appendix 1). 255 HCPPR was designed to develop evidence-based guidance on strategies to improve health worker performance and includes published and unpublished studies in any language from the 1960s to early 2016. Although the HCPPR is the most comprehensive and up-to-date review on the subject, it has limitations common to all reviews, such as implementation strength that varies across studies, and the unknown degree to which results from controlled study settings can be generalised to real-world programmes. The full review reported effect sizes for combinations of strategies, which are not discussed in detail here. Macro level improvement: financing for quality Health financing and provider payment can be used to leverage greater quality from the health system. Of the four core financing functions (revenue mobilisation, pooling, purchasing, and benefit design), purchasing—or the allocation of funds to providers—has the greatest direct influence on quality of care and we focus on it here. 252 Strategic purchasing refers to funding providers on the basis of information about populations and providers to achieve performance goals. Examples include provider payment strategies and selective contracting of facilities on the basis of quality. 307 Although most doctors and nurses are assumed to be motivated by altruism, they also seek a competitive wage. Input-based (eg, salary and capitation) and output-based (eg, fees-for-service, per case, or pay-for-performance) payments tend to exert opposite effects on providers’ intensity of effort, with input-based payments disincentivising and output-based payments promoting the number and intensity of services, leading to the duelling challenges of under-treatment and overtreatment described in Section 2. A mix of input and output financing might therefore be the best strategy to prevent undue attention to incentivised elements. Panel 14: Lessons in generating community demand for quality care from the White Ribbon Alliance (WRA) Uganda In 2011, WRA Uganda mobilised local advocacy teams to bring attention to the poor quality of obstetric services in the country in three underserved districts. The teams, comprising district leaders, health officers, community members, and midwives, assessed the status of facilities and found that none of the districts met the minimum requirements for treating complications: they had insufficient lifesaving commodities, skilled health workers, and infrastructure. On the basis of similar findings, WRA launched the Act Now to Save Mothers campaign to educate citizens on their rights and responsibilities related to quality health care. Community members participated in district planning and budget hearings and town halls. In one town hall, more than 2000 community members signed and presented a petition to district representatives and parliament demanding improvement. Community members served as citizen journalists, reporting on progress and budget allocations. The campaign resulted in increased procurement of essential medicines and equipment, increases in salary for—and recruitment of—additional health workers, and the reconstruction of dilapidated facilities. Tanzania After a woman died in childbirth in 2013, in Rukwa region, Tanzania, because of no available blood supply, communities demonstrated in protest of the poor-quality care. WRA Tanzania brought together citizens and decision makers to ensure that these concerns were heard. They worked with religious leaders and village health teams to raise awareness among community members, and they supported district and regional policy makers to respond and act on citizen demands. The Parliamentarian Group for Safe Motherhood was mobilised to add their support to the citizens’ voices. In 2015, Rukwa leaders expanded emergency maternal health services from only 10% to 50% of health centres. On the basis of this success, WRA Tanzania expanded their efforts nationally, resulting in the government approving an historic 50% increase in funding for maternal, newborn, and child health to support expansion of facilities, blood banks, and the recruitment of health workers throughout the country. Lessons Mobilise around existing political commitments for improvement Educate citizens about rights, responsibilities, and how to advocate Use data to create pressure for accountability Identify champions to amplify the voices of people Support decision makers to respond to citizen demand and collaborate with them to make change Source: Kristy Kade, Betsy McCallon, Rose Mlay, Robina Biteyi. Aligning financing and provision arrangements is crucial to the success of strategic purchasing. For example, facilities subject to selective contracting should be able to make the necessary purchasing and hiring decisions for improvement. In some countries, facilities might not have sufficient managing authority and legal changes will be required. Output-based financing is also data intensive and can be a substantial burden for providers. To align different payment methods and incentives, a strong data system to capture information on provider payments is crucial. 308 Such systems produce information with multiple uses beyond strategic purchasing. For example, in high-income countries, insurance claims data offer information on services rendered, fees received, and diagnoses made that can be used by payers, insurers, and researchers. One prominent form of strategic purchasing that has been widely implemented in LMICs is performance-based financing. Performance-based financing describes a set of approaches designed to improve health care by paying providers and facilities for the quantity and quality of care, though many programmes complement the financial incentives with direct improvement elements, such as training or supervision. 184,309–311 Most performance-based financing programmes in LMICs incentivise primarily the quantity of services and, although they appear to increase utilisation of care and service volume, the effect of performance-based financing on quality is less clear. 184,310 Several impact evaluations are forthcoming from the World Bank’s Health Results Innovation Trust Fund, a large funder of performance-based financing. 312,313 Overall, evidence to date suggests that performance-based financing has insufficient potential as a standalone strategy for system-wide quality improvement. Performance-based financing might modestly improve quality compared with no intervention in some contexts, but does not always outperform unconditional financing; the effect appears to be driven not by the financing mechanism as much as the equipment and workforce interventions. 314–317 Compared with alternative interventions, performance-based financing incurs unique costs for performance verification that can account for 10% to 15% of operating costs, including the cost of staff time. 318 There can also be unintended consequences of performance-based financing programmes, including reports that providers have threatened patients to report positive outcomes, but these programmes can also improve unrewarded dimensions of quality, including patient satisfaction. 314,316,319 Overall, performance-based financing does not appear to be highly cost-effective, especially vis-à-vis unconditional additional financing. 316,317 The HCPPR showed that interventions that include financial incentives have a median increase on quality of 7·6 percentage points. Panel 15: Case studies of learning at the district level* Midwifery Coordination Alliance Teams (MCAT) in Cambodia The MCAT programme is an area-based approach that started in select provinces in Cambodia, in 2009, and has since spread to all midwives, health centres and hospitals in all 98 districts of the country. The programme aims to strengthen collaboration between primary health care and hospital providers. All primary care midwives in a meso-level area meet doctors and midwives from the local hospital every 3 months for data review, updates, problem solving, and refresher trainings. The sessions are duplicated over 2 consecutive days to accommodate all health centre midwives without closing any services. Providers view and discuss data, such as maternal and perinatal deaths or near-misses, contraceptive uptake and mix, case-fatality of common conditions, and supervision results. The meetings include participatory learning sessions with simulations and discussions of current clinical procedures and guidelines. Supply chain issues, for example, surface and are solved with feedback and joint problem solving. The teams also foster local innovations. For example, midwives in one province instituted a clinical hotline, which enabled health centre midwives to call a hospital midwife for advice on emergency referrals and follow-up. This idea has spread to other districts. Another MCAT team suggested and instituted an extension of the livebirth incentive to also include appropriate emergency referrals. Although a formal evaluation has not been done, the MCAT programme provides a team approach to gradually improving care of maternal and newborn complications in the district, and it is believed to be a factor in Cambodia’s large health gains for women and children.A93,A94 Area-based planning and vertical integration in meso-America The Salud Mesoamerica Initiative (SMI) aims to reduce maternal and child health inequities through a results-based funding model to improve quality and effective coverage in seven Central American countries and in Chiapas state, Mexico. The programme features area-based plans within each health district to translate national plans to local teams. These plans include locally-tailored targets, activities, and timelines. Local implementers review their progress with national stakeholders every 3 months, fostering an experience-based learning environment.A95 SMI provides technical assistance to countries to create quality improvement strategies and standards through problem identification, prioritisation of areas for improvement, and development of improvement plans. Countries developed tools for data collection and analysis to support learning. Each country has adapted implementation to fit their priorities and systems. In Belize, the process started at the comprehensive emergency obstetric and newborn care level, then gradually added basic and ambulatory levels of care to allow teams to have a more holistic view of the health network. Teams collect data and review their own progress each month, and every quarter, a quality improvement officer reviews the performance to allocate a small incentive to teams through a Quality Innovation Fund. The quality improvement officer also offers supportive supervision, shares challenges and best practices, and helps teams to develop and test new ideas. Independent evaluation results showed that all indicators across levels of care have improved relative to baseline, with gains ranging from 30 to 85 percentage points. Source: Som Hun and Jerker Liljestrand. Source: Emma Margarita Iriarte and Jennifer Nelson. *Panel references can be found in appendix 1. For financial incentives, including performance-based financing programmes, to be successful, economic theory and research suggest that rewards will have smaller effects than penalties because of the tendency to avoid losses, and incentives are most effective when closely linked to processes under the direct control of providers. 320,321 Extrinsic incentives might crowd out intrinsic motivation, underlining the importance of aligning incentives with professional expectations and work norms. 320 Finally, aligning provider incentives with specific goals of care coordination or effective treatment, as opposed to inputs, offers potential for quality improvement. 322 Meso-level interventions: district-led learning District administrations and networks of facilities can be harnessed into learning systems that accelerate improvements in health-care performance with the potential for scale. This level of the health system is well positioned to facilitate systematic group learning among facilities of similar types and across tiers of the health system. District-led, area-based learning and planning brings together providers and administrators responsible for a catchment area to solve clinical and system problems, harmonise approaches, maximise often scarce resources, and create better communication and referral between facilities (panel 15). 323 Formal quality improvement collaboratives involve the use of teams from multiple health-care sites that work to improve performance on a specific topic by collecting and using data to test ideas with so-called plan-do-study-act cycles supported by coaching and learning sessions. Systematic reviews 324,325 of quality improvement collaboratives in predominantly high-income countries showed modest improvements, particularly when addressing a clear gap between evidence and practice on straightforward aspects of care. Evidence from LMICs is more scarce, leading this Commission to undertake a subanalysis of quality improvement collaboratives based on the HCPPR systematic review. Overall, the quality of evidence on quality improvement collaboratives from LMICs is low. Effect sizes for these collaboratives combined with clinical training were very large (mean range 52·4 to 111·7 percentage points) although how generalisable they are is uncertain, as three of the four reports targeted the same clinical outcome (postpartum haemorrhage), which was amenable to simple changes. The effectiveness of quality improvement collaboratives was more variable when implemented without training and when addressing other areas of care. Results on improving health worker practices ranged from modestly to highly effective (4·3 percentage points for continuous outcomes and 30·2 percentage points for percentage outcomes). For patient health outcomes, quality improvement collaboratives had no effect (1·4 percentage points for continuous outcomes and 0·3 percentage points for percentage outcomes). 255 Quality improvement collaboratives are not static structures, and they have been implemented and adapted in several ways to achieve their stated aims. Some common adaptations include their use for the generation of new ideas and for empowerment of health-care workers. In addition to understanding the effect of district-led learning on clinical practice and patient outcomes, the effects of this approach on communication, health worker motivation, and team dynamics are currently being explored. 326 Micro-level interventions: directly improving provider and facility performance Strategies that target the micro-level are presented here as opportunities to complement and extend broader systems-level reforms. For example, the improved education of health professionals can be reinforced through facility-level refresher training. This Commission recommends that, where possible, micro-level interventions should not be implemented in isolation or instead of strategies that assess and improve the foundations of health systems. We present in table 3 results of approaches to improve health worker performance, focusing on the six strategies tested by the largest number of studies and that included at least four low or moderate risk-of-bias studies. 255 All six strategies target the health system at the micro-level. Moderate effect sizes were found for training (9·7 percentage points) and supervision (11·2 percentage points). The combination of training and supervision had larger improvement effects, at 17·8 percentage points. Providing only printed information or job aids to health workers and only implementing mHealth (a mobile wireless technology) strategies tended to be largely ineffective. Table 3 Selected results of strategies to improve health worker performance from the Health Care Provider Performance Review 255 Training only Training plus supervision * Supervision * only Printed information or job aid for health workers only Information communication technology (mHealth) only Training plus supervision plus strengthening infrastructure * Median effect size for percentage outcomes, percentage points (IQR) 9·7 (5·5–21·3) 17·8 (5·5–25·9) 11·2 (5·8–25·6) 1·5 (–4·5 to 6·1) 1·0 (–2·8 to 10·3) 9·4 (–0·1 to 40·5) Study comparisons for percentage outcomes (comparisons with low or moderate risk of bias) 76 (32) 26 (11) 16 (8) 8 (5) 4 (4) 4 (1) Median effect size for continuous outcomes, percentage points (IQR) 17·5 (0·1–23·7) 11·1 (7·3–60·4) –3·0 (no IQR) –3·4 (no IQR) –38·9 (no IQR) 64·3 (31·9–88·7) Study comparisons for continuous outcomes (comparisons with low or moderate risk of bias) 16 (8) 8 (3) 3 (1) 3 (1) 1 (1) 4 (4) Countries in which studies were done for both outcomes types (number of WHO regions) 2 (6) 17 (5) 13 (5) 7 (3) 4 (1) 6 (3) Three most common categories of study outcomes for both continuous and percentage measures Treatment, counselling, assessment Treatment, counselling, assessment Treatment, counselling, universal precautions Treatment, documentation, case management† Counselling, case management,† treatment Treatment, diagnosis, referral Median baseline outcome value for percentage outcomes, % (IQR) 43·0 (19·0–70·0) 25·2 (9·2–52·5) 53·8 (36·0–63·5) 32·8 (24·8–58·6) 36·5 (5·4–60·6) 31·2 (7·7–55·6) Median number of health facilities in intervention group for percentage outcomes (IQR) 6 (1–20) 7 (2–32) 7 (5–24) 8 (5–10) 38 (35–47) 11 (2–21) Median duration of study follow-up‡ for percentage outcomes, in months (IQR) 4·0 (1·3–6·0) 4·5 (2·0–6·0) 5·0 (2·0–9·0) 1·9 (1·0–4·5) 7·3 (4·1–9·4) 1·6 (1·0–2·4) Strategies for health facility-based health workers were tested by at least four studies with low or moderate risk of bias, from at least one outcome group (percentage outcomes or continuous outcomes). Percentage outcomes are expressed as a percentage (eg, percentage of patients treated correctly) and continuous outcomes are outcomes that could not be expressed as a percentage (eg, average number of medicines prescribed per patient); for details, see appendix 1. * Supervision is either strengthened routine supervision visits (in terms of frequency or supervision quality) or other supervision-like strategies, such as audit with feedback; strengthening infrastructure is the provision of medicines or equipment, or otherwise improvement of conditions in health facilities. † The case management group of outcomes reflect multiple steps of the case-management process (eg, percentage of patients correctly diagnosed and treated). ‡ Study follow-up time was defined as the time from when the strategy was initially implemented to the last eligible follow-up measure; for most study comparisons, the follow-up time was the same for all study outcomes; when follow-up time varied among outcomes for a given study comparison, the longest follow-up time was used in the analysis. Most strategies that focused on improving the practices of lay or community health workers were tested by a single study and the quality of evidence was generally low. Again, training alone tended to have modest effect sizes (median of 7·3 percentage points). Strategies that included mHealth had a median effect size of 8·7 percentage points. Strategies that included training and supervision had a median effect size of 9·6 percentage points, and strategies that included training and community support approaches, such as patient education, had a median effect size of 22·7 percentage points. Despite the scope and range of the studies, it is difficult to draw conclusions about how generalisable these strategies are. Studies tended to only include small numbers of health facilities in the intervention group (often less than ten) and short post-intervention follow-up times (median of 7 months or less). Effect sizes for strategies tested by multiple studies included in the HCPPR also varied considerably, which might be due to study biases, random variation, and considerable heterogeneity of study methods and context. For example, the effectiveness of complex, multifaceted interventions with at least four strategy components varied substantially (from nearly 0 to 61 percentage points), which suggests that complex strategies are sometimes, but not always, more effective than simpler ones, and clearly more work is needed in designing and testing these approaches. The variability of effect sizes for a given strategy also shows the difficulty in predicting how effective a strategy will be in a given context. Therefore, it is important for programmes to monitor the effectiveness of any strategy implemented in the field, not just in the context of research. Additionally, the duration of strategy effectiveness is uncertain. Using HCPPR data, we modelled the effect of follow-up time on strategy effectiveness, using random-effects models (or fixed-effect models, if dealing with less than ten studies or outcomes) adjusted for baseline performance (appendix 1). We found that the effect of supervision appeared to increase over time, but we found no evidence of a time trend for group problem solving. Results for training were inconclusive. Our ability to examine time trends was limited by the small number of studies per strategy with repeated post-intervention measures. Section 5 conclusion All reforms for quality will need to be country-led, starting with a vision for quality health care shared and actively supported by heads of state and their ministers. Many of these political leaders have already made commitments to UHC, but without improving quality, that promise is an empty one. Sequencing improvement efforts to first target populations who have the worst quality of care and health outcomes will also be important to realising high-quality UHC. 135,327 Global partners are encouraged to support these efforts by aligning with each country’s priorities, not funding flotillas of small-scale interventions over short project-cycles, and instead selectively investing in fewer health system reforms over a longer time period. Reorienting research priorities to support country-led efforts for health system quality improvements is also sorely needed. Every country will decide how to implement the systemic changes needed for high-quality care. This Commission recommends a careful assessment of the foundations of the national health system, consideration of the four universal actions we have presented, and a tailored strategy that addresses quality gaps and maximises existing assets. Finally, countries should not expect that every improvement initiative will succeed, but leaders should not be discouraged. The process of iteratively adapting and developing effective solutions for a given context takes time. The key is to get started, monitor progress, and learn from both successes and failures. Section 6: Recommendations In this Section, we identify opportunities for national governments, civil society, global partners, and researchers to contribute to a global effort towards high-quality health systems. National governments (1) Invest in health systems and make them more accountable to people. National governments need to invest in high-quality health systems for their own people, and they must also be accountable to people for their performance. This requires legislating for people’s right to quality health care, educating the population and health system stakeholders about these rights, enacting strong regulation and standard setting, sharing actionable information on health system performance, and creating mechanisms for remedy and redress. These actions should be complemented by social accountability mechanisms that promote the participation of the population in health system decisions. Countries will know they are on the way towards a high-quality, accountable health system when policy makers choose to receive their health care in their own public institutions. (2) Look beyond the government health sector. Building high-quality health systems requires strong primary, secondary, and professional education, solid road and transport networks, and reliable communication infrastructure. Partnering with other sectors will be essential to create the conditions for health system reform. Involvement of private health-care providers and institutions can expand people’s choices and might spur the system to improve user focus; these private providers will need to be effectively regulated and incentivised to produce desired impacts. (3) Embed quality of care in UHC. Quality should be at the core of UHC initiatives, alongside coverage and financial protection. For this, countries should begin by establishing a national quality guarantee for services provided through UHC that specifies the level of competence and user experience that people can expect in the health system. To ensure that poor people benefit from improved services, expansion should start with them. Progress on UHC should be measured through effective (quality-corrected) coverage. (4) Measure better. Quality measurement should be parsimonious, timely, and transparent. Health systems should report their performance to the public annually using dashboards on health and wellbeing, user experience, system competence, and population confidence. Data should further be disaggregated across regions and vulnerable groups. Countries need to update their health system data toolkits, and they can begin by shedding uninformative indicators and instruments and improving data quality in existing systems. The high-quality health systems toolkit should include vital registries and real-time health system intelligence systems on supply chain and human resources, reliable routine information systems, and targeted studies, such as rapid facility surveys and updated population surveys. Investing in national institutions and expertise for measurement and translation of evidence to policy is crucial for making use of the data. Health and data literacy are also crucial for health-care users. (5) Improve quality by starting with four universal actions. This Commission recommends that countries consider four universal actions to shift the trajectory toward high-quality health systems. Additional targeted opportunities in areas such as health financing, district-level learning, and others can complement these efforts. All strategies need careful monitoring and evaluation to measure their effect and allow local adaptations. The first action is to govern for quality; this means creating a shared vision for a high-quality and learning health system with a national quality policy strategy and mechanisms for implementation and accountability. These should be developed in partnership with the private sector, civil society, and in collaboration with non-health sectors. A learning system needs accurate and timely data and a health system leadership committed to improvement. Improving data literacy for health workers and consumers will be needed to make use of the data. The second action is quality-focused service delivery redesign; this requires reorganising health services to maximise health outcomes rather than solely geographic access to clinics. Primary care clinics should not tackle serious or rare health needs with elevated risk of mortality, such as deliveries, but should instead expand on their core competencies: integrated and continuous care for stable patients and community outreach and prevention. Governments and civil society need to work together to ensure that people can reach the care they need, when they need it, and that they receive respectful care; a range of strategies within and beyond the health sector are available. The third action is transforming the workforce, starting with a move to competency-based clinical education that includes active learning, early clinical exposure, and problem-based learning. The curriculum should include ethics, respectful care, and core quality concepts. Classroom instruction needs to be buttressed with role-modelling and supervision in practice settings. The workforce should be supported with good working conditions, regular pay, and clinical mentorship and be provided with opportunities to learn and grow. Health workers and their professional associations must redouble efforts to maintain and enforce high standards of practice to earn and keep the public’s trust. The fourth action is igniting demand for quality, which requires educating people about their health entitlements according to national resources and use targeted quality reporting, social networks, and mobile technologies to empower people to become active patients who seek and motivate health workers to provide good quality care. Civil society and non-governmental organisations (1) Demand more from providers and health systems. People need to inform themselves on their rights and entitlements in the health system, including the right to competent care, respect, information, privacy, consent, and confidentiality. People enrolled in UHC programmes need to understand their benefit packages, care options, and communicate their needs and preferences to their providers. They should make use of redress options when care falls below the quality standard. (2) Agitate for change and hold systems to account. Civil society should insist on transparent sharing of health system capacity and performance. They should press for greater social accountability through citizen report cards, community monitoring, social audits, participatory budgeting, citizen charters, and health committees. However, social accountability is not a replacement for government-led accountability; they are most successful in improving health system performance when combined. Global bilateral, multilateral, and foundation partners (1) Invest in national institutions to produce evidence on health system quality. Many LMICs do not have effective institutions to do the functions in metrics, research, and evidence-based planning required for a learning health system. Global partners should support the international and national training of data scientists and help build institutional capability through mentoring and sharing of organisational best practices. Policy uptake of analytical findings from local institutions can in turn build confidence in and demand for locally generated evidence. (2) Support development of health system quality measures. LMICs do not have measures that capture the elements of health system performance that matter to people and can inform improvement. Continued support of vital registries and health information systems to measure health and impacts is crucial. Agile facility surveys and real-time measures that capture quality of care and people’s voice and that can be linked to population health data are needed. Global repositories of validated comparable measures, instruments, and best practices in analysis can be a valuable resource. Panel 16: High-quality health systems research agenda Measuring and analysing quality Develop and validate quality measures suitable for resource-constrained settings for: health outcomes that can be attributed to health systems and patient-reported outcomes; competent care for mothers and newborn babies, cardiovascular diseases, chronic respiratory diseases, diabetes, cancer, mental health, and injuries; user experience, including respect, dignity, and autonomy; system and platform competence (eg, timeliness, safety, and integration), including quality of community outreach, primary care, and hospital care Understand the extent and causes of variations in quality: identify best performing countries, regions, and facilities and determine the factors contributing to their higher-quality care; explore causes of poor quality across different contexts Assess equity of quality care across dimensions of vulnerability, including setting of care, demographics, and disease type Analyse the effect of quality care on health, confidence, and economic outcomes, including patient-reported outcomes, demand for health care and bypassing, health system waste, and catastrophic and impoverishing expenditures Improving quality Test the effect of innovations in the preservice education of health professionals on delivery of competent and respectful care Evaluate effects of quality-centred health service design on health, user experience, equity of care, and health system function Explore individual and combinations of interventions to generate community demand for quality, including dissemination of locally relevant information and innovations that use new technologies Refine the best design for district-level learning strategies (eg, quality improvement collaboratives and other approaches) Analyse the effects of legal, performance, and social mechanisms to promote accountability in low-income and middle-income countries Test management innovations and intrinsic and extrinsic approaches to motivate providers Measure the costs and cost-effectiveness of improvement approaches and their sustainability Methods and tools Develop an agile facility survey for rapid measurement of health system quality that focus on measures that matter: competent care and systems and user experience Update population surveys to measure a broader range of health conditions Explore new technologies to improve accuracy and reduce the burden of process and outcome measurements (eg, wearable trackers, big data analytics) Expand and validate methods for measuring effective coverage Develop new methods to test system competence over time, such as tracer patients Incorporate implementation science in assessments of health system improvement strategies to understand what works, why, and in what contexts Expand the use of qualitative methods and approaches from social sciences, such as political and management science, in describing and diagnosing quality failures and successes Expand sample sizes and extend length of time in studies of all improvement strategies, to characterise the generalisability and sustainability of these approaches Include patient experience and patient-reported outcomes in improvement research (3) Include quality in tracking progress of global initiatives. Progress on UHC and the SDGs should include both coverage and quality, and effective (quality-corrected) coverage brings these concepts together. Several appropriate indicators are available while others require validation; more work is needed to build these indicators into global measure sets. (4) Channel donor funding to universal actions for improvement. Large-scale improvements such as health education reform or service delivery redesign are costly, and some low-income countries will require external financing to undertake it. More generally, funders should align their support with country strategies that promote the evolution toward a higher-quality health system and avoid funding a multitude of small scale or vertical initiatives, which contributes to policy and programming confusion and reduces resources for large-scale action. (5) Fund research on system-wide improvement strategies. Rigorous evaluation of improvement reforms is needed to gauge the effect of investing in reforms on health. Research can inform future national investment, help develop local capacity, and benefit other countries with similar contexts. Creating platforms for regional learning through networks and meetings can promote dissemination of success and avoid the replication of failed ideas. Researchers (1) Measure quality and evaluate quality improvement. Research is not a luxury: mismeasurement, reliance in assumptions rather than evidence, and the replication of failed ideas costs lives, squanders trust, and wastes resources. Data on health-care quality in LMICs do not reflect the current disease burden; for example, we know little about quality of care for diabetes and cardiovascular diseases and almost nothing about respiratory disease, cancer, mental health, injuries, and surgery. Adolescents and older adults are less visible in the available data than other age groups. Available data give a better picture of episodic, routine care than of longitudinal services or treatment of acute events, such as maternal or newborn complications or medical and surgical emergencies. Filling in these gaps will require better routine data collection and new research. In assessing quality improvement, we found that the evidence base for many popular approaches is surprisingly weak. Rigorous assessments of all improvement strategies, ideally with implementation science methods, will be essential to justify their scale-up. This Commission’s research priorities are shown in panel 16. Conclusion Although health systems will look different in different settings, all people should be able to count on receiving high-quality care that will improve their health and earn their trust. It is time to rethink our past approaches: to ask more from and invest more in this crucial determinant of health.
[k
]Health Policy Research Group, University of Nigeria Enugu Campus, Enugu, Nigeria
[l
]Department of Community Medicine, College of Medicine, University of Ibadan, Nigeria
[m
]Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan,
Ibadan, Nigeria
[n
]Center for Research on Genomics and Global Health, National Human Genome Research
Institute, National Institutes of Health, Bethesda, USA
[o
]National Agency for the Control of AIDS, Abuja, Nigeria
[p
]Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville,
TN, USA
[q
]Infectious Disease and Microbiology, Addenbrookes Hospital, Cambridge University Hospitals
NHS Foundation Trust, Cambridge, UK
[r
]Division of Paediatric Surgery, National Hospital, Abuja, Nigeria
[s
]Department of Economics, Barnard College, Columbia University, New York, NY, USA
[t
]Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA
[u
]Nigeria Centre for Disease Control, Abuja, Nigeria
[v
]Nigeria Health Watch, Abuja, Nigeria
[w
]Hospital for Tropical Diseases, University College London Hospitals NHS Foundation
Trust, London, UK
[x
]National Health Insurance Scheme, Abuja, Nigeria
[y
]Department of Pediatric Infectious Diseases, University of Nebraska Medical Center,
Omaha, Nebraska, USA
[z
]International Foundation Against Infectious Diseases in Nigeria, Abuja, Nigeria
[aa
]Centre of Excellence in Reproductive Health Innovation, University of Benin, Benin
City, Nigeria
[ab
]University of Medical Sciences, Ondo City, Nigeria
[ac
]MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
[ad
]Research Initiative for Cities Health and Equity, School of Public Health and Family
Medicine, University of Cape Town, South Africa
[ae
]Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford,
UK
[af
]Health, Nutrition and Population (HNP) Global Practice and Global Financing Facility
for Women, Children and Adolescents, World Bank, Washington DC, WA, USA
[ag
]Harvard T Chan School of Public Health, Boston, MA, USA
[ah
]Nigeria Institute for Medical Research, Lagos, Nigeria
[ai
]National Primary Health Care Development Agency, Abuja, Nigeria
Author notes
[*
]Correspondence to: Prof Ibrahim Abubakar, UCL Institute for Global Health, London
WC1N 1EH, UK
i.abubakar@
123456ucl.ac.uk
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.